DATE ADDED TO CATALOG	PUBMEDID	FIRST AUTHOR	DATE	JOURNAL	LINK	STUDY	DISEASE/TRAIT	INITIAL SAMPLE SIZE	REPLICATION SAMPLE SIZE	REGION	CHR_ID	CHR_POS	REPORTED GENE(S)	MAPPED_GENE	UPSTREAM_GENE_ID	DOWNSTREAM_GENE_ID	SNP_GENE_IDS	UPSTREAM_GENE_DISTANCE	DOWNSTREAM_GENE_DISTANCE	STRONGEST SNP-RISK ALLELE	SNPS	MERGED	SNP_ID_CURRENT	CONTEXT	INTERGENIC	RISK ALLELE FREQUENCY	P-VALUE	PVALUE_MLOG	P-VALUE (TEXT)	OR or BETA	95% CI (TEXT)	PLATFORM [SNPS PASSING QC]	CNV
2014-07-29	24325915	Purrington KS	2013-12-09	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/24325915	Genome-wide association study identifies 25 known breast cancer susceptibility loci as risk factors for triple-negative breast cancer.	Breast cancer (estrogen-receptor negative, progesterone-receptor negative, and human epidermal growth factor-receptor negative)	1,529 European ancestry cases, 3,399 European ancestry controls	2,148 European ancestry cases, 1,309 European ancestry controls	1q32.1	1	204549714	MDM4	MDM4			4194			rs4245739-C	rs4245739	0	4245739	3_prime_UTR_variant	0		4E-6	5.3979400086720375		1.19	[1.11-1.29]	Illumina [NR] (imputed)	N
2014-07-29	24325915	Purrington KS	2013-12-09	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/24325915	Genome-wide association study identifies 25 known breast cancer susceptibility loci as risk factors for triple-negative breast cancer.	Breast cancer (estrogen-receptor negative, progesterone-receptor negative, and human epidermal growth factor-receptor negative)	1,529 European ancestry cases, 3,399 European ancestry controls	2,148 European ancestry cases, 1,309 European ancestry controls	5p15.33	5	1279675	TERT	TERT			7015			rs10069690-A	rs10069690	0	10069690	intron_variant	0		1E-7	7.0		1.24	[1.14-1.34]	Illumina [NR] (imputed)	N
2014-07-29	24325915	Purrington KS	2013-12-09	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/24325915	Genome-wide association study identifies 25 known breast cancer susceptibility loci as risk factors for triple-negative breast cancer.	Breast cancer (estrogen-receptor negative, progesterone-receptor negative, and human epidermal growth factor-receptor negative)	1,529 European ancestry cases, 3,399 European ancestry controls	2,148 European ancestry cases, 1,309 European ancestry controls	6q25.1	6	151592978	ESR1	CCDC170			80129			rs3757318-A	rs3757318	0	3757318	intron_variant	0		9E-6	5.045757490560675		1.33	[1.17-1.51]	Illumina [NR] (imputed)	N
2014-07-29	24325915	Purrington KS	2013-12-09	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/24325915	Genome-wide association study identifies 25 known breast cancer susceptibility loci as risk factors for triple-negative breast cancer.	Breast cancer (estrogen-receptor negative, progesterone-receptor negative, and human epidermal growth factor-receptor negative)	1,529 European ancestry cases, 3,399 European ancestry controls	2,148 European ancestry cases, 1,309 European ancestry controls	19p13.11	19	17283315	intergenic	ANKLE1			126549			rs2363956-C	rs2363956	0	2363956	missense_variant	0		2E-8	7.698970004336019		1.2195	[1.14-1.3]	Illumina [NR] (imputed)	N
2017-07-17	28429243	Dudenkov TM	2017-04-20	Breast Cancer Res Treat	www.ncbi.nlm.nih.gov/pubmed/28429243	SLCO1B1 polymorphisms and plasma estrone conjugates in postmenopausal women with ER+ breast cancer: genome-wide association studies of the estrone pathway.	Plasma estrone conjugates levels in resected early stage estrogen-receptor positive breast cancer	707 European ancestry postmenopausal cases, 52 African ancestry postmenopausal cases, 15 Asian ancestry postmenopausal cases	NA	12p12.1	12	21178615	SLCO1B1	SLCO1B1			10599			rs4149056-C	rs4149056	0	4149056	missense_variant	0	0.136	4E-11	10.397940008672037		0.5	[0.35-0.65] pg/mL increase	Illumina [8203257] (imputed)	N
2017-07-17	28429243	Dudenkov TM	2017-04-20	Breast Cancer Res Treat	www.ncbi.nlm.nih.gov/pubmed/28429243	SLCO1B1 polymorphisms and plasma estrone conjugates in postmenopausal women with ER+ breast cancer: genome-wide association studies of the estrone pathway.	Plasma estrone conjugates levels in resected early stage estrogen-receptor positive breast cancer	707 European ancestry postmenopausal cases, 52 African ancestry postmenopausal cases, 15 Asian ancestry postmenopausal cases	NA	12p12.1	12	21215863	SLCO1B1	SLCO1B1			10599			rs2900478-A	rs2900478	0	2900478	intron_variant	0	0.14	7E-10	9.154901959985743		0.48	[0.33-0.63] pg/mL increase	Illumina [8203257] (imputed)	N
2017-07-17	28429243	Dudenkov TM	2017-04-20	Breast Cancer Res Treat	www.ncbi.nlm.nih.gov/pubmed/28429243	SLCO1B1 polymorphisms and plasma estrone conjugates in postmenopausal women with ER+ breast cancer: genome-wide association studies of the estrone pathway.	Plasma estrone levels in resected estrogen-receptor positive breast cancer	707 European ancestry postmenopausal cases, 52 African ancestry postmenopausal cases, 15 Asian ancestry postmenopausal cases	NA	14q24.2	14	70423423	ADAM21, LOC105370555, C14orf55	LOC105370555			105370555			rs12586722-A	rs12586722	0	12586722	downstream_gene_variant	0	0.155	1E-6	6.0		0.3	[0.18-0.42] pg/mL increase	Illumina [8203257] (imputed)	N
2017-07-17	28429243	Dudenkov TM	2017-04-20	Breast Cancer Res Treat	www.ncbi.nlm.nih.gov/pubmed/28429243	SLCO1B1 polymorphisms and plasma estrone conjugates in postmenopausal women with ER+ breast cancer: genome-wide association studies of the estrone pathway.	Plasma estrone levels in resected estrogen-receptor positive breast cancer	707 European ancestry postmenopausal cases, 52 African ancestry postmenopausal cases, 15 Asian ancestry postmenopausal cases	NA	14q24.2	14	70452982	PLEKHD1	LOC105370555, ADAM21			105370555, 8747			rs8014252-G	rs8014252	0	8014252	intron_variant	0	0.1556	2E-6	5.698970004336019		0.2981	[0.18-0.42] pg/mL increase	Illumina [8203257] (imputed)	N
2017-07-17	28429243	Dudenkov TM	2017-04-20	Breast Cancer Res Treat	www.ncbi.nlm.nih.gov/pubmed/28429243	SLCO1B1 polymorphisms and plasma estrone conjugates in postmenopausal women with ER+ breast cancer: genome-wide association studies of the estrone pathway.	Plasma androstenedione levels in resected early stage-receptor positive breast cancer	707 European ancestry postmenopausal cases, 52 African ancestry postmenopausal cases, 15 Asian ancestry postmenopausal cases	NA	19p13.12	19	14774988	EMR2, ADGRE2	ADGRE2			30817			rs57712673-A	rs57712673	0	57712673	intron_variant	0	0.349	1E-7	7.0		0.36	[0.23-0.49] pg/mL increase	Illumina [8203257] (imputed)	N
2017-07-17	28429243	Dudenkov TM	2017-04-20	Breast Cancer Res Treat	www.ncbi.nlm.nih.gov/pubmed/28429243	SLCO1B1 polymorphisms and plasma estrone conjugates in postmenopausal women with ER+ breast cancer: genome-wide association studies of the estrone pathway.	Plasma androstenedione levels in resected early stage-receptor positive breast cancer	707 European ancestry postmenopausal cases, 52 African ancestry postmenopausal cases, 15 Asian ancestry postmenopausal cases	NA	7p14.2	7	36899717	ELMO1	ELMO1			9844			rs59964204-A	rs59964204	0	59964204	intron_variant	0	0.096	3E-7	6.522878745280337		0.45	[0.28-0.62] pg/mL decrease	Illumina [8203257] (imputed)	N
2017-07-17	28429243	Dudenkov TM	2017-04-20	Breast Cancer Res Treat	www.ncbi.nlm.nih.gov/pubmed/28429243	SLCO1B1 polymorphisms and plasma estrone conjugates in postmenopausal women with ER+ breast cancer: genome-wide association studies of the estrone pathway.	Plasma androstenedione levels in resected early stage-receptor positive breast cancer	707 European ancestry postmenopausal cases, 52 African ancestry postmenopausal cases, 15 Asian ancestry postmenopausal cases	NA	10q23.2	10	86667452	LDB3	LDB3			11155			rs34346910-C	rs34346910	0	34346910	upstream_gene_variant	0	0.111	6E-7	6.221848749616356		0.49	[0.3-0.68] pg/mL increase	Illumina [8203257] (imputed)	N
2017-07-17	28429243	Dudenkov TM	2017-04-20	Breast Cancer Res Treat	www.ncbi.nlm.nih.gov/pubmed/28429243	SLCO1B1 polymorphisms and plasma estrone conjugates in postmenopausal women with ER+ breast cancer: genome-wide association studies of the estrone pathway.	Plasma androstenedione levels in resected early stage-receptor positive breast cancer	707 European ancestry postmenopausal cases, 52 African ancestry postmenopausal cases, 15 Asian ancestry postmenopausal cases	NA	8q24.3	8	142925688	LOC100288248, CYP11B2	LOC105375794			105375794			rs6988985-C	rs6988985	0	6988985	intergenic_variant	0	0.461	7E-7	6.154901959985743		0.25	[0.15-0.35] pg/mL increase	Illumina [8203257] (imputed)	N
2017-07-17	28429243	Dudenkov TM	2017-04-20	Breast Cancer Res Treat	www.ncbi.nlm.nih.gov/pubmed/28429243	SLCO1B1 polymorphisms and plasma estrone conjugates in postmenopausal women with ER+ breast cancer: genome-wide association studies of the estrone pathway.	Plasma androstenedione levels in resected early stage-receptor positive breast cancer	707 European ancestry postmenopausal cases, 52 African ancestry postmenopausal cases, 15 Asian ancestry postmenopausal cases	NA	10p14	10	8346355	LOC100507143	LINC00708 - LOC105376396	100507143	105376396		78050	36118	rs7075481-G	rs7075481	0	7075481	intergenic_variant	1	0.1279	8E-7	6.096910013008056		0.3776	[0.23-0.53] pg/mL increase	Illumina [8203257] (imputed)	N
2017-03-28	27764800	Cox DG	2016-10-14	Oncotarget	www.ncbi.nlm.nih.gov/pubmed/27764800	GWAS in the SIGNAL/PHARE clinical cohort restricts the association between the FGFR2 locus and estrogen receptor status to HER2-negative breast cancer patients.	Estrogen receptor status in breast cancer	6,211 French ancestry estrogen receptor positive cases, 2,516 French ancestry estrogen receptor negative cases	NA	10q26.13	10	121594355	FGFR2	FGFR2			2263			rs3135718-?	rs3135718	0	3135718	intron_variant	0	NR	6E-12	11.221848749616356		1.33	[1.23 - 1.45]	Illumina [914144] (imputed)	N
2015-12-07	25890600	Guo Q	2015-04-18	J Natl Cancer Inst	www.ncbi.nlm.nih.gov/pubmed/25890600	Identification of novel genetic markers of breast cancer survival.	Breast cancer (survival)	23,059 European ancestry estrogen-receptor positive cases, 6,881 European ancestry estrogen-receptor negative cases, 8,014 European ancestry cases		11q24.2	11	125389528	HEPACAM, HEPN1, CCDC15, SLC37A2, TMEM218, FEZ1, MGC39545, STT3A, CHEK1, ACRV1, PATE1, PATE2, PATE3, PATE4, HYLS1, PKNOX2, ROBO4	PKNOX2			63876			rs2059614-?	rs2059614	0	2059614	intron_variant	0	0.06	1E-9	9.0	(ER -ve)	1.9	[1.54-2.33]	Affymetrix, Illumina [9000000] (imputed)	N
2015-12-07	25890600	Guo Q	2015-04-18	J Natl Cancer Inst	www.ncbi.nlm.nih.gov/pubmed/25890600	Identification of novel genetic markers of breast cancer survival.	Breast cancer (survival)	23,059 European ancestry estrogen-receptor positive cases, 6,881 European ancestry estrogen-receptor negative cases, 8,014 European ancestry cases		14q24.1	14	67599772	NR	GPHN, PIGH			10243, 5283			rs7149859-?	rs7149859	0	7149859	intron_variant	0		7E-7	6.154901959985743	(ER +ve)	1.22	[1.13-1.33]	Affymetrix, Illumina [9000000] (imputed)	N
2017-03-31	27117709	Couch FJ	2016-04-27	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27117709	Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.	Breast cancer (estrogen-receptor negative)	4,939 European ancestry cases, 14,352 European ancestry controls	7,333 European ancestry cases, 42,468 European ancestry controls	1p36.22	1	10503552	PEX14	PEX14			5195			rs10864459-?	rs10864459	0	10864459	intron_variant	0	0.6799999999999999	2E-9	8.698970004336019		1.1111112	[1.08-1.15]	Illumina [10909381] (imputed)	N
2017-03-31	27117709	Couch FJ	2016-04-27	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27117709	Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.	Breast cancer (estrogen-receptor negative)	4,939 European ancestry cases, 14,352 European ancestry controls	7,333 European ancestry cases, 42,468 European ancestry controls	1q32.1	1	202209914	LGR6	LGR6			59352			rs17489300-?	rs17489300	0	17489300	intron_variant	0	0.6	9E-10	9.045757490560675		1.1111112	[1.08-1.15]	Illumina [10909381] (imputed)	N
2017-03-31	27117709	Couch FJ	2016-04-27	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27117709	Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.	Breast cancer (estrogen-receptor negative)	4,939 European ancestry cases, 14,352 European ancestry controls	7,333 European ancestry cases, 42,468 European ancestry controls	1q32.1	1	204549714	MDM4	MDM4			4194			rs4245739-?	rs4245739	0	4245739	3_prime_UTR_variant	0	0.26	6E-15	14.221848749616356		1.13	[1.11-1.19]	Illumina [10909381] (imputed)	N
2017-03-31	27117709	Couch FJ	2016-04-27	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27117709	Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.	Breast cancer (estrogen-receptor negative)	4,939 European ancestry cases, 14,352 European ancestry controls	7,333 European ancestry cases, 42,468 European ancestry controls	2p24.1	2	19121042	Intergenic	LOC105373455 - MIR4757	105373455	100616307		54972	227387	rs12710696-?	rs12710696	0	12710696	intron_variant	1	0.36	2E-8	7.698970004336019		1.1	[1.06-1.13]	Illumina [10909381] (imputed)	N
2017-03-31	27117709	Couch FJ	2016-04-27	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27117709	Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.	Breast cancer (estrogen-receptor negative)	4,939 European ancestry cases, 14,352 European ancestry controls	7,333 European ancestry cases, 42,468 European ancestry controls	2q14.2	2	120330606	INHBB	LOC105373584 - LOC105373989	105373584	105373989		11282	11844	rs11903787-?	rs11903787	0	11903787	downstream_gene_variant	1	0.75	9E-7	6.045757490560675		1.1111112	[1.06-1.16]	Illumina [10909381] (imputed)	N
2017-03-31	27117709	Couch FJ	2016-04-27	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27117709	Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.	Breast cancer (estrogen-receptor negative)	4,939 European ancestry cases, 14,352 European ancestry controls	7,333 European ancestry cases, 42,468 European ancestry controls	5p15.33	5	1279913	TERT	TERT			7015			rs2242652-?	rs2242652	0	2242652	intron_variant	0	0.2	3E-14	13.522878745280337		1.18	[1.13-1.23]	Illumina [10909381] (imputed)	N
2017-03-31	27117709	Couch FJ	2016-04-27	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27117709	Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.	Breast cancer (estrogen-receptor negative)	4,939 European ancestry cases, 14,352 European ancestry controls	7,333 European ancestry cases, 42,468 European ancestry controls	5p15.33	5	1282204	TERT	TERT			7015			rs7726159-?	rs7726159	0	7726159	intron_variant	0	0.34	2E-6	5.698970004336019		1.09	[1.05-1.13]	Illumina [10909381] (imputed)	N
2017-03-31	27117709	Couch FJ	2016-04-27	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27117709	Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.	Breast cancer (estrogen-receptor negative)	4,939 European ancestry cases, 14,352 European ancestry controls	7,333 European ancestry cases, 42,468 European ancestry controls	5p15.33	5	1297373	TERT	TERT - MIR4457	7015	100616235		1747	11937	rs2736108-?	rs2736108	0	2736108	upstream_gene_variant	1	0.71	1E-8	8.0		1.1235955	[1.08-1.16]	Illumina [10909381] (imputed)	N
2017-03-31	27117709	Couch FJ	2016-04-27	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27117709	Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.	Breast cancer (estrogen-receptor negative)	4,939 European ancestry cases, 14,352 European ancestry controls	7,333 European ancestry cases, 42,468 European ancestry controls	6q25.1	6	151597721	ESR1	CCDC170			80129			rs12662670-?	rs12662670	0	12662670	intron_variant	0	0.08	9E-15	14.045757490560675		1.2	[1.18-1.32]	Illumina [10909381] (imputed)	N
2017-03-31	27117709	Couch FJ	2016-04-27	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27117709	Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.	Breast cancer (estrogen-receptor negative)	4,939 European ancestry cases, 14,352 European ancestry controls	7,333 European ancestry cases, 42,468 European ancestry controls	6q25.1	6	151625017	ESR1	CCDC170 - ESR1	80129	2099		3824	29131	rs11155804-?	rs11155804	0	11155804	downstream_gene_variant	1	0.34	8E-18	17.096910013008056		1.16	[1.12-1.19]	Illumina [10909381] (imputed)	N
2017-03-31	27117709	Couch FJ	2016-04-27	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27117709	Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.	Breast cancer (estrogen-receptor negative)	4,939 European ancestry cases, 14,352 European ancestry controls	7,333 European ancestry cases, 42,468 European ancestry controls	10q21.2	10	62518923	ZNF365	ZNF365			22891			rs10995190-?	rs10995190	0	10995190	intron_variant	0	0.84	4E-8	7.3979400086720375		1.1235955	[1.08-1.18]	Illumina [10909381] (imputed)	N
2017-03-31	27117709	Couch FJ	2016-04-27	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27117709	Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.	Breast cancer (estrogen-receptor negative)	4,939 European ancestry cases, 14,352 European ancestry controls	7,333 European ancestry cases, 42,468 European ancestry controls	11p15.5	11	1880867	LSP1	LSP1			4046			rs4980383-?	rs4980383	0	4980383	non_coding_transcript_exon_variant	0	0.44	3E-6	5.522878745280337		1.08	[1.05-1.12]	Illumina [10909381] (imputed)	N
2017-03-31	27117709	Couch FJ	2016-04-27	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27117709	Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.	Breast cancer (estrogen-receptor negative)	4,939 European ancestry cases, 14,352 European ancestry controls	7,333 European ancestry cases, 42,468 European ancestry controls	12p11.22	12	28021884	PTHLH	PTHLH - LOC105369710	5744	105369710		47697	39757	rs7297051-?	rs7297051	0	7297051	regulatory_region_variant	1	0.76	1E-14	14.0		1.1627907	[1.12-1.2]	Illumina [10909381] (imputed)	N
2017-03-31	27117709	Couch FJ	2016-04-27	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27117709	Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.	Breast cancer (estrogen-receptor negative)	4,939 European ancestry cases, 14,352 European ancestry controls	7,333 European ancestry cases, 42,468 European ancestry controls	12p11.22	12	28002147	PTHLH	PTHLH - LOC105369710	5744	105369710		27960	59494	rs10771399-?	rs10771399	0	10771399	intergenic_variant	1	0.88	4E-13	12.397940008672037		1.2658228	[1.15-1.28]	Illumina [10909381] (imputed)	N
2017-03-31	27117709	Couch FJ	2016-04-27	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27117709	Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.	Breast cancer (estrogen-receptor negative)	4,939 European ancestry cases, 14,352 European ancestry controls	7,333 European ancestry cases, 42,468 European ancestry controls	16q12.1	16	52565276	TOX3	CASC16			643714			rs4784227-?	rs4784227	0	4784227	intron_variant	0	0.24	1E-14	14.0		1.15	[1.11-1.19]	Illumina [10909381] (imputed)	N
2017-03-31	27117709	Couch FJ	2016-04-27	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27117709	Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.	Breast cancer (estrogen-receptor negative)	4,939 European ancestry cases, 14,352 European ancestry controls	7,333 European ancestry cases, 42,468 European ancestry controls	16q12.2	16	53779455	FTO	FTO			79068			rs17817449-?	rs17817449	0	17817449	intron_variant	0	0.5900000000000001	3E-7	6.522878745280337		1.098901	[1.05-1.12]	Illumina [10909381] (imputed)	N
2017-03-31	27117709	Couch FJ	2016-04-27	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27117709	Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.	Breast cancer (estrogen-receptor negative)	4,939 European ancestry cases, 14,352 European ancestry controls	7,333 European ancestry cases, 42,468 European ancestry controls	16q12.2	16	53821379	FTO	FTO			79068			rs11075995-?	rs11075995	0	11075995	intron_variant	0	0.24	3E-8	7.522878745280337		1.11	[1.07-1.15]	Illumina [10909381] (imputed)	N
2017-03-31	27117709	Couch FJ	2016-04-27	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27117709	Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.	Breast cancer (estrogen-receptor negative)	4,939 European ancestry cases, 14,352 European ancestry controls	7,333 European ancestry cases, 42,468 European ancestry controls	19p13.11	19	17283116	ADHB8	ANKLE1			126549			rs56069439-?	rs56069439	0	56069439	non_coding_transcript_exon_variant	0	0.3	8E-19	18.096910013008056		1.16	[1.13-1.20]	Illumina [10909381] (imputed)	N
2017-03-31	27117709	Couch FJ	2016-04-27	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27117709	Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.	Breast cancer (estrogen-receptor negative)	4,939 European ancestry cases, 14,352 European ancestry controls	7,333 European ancestry cases, 42,468 European ancestry controls	19p13.11	19	17278895	MERIT40	BABAM1			29086			rs8170-?	rs8170	0	8170	synonymous_variant	0	0.19	1E-12	12.0		1.15	[1.11-1.20]	Illumina [10909381] (imputed)	N
2017-03-31	27117709	Couch FJ	2016-04-27	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27117709	Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.	Breast cancer (estrogen-receptor negative)	4,939 European ancestry cases, 14,352 European ancestry controls	7,333 European ancestry cases, 42,468 European ancestry controls	2p23.2	2	28896719	WDR43	WDR43			23160			rs67073037-?	rs67073037	0	67073037	intron_variant	0	0.76	3E-6	5.522878745280337		1.0869565	[1.05-1.14]	Illumina [10909381] (imputed)	N
2017-03-31	27117709	Couch FJ	2016-04-27	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27117709	Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.	Breast cancer (estrogen-receptor negative)	4,939 European ancestry cases, 14,352 European ancestry controls	7,333 European ancestry cases, 42,468 European ancestry controls	2q33.1	2	200878871	PPIL3, CLK1, FAM126B, NDUFB3	PPIL3			53938			rs115635831-?	rs115635831	0	115635831	intron_variant	0	0.015	1E-6	6.0		1.36	[1.20-1.54]	Illumina [10909381] (imputed)	N
2017-03-31	27117709	Couch FJ	2016-04-27	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27117709	Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.	Breast cancer (estrogen-receptor negative)	4,939 European ancestry cases, 14,352 European ancestry controls	7,333 European ancestry cases, 42,468 European ancestry controls	13q22.1	13	73232845	KLF5, KLF12	RNY1P8 - MARK2P12	100873807	100421565		5585	174944	rs12870942-?	rs12870942	0	12870942	intergenic_variant	1	0.32	3E-7	6.522878745280337		1.09	[1.05-1.13]	Illumina [10909381] (imputed)	N
2017-03-31	27117709	Couch FJ	2016-04-27	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27117709	Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.	Breast cancer (estrogen-receptor negative)	4,939 European ancestry cases, 14,352 European ancestry controls	7,333 European ancestry cases, 42,468 European ancestry controls	9p21.3	9	22062135	NR	CDKN2B-AS1			100048912			rs1011970-?	rs1011970	0	1011970	intron_variant	0	0.17	2E-6	5.698970004336019		1.11	[1.06-1.15]	Illumina [10909381] (imputed)	N
2017-03-31	27117709	Couch FJ	2016-04-27	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27117709	Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.	Breast cancer (estrogen-receptor negative)	4,939 European ancestry cases, 14,352 European ancestry controls	7,333 European ancestry cases, 42,468 European ancestry controls	12q22	12	95633983	NR	USP44 - PGAM1P5	84101	100132594		82454	15272	rs17356907-?	rs17356907	0	17356907	intron_variant	1	0.7	3E-6	5.522878745280337		1.098901	[1.69-1.14]	Illumina [10909381] (imputed)	N
2017-03-31	27117709	Couch FJ	2016-04-27	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27117709	Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.	Breast cancer (estrogen-receptor negative)	4,939 European ancestry cases, 14,352 European ancestry controls	7,333 European ancestry cases, 42,468 European ancestry controls	13q13.1	13	32398489	NR	BRCA2			675			rs11571833-?	rs11571833	0	11571833	stop_gained	0	0.01	6E-6	5.221848749616356		1.32	[1.20-1.43]	Illumina [10909381] (imputed)	N
2017-03-20	28171663	Huo D	2016-09-04	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/28171663	Genome-wide Association Studies in Women of African Ancestry Identified 3q26.21 as a Novel Susceptibility Locus for Estrogen Receptor Negative Breast Cancer.	Breast cancer (estrogen-receptor negative)	1349 African American cases, 42 African ancestry cases, 4,150 African American controls, 624 African ancestry controls	573 African American cases, 2,939 African American controls	3q26.31	3	172550013	TNFSF10	TNFSF10 - LOC105374219	8743	105374219		26506	42844	rs13074711-T	rs13074711	0	13074711	intergenic_variant	1	0.69	2E-8	7.698970004336019		1.29	[1.18-1.40]	Illumina [16147413] (imputed)	N
2017-03-20	28171663	Huo D	2016-09-04	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/28171663	Genome-wide Association Studies in Women of African Ancestry Identified 3q26.21 as a Novel Susceptibility Locus for Estrogen Receptor Negative Breast Cancer.	Breast cancer (estrogen-receptor negative)	1349 African American cases, 42 African ancestry cases, 4,150 African American controls, 624 African ancestry controls	573 African American cases, 2,939 African American controls	5p15.33	5	1279675	TERT	TERT			7015			rs10069690-T	rs10069690	0	10069690	intron_variant	0	0.6	2E-10	9.698970004336019		1.3	[1.20-1.41]	Illumina [16147413] (imputed)	N
2017-03-20	28171663	Huo D	2016-09-04	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/28171663	Genome-wide Association Studies in Women of African Ancestry Identified 3q26.21 as a Novel Susceptibility Locus for Estrogen Receptor Negative Breast Cancer.	Breast cancer (estrogen-receptor positive)	1795 African American cases, 99 African ancestry cases, 4,150 African American controls, 624 African ancestry controls	1093 African American cases, 2939 African American controls	2q35	2	217029040	intergenic	LOC101928278			101928278			rs12998806-G	rs12998806	0	12998806	intergenic_variant	0	0.86	2E-8	7.698970004336019		1.34	[1.21-1.48]	Illumina [16147413] (imputed)	N
2014-07-29	24325915	Purrington KS	2013-12-09	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/24325915	Genome-wide association study identifies 25 known breast cancer susceptibility loci as risk factors for triple-negative breast cancer.	Breast cancer (estrogen-receptor negative, progesterone-receptor negative, and human epidermal growth factor-receptor negative)	1,529 European ancestry cases, 3,399 European ancestry controls	2,148 European ancestry cases, 1,309 European ancestry controls	12p11.22	12	28002147	PTHLH	PTHLH - LOC105369710	5744	105369710		27960	59494	rs10771399-G	rs10771399	0	10771399	intergenic_variant	1		2E-8	7.698970004336019		1.3889	[1.25-1.56]	Illumina [NR] (imputed)	N
2017-03-28	27764800	Cox DG	2016-10-14	Oncotarget	www.ncbi.nlm.nih.gov/pubmed/27764800	GWAS in the SIGNAL/PHARE clinical cohort restricts the association between the FGFR2 locus and estrogen receptor status to HER2-negative breast cancer patients.	Estrogen receptor status in HER2 negative breast cancer	4,267 French ancestry estrogen receptor positive cases,  1,185 French ancestry estrogen receptor negative cases	NA	10q26.13	10	121592706	FGFR2	FGFR2			2263			rs3135724-?	rs3135724	0	3135724	intron_variant	0	NR	5E-11	10.301029995663981		1.79	[1.49 - 2.13] 	Illumina [914144] (imputed)	N
2017-07-18	28240269	Suhre K	2017-02-27	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28240269	Connecting genetic risk to disease end points through the human blood plasma proteome.	Blood protein levels	997 European ancestry individuals	338 Arab, South Asian and Filipino ancestry individuals	17q11.2	17	28283487	KRT18P55	KRT18P55			284085			rs9901901-C	rs9901901	0	9901901	intron_variant	0	0.4773869	1E-13	13.0	(EA, Breast cancer anti-estrogen resistance protein 3)	0.3202	[0.24-0.4] unit increase	Affymetrix [509946]	N
2017-07-17	28429243	Dudenkov TM	2017-04-20	Breast Cancer Res Treat	www.ncbi.nlm.nih.gov/pubmed/28429243	SLCO1B1 polymorphisms and plasma estrone conjugates in postmenopausal women with ER+ breast cancer: genome-wide association studies of the estrone pathway.	Estrone conjugates/estrone ratio in resected early stage estrogen-receptor positive breast cancer	707 European ancestry postmenopausal cases, 52 African ancestry postmenopausal cases, 15 Asian ancestry postmenopausal cases	NA	12p12.1	12	21168436	SLCO1B1	SLCO1B1			10599			rs10841753-C	rs10841753	0	10841753	intron_variant	0	0.208	3E-12	11.522878745280337		0.43	[0.31-0.55] unit decrease	Illumina [8203257] (imputed)	N
2017-07-17	28429243	Dudenkov TM	2017-04-20	Breast Cancer Res Treat	www.ncbi.nlm.nih.gov/pubmed/28429243	SLCO1B1 polymorphisms and plasma estrone conjugates in postmenopausal women with ER+ breast cancer: genome-wide association studies of the estrone pathway.	Estrone/androstenedione ratio in resected early stage-receptor positive breast cancer	707 European ancestry postmenopausal cases, 52 African ancestry postmenopausal cases, 15 Asian ancestry postmenopausal cases	NA	7q21.13	7	90874752	CDK14	CDK14			5218			rs10953024-C	rs10953024	0	10953024	intron_variant	0	0.088	1E-6	6.0		0.49	[0.29-0.69] unit decrease	Illumina [8203257] (imputed)	N
2017-07-17	28429243	Dudenkov TM	2017-04-20	Breast Cancer Res Treat	www.ncbi.nlm.nih.gov/pubmed/28429243	SLCO1B1 polymorphisms and plasma estrone conjugates in postmenopausal women with ER+ breast cancer: genome-wide association studies of the estrone pathway.	Estrone/androstenedione ratio in resected early stage-receptor positive breast cancer	707 European ancestry postmenopausal cases, 52 African ancestry postmenopausal cases, 15 Asian ancestry postmenopausal cases	NA	2q37.2	2	236277682	ASB18	ASB18 - IQCA1	401036	79781		13337	46465	rs1453308-A	rs1453308	0	1453308	intron_variant	1	0.198	2E-6	5.698970004336019		0.33	[0.19-0.47] unit decrease	Illumina [8203257] (imputed)	N
2017-07-17	28429243	Dudenkov TM	2017-04-20	Breast Cancer Res Treat	www.ncbi.nlm.nih.gov/pubmed/28429243	SLCO1B1 polymorphisms and plasma estrone conjugates in postmenopausal women with ER+ breast cancer: genome-wide association studies of the estrone pathway.	Estrone/androstenedione ratio in resected early stage-receptor positive breast cancer	707 European ancestry postmenopausal cases, 52 African ancestry postmenopausal cases, 15 Asian ancestry postmenopausal cases	NA	18p11.23	18	7807950	PTPRM	PTPRM			5797			rs16952550-C	rs16952550	0	16952550	intron_variant	0	0.171	2E-6	5.698970004336019		0.33	[0.19-0.47] unit decrease	Illumina [8203257] (imputed)	N
2017-07-17	28429243	Dudenkov TM	2017-04-20	Breast Cancer Res Treat	www.ncbi.nlm.nih.gov/pubmed/28429243	SLCO1B1 polymorphisms and plasma estrone conjugates in postmenopausal women with ER+ breast cancer: genome-wide association studies of the estrone pathway.	Estrone/androstenedione ratio in resected early stage-receptor positive breast cancer	707 European ancestry postmenopausal cases, 52 African ancestry postmenopausal cases, 15 Asian ancestry postmenopausal cases	NA	15q21.2	15	51261712	CYP19A1	CYP19A1			1588			rs17601876-A	rs17601876	0	17601876	intron_variant	0	0.5	4E-6	5.3979400086720375		0.24	[0.14-0.34] unit increase	Illumina [8203257] (imputed)	N
2017-07-17	28429243	Dudenkov TM	2017-04-20	Breast Cancer Res Treat	www.ncbi.nlm.nih.gov/pubmed/28429243	SLCO1B1 polymorphisms and plasma estrone conjugates in postmenopausal women with ER+ breast cancer: genome-wide association studies of the estrone pathway.	Estrone/androstenedione ratio in resected early stage-receptor positive breast cancer	707 European ancestry postmenopausal cases, 52 African ancestry postmenopausal cases, 15 Asian ancestry postmenopausal cases	NA	2q37.2	2	236278055	ASB18	ASB18 - IQCA1	401036	79781		13710	46092	rs1453307-G	rs1453307	0	1453307	intron_variant	1	0.1638	3E-6	5.522878745280337		0.3463	[0.2-0.49] unit increase	Illumina [8203257] (imputed)	N
2017-07-17	28429243	Dudenkov TM	2017-04-20	Breast Cancer Res Treat	www.ncbi.nlm.nih.gov/pubmed/28429243	SLCO1B1 polymorphisms and plasma estrone conjugates in postmenopausal women with ER+ breast cancer: genome-wide association studies of the estrone pathway.	Estrone/androstenedione ratio in resected early stage-receptor positive breast cancer	707 European ancestry postmenopausal cases, 52 African ancestry postmenopausal cases, 15 Asian ancestry postmenopausal cases	NA	17q22	17	58163947	OR4D2	MSX2P1 - OR4D2	55545	124538		4827	5709	rs16942732-T	rs16942732	0	16942732	upstream_gene_variant	1	0.2054	8E-6	5.096910013008056		0.2847	[0.16-0.41] unit decrease	Illumina [8203257] (imputed)	N
2017-07-17	28429243	Dudenkov TM	2017-04-20	Breast Cancer Res Treat	www.ncbi.nlm.nih.gov/pubmed/28429243	SLCO1B1 polymorphisms and plasma estrone conjugates in postmenopausal women with ER+ breast cancer: genome-wide association studies of the estrone pathway.	Estrone/androstenedione ratio in resected early stage-receptor positive breast cancer	707 European ancestry postmenopausal cases, 52 African ancestry postmenopausal cases, 15 Asian ancestry postmenopausal cases	NA	11q24.2	11	126175935	RPUSD4	LOC105369591 - RPUSD4	105369591	84881		35297	26159	rs7105310-G	rs7105310	0	7105310	non_coding_transcript_exon_variant	1	0.1072	7E-6	5.154901959985743		0.3841	[0.22-0.55] unit increase	Illumina [8203257] (imputed)	N
2017-07-17	28429243	Dudenkov TM	2017-04-20	Breast Cancer Res Treat	www.ncbi.nlm.nih.gov/pubmed/28429243	SLCO1B1 polymorphisms and plasma estrone conjugates in postmenopausal women with ER+ breast cancer: genome-wide association studies of the estrone pathway.	Estrone/androstenedione ratio in resected early stage-receptor positive breast cancer	707 European ancestry postmenopausal cases, 52 African ancestry postmenopausal cases, 15 Asian ancestry postmenopausal cases	NA				LOC100506029							chr1:101579551-A	chr1:101579551	0			1	0.1747	6E-6	5.221848749616356		0.322	[0.18-0.46] unit decrease	Illumina [8203257] (imputed)	N
2017-07-17	28429243	Dudenkov TM	2017-04-20	Breast Cancer Res Treat	www.ncbi.nlm.nih.gov/pubmed/28429243	SLCO1B1 polymorphisms and plasma estrone conjugates in postmenopausal women with ER+ breast cancer: genome-wide association studies of the estrone pathway.	Estrone/androstenedione ratio in resected early stage-receptor positive breast cancer	707 European ancestry postmenopausal cases, 52 African ancestry postmenopausal cases, 15 Asian ancestry postmenopausal cases	NA	1q42.13	1	230289344	GALNT2	GALNT2 - PGBD5	2590	79605		7214	32302	rs16851421-G	rs16851421	0	16851421	intergenic_variant	1	0.3271	8E-6	5.096910013008056		0.2489	[0.14-0.36] unit decrease	Illumina [8203257] (imputed)	N
2017-07-17	28429243	Dudenkov TM	2017-04-20	Breast Cancer Res Treat	www.ncbi.nlm.nih.gov/pubmed/28429243	SLCO1B1 polymorphisms and plasma estrone conjugates in postmenopausal women with ER+ breast cancer: genome-wide association studies of the estrone pathway.	Estrone/androstenedione ratio in resected early stage-receptor positive breast cancer	707 European ancestry postmenopausal cases, 52 African ancestry postmenopausal cases, 15 Asian ancestry postmenopausal cases	NA	5q23.1	5	117038818	RPL35AP15	LOC107986375 - LOC105379138	107986375	105379138		19139	233113	rs113883744-T	rs113883744	0	113883744	downstream_gene_variant	1	0.2103	8E-6	5.096910013008056		0.2971	[0.17-0.43] unit increase	Illumina [8203257] (imputed)	N
2017-07-17	28429243	Dudenkov TM	2017-04-20	Breast Cancer Res Treat	www.ncbi.nlm.nih.gov/pubmed/28429243	SLCO1B1 polymorphisms and plasma estrone conjugates in postmenopausal women with ER+ breast cancer: genome-wide association studies of the estrone pathway.	Estrone/androstenedione ratio in resected early stage-receptor positive breast cancer	707 European ancestry postmenopausal cases, 52 African ancestry postmenopausal cases, 15 Asian ancestry postmenopausal cases	NA	17q22	17	58165213	LOC100419764	MSX2P1 - OR4D2	55545	124538		6093	4443	rs1468574-A	rs1468574	0	1468574	upstream_gene_variant	1	0.2052	8E-6	5.096910013008056		0.2847	[0.16-0.41] unit decrease	Illumina [8203257] (imputed)	N
2017-07-17	28429243	Dudenkov TM	2017-04-20	Breast Cancer Res Treat	www.ncbi.nlm.nih.gov/pubmed/28429243	SLCO1B1 polymorphisms and plasma estrone conjugates in postmenopausal women with ER+ breast cancer: genome-wide association studies of the estrone pathway.	Estrone/androstenedione ratio in resected early stage-receptor positive breast cancer	707 European ancestry postmenopausal cases, 52 African ancestry postmenopausal cases, 15 Asian ancestry postmenopausal cases	NA	7p14.3	7	34103644	BMPER	BMPER			168667			rs1420338-G	rs1420338	0	1420338	intron_variant	0	0.3988	7E-6	5.154901959985743		0.2432	[0.14-0.35] unit decrease	Illumina [8203257] (imputed)	N
2017-07-17	28429243	Dudenkov TM	2017-04-20	Breast Cancer Res Treat	www.ncbi.nlm.nih.gov/pubmed/28429243	SLCO1B1 polymorphisms and plasma estrone conjugates in postmenopausal women with ER+ breast cancer: genome-wide association studies of the estrone pathway.	Estrone/androstenedione ratio in resected early stage-receptor positive breast cancer	707 European ancestry postmenopausal cases, 52 African ancestry postmenopausal cases, 15 Asian ancestry postmenopausal cases	NA	9p24.1	9	8211949	PTPRD	LOC105375971 - PTPRD	105375971	5789		250722	102297	rs1416584-G	rs1416584	0	1416584	intergenic_variant	1	0.0787	6E-6	5.221848749616356		0.4453	[0.25-0.64] unit decrease	Illumina [8203257] (imputed)	N
2017-07-17	28429243	Dudenkov TM	2017-04-20	Breast Cancer Res Treat	www.ncbi.nlm.nih.gov/pubmed/28429243	SLCO1B1 polymorphisms and plasma estrone conjugates in postmenopausal women with ER+ breast cancer: genome-wide association studies of the estrone pathway.	Estrone/androstenedione ratio in resected early stage-receptor positive breast cancer	707 European ancestry postmenopausal cases, 52 African ancestry postmenopausal cases, 15 Asian ancestry postmenopausal cases	NA	10p12.2	10	23061174	ARMC3	LOC107984215			107984215			rs3858207-C	rs3858207	0	3858207	intergenic_variant	0	0.4898	5E-6	5.301029995663981		0.2398	[0.14-0.34] unit decrease	Illumina [8203257] (imputed)	N
2012-04-28	22452962	Kim HC	2012-03-27	Breast Cancer Res	www.ncbi.nlm.nih.gov/pubmed/22452962	A genome-wide association study identifies a breast cancer risk variant in ERBB4 at 2q34: results from the Seoul Breast Cancer Study.	Breast cancer	2,273 Korean ancestry cases, 2,052 Korean ancestry controls	4,049 Korean ancestry cases, 3,845 Korean ancestry controls	2q34	2	212432139	ERBB4	ERBB4			2066			rs13393577-T	rs13393577	0	13393577	intron_variant	0	0.051	9E-14	13.045757490560675		1.53	[1.37-1.70]	Affymetrix [555525]	N
2014-03-26	24025145	Chung S	2013-09-11	Breast Cancer Res	www.ncbi.nlm.nih.gov/pubmed/24025145	A genome-wide association study of chemotherapy-induced alopecia in breast cancer patients.	Adverse response to chemotherapy in breast cancer (alopecia)	303 Japanese ancestry cases, 880 Japanese ancestry controls	23 Japanese ancestry cases	2q23.3	2	152100897	CACNB4	CACNB4 - STAM2	785	10254		909	15904	rs3820706-G	rs3820706	0	3820706	intron_variant	1	0.57	2E-9	8.698970004336019	(Recessive)	2.38	[1.44-3.93]	Illumina [555600]	N
2014-03-26	24025145	Chung S	2013-09-11	Breast Cancer Res	www.ncbi.nlm.nih.gov/pubmed/24025145	A genome-wide association study of chemotherapy-induced alopecia in breast cancer patients.	Adverse response to chemotherapy in breast cancer (alopecia)	303 Japanese ancestry cases, 880 Japanese ancestry controls	23 Japanese ancestry cases	2q23.3	2	152124821	STAM2	STAM2			10254			rs16830728-T	rs16830728	0	16830728	intron_variant	0	0.59	3E-8	7.522878745280337	(Recessive)	3.61	[2.17-5.98]	Illumina [555600]	N
2014-03-26	24025145	Chung S	2013-09-11	Breast Cancer Res	www.ncbi.nlm.nih.gov/pubmed/24025145	A genome-wide association study of chemotherapy-induced alopecia in breast cancer patients.	Adverse response to chemotherapy in breast cancer (alopecia)	303 Japanese ancestry cases, 880 Japanese ancestry controls	23 Japanese ancestry cases	10q21.1	10	54444531	PCDH15	PCDH15			65217			rs7476422-G	rs7476422	0	7476422	intron_variant	0	0.82	3E-7	6.522878745280337	(Allelic)	2.06	[1.54-2.75]	Illumina [555600]	N
2014-03-26	24025145	Chung S	2013-09-11	Breast Cancer Res	www.ncbi.nlm.nih.gov/pubmed/24025145	A genome-wide association study of chemotherapy-induced alopecia in breast cancer patients.	Adverse response to chemotherapy in breast cancer (alopecia) (paclitaxel)	57 Japanese ancestry cases, 63 Japanese ancestry controls	NA	12q24.32	12	128297477	TMEM132C	TMEM132C			92293			rs11059635-G	rs11059635	0	11059635	intron_variant	0	0.67	2E-7	6.698970004336019	(Dominant)	6.63	[2.95-14.9]	Illumina [555600]	N
2014-03-26	24025145	Chung S	2013-09-11	Breast Cancer Res	www.ncbi.nlm.nih.gov/pubmed/24025145	A genome-wide association study of chemotherapy-induced alopecia in breast cancer patients.	Adverse response to chemotherapy in breast cancer (alopecia) (paclitaxel)	57 Japanese ancestry cases, 63 Japanese ancestry controls	NA	16q23.3	16	82612728	CDH13	LOC101928392 - CDH13	101928392	1012		37267	14066	rs3844412-A	rs3844412	0	3844412	intergenic_variant	1	0.11	4E-7	6.3979400086720375	(Dominant)	5.22	[2.67-10.2]	Illumina [555600]	N
2014-03-26	24025145	Chung S	2013-09-11	Breast Cancer Res	www.ncbi.nlm.nih.gov/pubmed/24025145	A genome-wide association study of chemotherapy-induced alopecia in breast cancer patients.	Adverse response to chemotherapy in breast cancer (alopecia) (paclitaxel)	57 Japanese ancestry cases, 63 Japanese ancestry controls	NA	5p15.2	5	14071948	TRIO	DNAH5 - TRIO	1767	7204		60119	71402	rs163818-C	rs163818	0	163818	intergenic_variant	1	0.02	6E-7	6.221848749616356	(Dominant)	11.5	[3.37-39.3]	Illumina [555600]	N
2014-03-26	24025145	Chung S	2013-09-11	Breast Cancer Res	www.ncbi.nlm.nih.gov/pubmed/24025145	A genome-wide association study of chemotherapy-induced alopecia in breast cancer patients.	Adverse response to chemotherapy in breast cancer (alopecia) (paclitaxel)	57 Japanese ancestry cases, 63 Japanese ancestry controls	NA	2p21	2	44478476	C2orf34	CAMKMT			79823			rs698813-C	rs698813	0	698813	intron_variant	0	0.52	1E-6	6.0	(Allelic)	4.27	[2.35-7.76]	Illumina [555600]	N
2014-03-26	24025145	Chung S	2013-09-11	Breast Cancer Res	www.ncbi.nlm.nih.gov/pubmed/24025145	A genome-wide association study of chemotherapy-induced alopecia in breast cancer patients.	Adverse response to chemotherapy in breast cancer (alopecia) (paclitaxel)	57 Japanese ancestry cases, 63 Japanese ancestry controls	NA	21q22.3	21	41672041	NCRNA00111	LOC105372813			105372813			rs2838088-A	rs2838088	0	2838088	intergenic_variant	0	0.12	1E-6	6.0	(Dominant)	4.48	[2.32-8.66]	Illumina [555600]	N
2014-03-26	24025145	Chung S	2013-09-11	Breast Cancer Res	www.ncbi.nlm.nih.gov/pubmed/24025145	A genome-wide association study of chemotherapy-induced alopecia in breast cancer patients.	Adverse response to chemotherapy in breast cancer (alopecia) (docetaxel)	62 Japanese ancestry cases, 42 Japanese ancestry controls	NA	15q25.3	15	85919621	KLHL25	LOC105370953 - AGBL1	105370953	123624		18577	160014	rs4262906-C	rs4262906	0	4262906	intergenic_variant	1	0.31	7E-7	6.154901959985743	(Allelic)	4.36	[2.41-7.89]	Illumina [555600]	N
2014-03-26	24025145	Chung S	2013-09-11	Breast Cancer Res	www.ncbi.nlm.nih.gov/pubmed/24025145	A genome-wide association study of chemotherapy-induced alopecia in breast cancer patients.	Adverse response to chemotherapy in breast cancer (alopecia) (docetaxel)	62 Japanese ancestry cases, 42 Japanese ancestry controls	NA	3q21.3	3	127231283	C3orf56	LOC101060159 - RNU6-1047P	101060159	106481511		7744	9685	rs4234284-T	rs4234284	0	4234284	regulatory_region_variant	1	0.23	3E-6	5.522878745280337	(Dominant)	3.01	[1.62-5.6]	Illumina [555600]	N
2014-03-26	24025145	Chung S	2013-09-11	Breast Cancer Res	www.ncbi.nlm.nih.gov/pubmed/24025145	A genome-wide association study of chemotherapy-induced alopecia in breast cancer patients.	Adverse response to chemotherapy in breast cancer (alopecia) (docetaxel)	62 Japanese ancestry cases, 42 Japanese ancestry controls	NA	20p13	20	778672	C20orf54	SLC52A3 - FAM110A	113278	83541		2687	55025	rs6117615-C	rs6117615	0	6117615	upstream_gene_variant	1	0.24	7E-6	5.154901959985743	(Dominant)	3.89	[2.1-7.18]	Illumina [555600]	N
2014-03-26	24025145	Chung S	2013-09-11	Breast Cancer Res	www.ncbi.nlm.nih.gov/pubmed/24025145	A genome-wide association study of chemotherapy-induced alopecia in breast cancer patients.	Adverse response to chemotherapy in breast cancer (alopecia) (docetaxel)	62 Japanese ancestry cases, 42 Japanese ancestry controls	NA	1p32.2	1	55647101	LOC100507652	RNU6-830P - LOC105378740	106480613	105378740		248481	136560	rs10443215-C	rs10443215	0	10443215	intron_variant	1	0.04	9E-6	5.045757490560675	(Allelic)	9.39	[2.77-31.8]	Illumina [555600]	N
2014-03-26	24025145	Chung S	2013-09-11	Breast Cancer Res	www.ncbi.nlm.nih.gov/pubmed/24025145	A genome-wide association study of chemotherapy-induced alopecia in breast cancer patients.	Adverse response to chemotherapy in breast cancer (alopecia) (anti-microtubule)	119 Japanese ancestry cases, 105 Japanese ancestry controls	NA	9q31.2	9	106914612	ZNF462	ZNF462			58499			rs1858231-C	rs1858231	0	1858231	intron_variant	0	0.22	2E-6	5.698970004336019	(Allelic)	2.71	[1.79-4.12]	Illumina [555600]	N
2014-03-26	24025145	Chung S	2013-09-11	Breast Cancer Res	www.ncbi.nlm.nih.gov/pubmed/24025145	A genome-wide association study of chemotherapy-induced alopecia in breast cancer patients.	Adverse response to chemotherapy in breast cancer (alopecia) (anti-microtubule)	119 Japanese ancestry cases, 105 Japanese ancestry controls	NA	11q14.2	11	86477110	ME3	ME3			10873			rs1870323-T	rs1870323	0	1870323	intron_variant	0	0.64	2E-6	5.698970004336019	(Allelic)	2.92	[1.87-4.57]	Illumina [555600]	N
2014-03-26	24025145	Chung S	2013-09-11	Breast Cancer Res	www.ncbi.nlm.nih.gov/pubmed/24025145	A genome-wide association study of chemotherapy-induced alopecia in breast cancer patients.	Adverse response to chemotherapy in breast cancer (alopecia) (anti-microtubule)	119 Japanese ancestry cases, 105 Japanese ancestry controls	NA	15q25.3	15	85919621	KLHL25	LOC105370953 - AGBL1	105370953	123624		18577	160014	rs4262906-C	rs4262906	0	4262906	intergenic_variant	1	0.35	3E-6	5.522878745280337	(Allelic)	2.5	[1.71-3.67]	Illumina [555600]	N
2014-03-26	24025145	Chung S	2013-09-11	Breast Cancer Res	www.ncbi.nlm.nih.gov/pubmed/24025145	A genome-wide association study of chemotherapy-induced alopecia in breast cancer patients.	Adverse response to chemotherapy in breast cancer (alopecia) (anti-microtubule)	119 Japanese ancestry cases, 105 Japanese ancestry controls	NA	5q14.3	5	86881956	RPL10AP9	LOC100505878 - RPL10AP9	100505878	728979		132184	2254	rs2471042-T	rs2471042	0	2471042	downstream_gene_variant	1	0.21	5E-6	5.301029995663981	(Dominant)	2.51	[1.64-3.81]	Illumina [555600]	N
2014-03-26	24025145	Chung S	2013-09-11	Breast Cancer Res	www.ncbi.nlm.nih.gov/pubmed/24025145	A genome-wide association study of chemotherapy-induced alopecia in breast cancer patients.	Adverse response to chemotherapy in breast cancer (alopecia) (anti-microtubule)	119 Japanese ancestry cases, 105 Japanese ancestry controls	NA	10p14	10	8282926	LOC100507143	LINC00708 - LOC105376396	100507143	105376396		14621	99547	rs11255615-G	rs11255615	0	11255615	intergenic_variant	1	0.38	5E-6	5.301029995663981	(Allelic)	2.4	[1.65-3.53]	Illumina [555600]	N
2014-03-26	24025145	Chung S	2013-09-11	Breast Cancer Res	www.ncbi.nlm.nih.gov/pubmed/24025145	A genome-wide association study of chemotherapy-induced alopecia in breast cancer patients.	Adverse response to chemotherapy in breast cancer (alopecia) (anti-microtubule)	119 Japanese ancestry cases, 105 Japanese ancestry controls	NA	5q14.3	5	86878330	RPL10AP9	LOC100505878 - RPL10AP9	100505878	728979		128558	5880	rs1493354-T	rs1493354	0	1493354	intergenic_variant	1	0.22	9E-6	5.045757490560675	(Dominant)	2.37	[1.56-3.6]	Illumina [555600]	N
2014-03-26	24025145	Chung S	2013-09-11	Breast Cancer Res	www.ncbi.nlm.nih.gov/pubmed/24025145	A genome-wide association study of chemotherapy-induced alopecia in breast cancer patients.	Adverse response to chemotherapy in breast cancer (alopecia) (anti-microtubule)	119 Japanese ancestry cases, 105 Japanese ancestry controls	NA	18q21.33	18	63509033	SERPINB5	SERPINB5 - SERPINB12	5268	89777		3948	10131	rs2032224-A	rs2032224	0	2032224	downstream_gene_variant	1	0.62	9E-6	5.045757490560675	(Recessive)	2.16	[1.42-3.27]	Illumina [555600]	N
2016-04-28	25964295	Khan S	2015-05-11	Clin Cancer Res	www.ncbi.nlm.nih.gov/pubmed/25964295	Polymorphism at 19q13.41 predicts breast cancer survival specifically after endocrine therapy.	Survival in endocrine treated breast cancer (estrogen-receptor positive)	352 European ancestry cases with endocrine therapy, 254 European ancestry cases without endocrine therapy, 597 European ancestry controls	3,330 European ancestry cases with endocrine therapy, 42 European ancestry cases without endocrine therapy, 1,351 European ancestry controls	19q13.41	19	51942133	ZNF613	ZNF613			79898			rs8113308-G	rs8113308	0	8113308	intron_variant	0	0.152	6E-7	6.221848749616356		1.69	[1.37-2.07]	Illumina [486478]	N
2008-10-14	18463975	Kibriya MG	2008-05-08	Breast Cancer Res Treat	www.ncbi.nlm.nih.gov/pubmed/18463975	A pilot genome-wide association study of early-onset breast cancer.	Breast cancer	26 European ancestry cases, 3 Hispanic cases, 1 African American case, 26 European ancestry controls, 3 Hispanic controls, 1 African American control	NA	16q23.1	16	74438798	GLG1	LOC107984827 - GLG1	107984827	2734		3372	8629	3-SNP haplotype 1	rs10871290	0	10871290	downstream_gene_variant	1	0.34	4E-7	6.3979400086720375				Affymetrix [200220]	N
2011-09-30	21908515	Cai Q	2011-09-09	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/21908515	Genome-wide association study identifies breast cancer risk variant at 10q21.2: results from the Asia Breast Cancer Consortium.	Breast cancer	2,062 East Asian ancestry cases, 2,066 East Asian ancestry controls	15,091 East Asian ancestry cases, 14,877 East Asian ancestry controls	7q32.3	7	130969092	NR	LINC-PINT			378805			rs2048672-C	rs2048672	0	2048672	intron_variant	0	0.45	6E-6	5.221848749616356		1.11	[1.05-1.17]	Affymetrix [684457]	N
2011-09-30	21908515	Cai Q	2011-09-09	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/21908515	Genome-wide association study identifies breast cancer risk variant at 10q21.2: results from the Asia Breast Cancer Consortium.	Breast cancer	2,062 East Asian ancestry cases, 2,066 East Asian ancestry controls	15,091 East Asian ancestry cases, 14,877 East Asian ancestry controls	10q21.2	10	62492218	ZNF365	ZNF365			22891			rs10822013-T	rs10822013	0	10822013	intron_variant	0	0.47	6E-9	8.221848749616356		1.12	[1.06-1.18]	Affymetrix [684457]	N
2010-10-07	20852631	Antoniou AC	2010-09-19	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20852631	A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor-negative breast cancer in the general population.	Breast cancer	1,193 European ancestry cases, 1,190 European ancestry controls	2,974 European ancestry cases, 3,012 European ancestry controls	19p13.11	19	17278895	ANKLE1, C19orf62, ABHD8	BABAM1			29086			rs8170-A	rs8170	0	8170	synonymous_variant	0	0.17	2E-9	8.698970004336019		1.26	[1.17-1.35]	Illumina [555616]	N
2010-10-15	20872241	Li J	2010-09-26	Breast Cancer Res Treat	www.ncbi.nlm.nih.gov/pubmed/20872241	A combined analysis of genome-wide association studies in breast cancer.	Breast cancer	2,702 European ancestry female cases, 5,726 European ancestry controls	Up to 7,386 cases, 7,576 controls	10q26.13	10	121586676	FGFR2	FGFR2			2263			rs1219648-G	rs1219648	0	1219648	intron_variant	0	0.42	2E-13	12.698970004336019		1.32	[1.22-1.42]	Illumina [285984]	N
2010-10-15	20872241	Li J	2010-09-26	Breast Cancer Res Treat	www.ncbi.nlm.nih.gov/pubmed/20872241	A combined analysis of genome-wide association studies in breast cancer.	Breast cancer	2,702 European ancestry female cases, 5,726 European ancestry controls	Up to 7,386 cases, 7,576 controls	16q12.1	16	52552429	TOX3	CASC16			643714			rs3803662-A	rs3803662	0	3803662	non_coding_transcript_exon_variant	0	0.30	4E-7	6.3979400086720375		1.22	[1.13-1.32]	Illumina [285984]	N
2010-10-15	20872241	Li J	2010-09-26	Breast Cancer Res Treat	www.ncbi.nlm.nih.gov/pubmed/20872241	A combined analysis of genome-wide association studies in breast cancer.	Breast cancer	2,702 European ancestry female cases, 5,726 European ancestry controls	Up to 7,386 cases, 7,576 controls	5p12	5	44874903	MRPS30	MRPS30 - HCN1	10884	348980		59389	380047	rs7716600-A	rs7716600	0	7716600	intergenic_variant	1	0.23	7E-7	6.154901959985743		1.24	[1.14-1.34]	Illumina [285984]	N
2010-10-15	20872241	Li J	2010-09-26	Breast Cancer Res Treat	www.ncbi.nlm.nih.gov/pubmed/20872241	A combined analysis of genome-wide association studies in breast cancer.	Breast cancer	2,702 European ancestry female cases, 5,726 European ancestry controls	Up to 7,386 cases, 7,576 controls	2q35	2	217041109	intergenic	LOC105373874, LOC101928278			105373874, 101928278			rs13387042-?	rs13387042	0	13387042	intergenic_variant	0	0.53	9E-6	5.045757490560675		1.18	[1.10-1.27]	Illumina [285984]	N
2010-07-12	20585626	Long J	2010-06-24	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/20585626	Identification of a functional genetic variant at 16q12.1 for breast cancer risk: results from the Asia Breast Cancer Consortium.	Breast cancer	2,073 Chinese ancestry cases, 2,084 Chinese ancestry controls	15,159 East Asian ancestry cases, 12,993 East Asian ancestry controls, 2,797 European ancestry cases, 2,662 European ancestry controls	16q12.1	16	52565276	TOX3	CASC16			643714			rs4784227-T	rs4784227	0	4784227	intron_variant	0	0.24	1E-28	28.0	(all races combined)	1.24	[1.20-1.29]	Affymetrix [684457]	N
2014-11-12	24785509	Barnett GC	2014-04-28	Radiother Oncol	www.ncbi.nlm.nih.gov/pubmed/24785509	A genome wide association study (GWAS) providing evidence of an association between common genetic variants and late radiotherapy toxicity.	Response to radiotherapy in cancer (late toxicity)	579 European ancestry prostate cancer cases, 1,194 European ancestry breast cancer cases	516 European ancestry prostate cancer cases, 862 prostate cancer cases, 355 breast cancer cases	15q21.1	15	46737708	SEMA6D	LOC729316			729316			rs16958536-?	rs16958536	0	16958536	intron_variant	0	0.22	4E-6	5.3979400086720375	(Breast cancer, telangiectasia, multivariable analysis)	1.66		Illumina [2417493] (imputed)	N
2014-11-12	24785509	Barnett GC	2014-04-28	Radiother Oncol	www.ncbi.nlm.nih.gov/pubmed/24785509	A genome wide association study (GWAS) providing evidence of an association between common genetic variants and late radiotherapy toxicity.	Response to radiotherapy in cancer (late toxicity)	579 European ancestry prostate cancer cases, 1,194 European ancestry breast cancer cases	516 European ancestry prostate cancer cases, 862 prostate cancer cases, 355 breast cancer cases	10p12.31	10	21147293	C10orf113	NEBL			10529			rs12243039-?	rs12243039	0	12243039	intron_variant	0	0.01	8E-6	5.096910013008056	(Breast cancer, overall toxicity, multivariable analysis)	3.28		Illumina [2417493] (imputed)	N
2014-11-12	24785509	Barnett GC	2014-04-28	Radiother Oncol	www.ncbi.nlm.nih.gov/pubmed/24785509	A genome wide association study (GWAS) providing evidence of an association between common genetic variants and late radiotherapy toxicity.	Response to radiotherapy in cancer (late toxicity)	579 European ancestry prostate cancer cases, 1,194 European ancestry breast cancer cases	516 European ancestry prostate cancer cases, 862 prostate cancer cases, 355 breast cancer cases	17q12	17	35565049	SLFN14	SLFN14 - RPL39P32	342618	100131387		4208	1411	rs2840044-?	rs2840044	0	2840044	upstream_gene_variant	1	0.33	8E-6	5.096910013008056	(Breast cancer, overal toxicity, multivariable analysis)	1.56		Illumina [2417493] (imputed)	N
2014-11-12	24785509	Barnett GC	2014-04-28	Radiother Oncol	www.ncbi.nlm.nih.gov/pubmed/24785509	A genome wide association study (GWAS) providing evidence of an association between common genetic variants and late radiotherapy toxicity.	Response to radiotherapy in cancer (late toxicity)	579 European ancestry prostate cancer cases, 1,194 European ancestry breast cancer cases	516 European ancestry prostate cancer cases, 862 prostate cancer cases, 355 breast cancer cases	5q21.1	5	101043689	ST8SIA4	LOC107986437 - LOC107986438	107986437	107986438		99140	201910	rs575018-?	rs575018	0	575018	intergenic_variant	1	0.34	7E-7	6.154901959985743	(Breast cancer, overall toxicity, univariable analysis)	0.13	[NR] unit decrease	Illumina [2417493] (imputed)	N
2014-11-12	24785509	Barnett GC	2014-04-28	Radiother Oncol	www.ncbi.nlm.nih.gov/pubmed/24785509	A genome wide association study (GWAS) providing evidence of an association between common genetic variants and late radiotherapy toxicity.	Response to radiotherapy in cancer (late toxicity)	579 European ancestry prostate cancer cases, 1,194 European ancestry breast cancer cases	516 European ancestry prostate cancer cases, 862 prostate cancer cases, 355 breast cancer cases	6p25.1	6	6550516	LY86-AS1	LY86-AS1			285780			rs17142289-?	rs17142289	0	17142289	intron_variant	0	0.02	4E-6	5.3979400086720375	(Breast cancer, overall toxicity, univariable analysis)	0.35	[NR] unit increase	Illumina [2417493] (imputed)	N
2017-08-17	28649644	Pivot X	2017-02-23	NPJ Breast Cancer	www.ncbi.nlm.nih.gov/pubmed/28649644	Constitutional variants are not associated with HER2-positive breast cancer: results from the SIGNAL/PHARE clinical cohort.	HER2 status in breast cancer	5,473 European ancestry  HER2-negative cases, 3,230 European ancestry HER2-positive cases	NA	2q31.1	2	172285284	NR	LOC107985960			107985960			rs68130068-T	rs68130068	0	68130068	regulatory_region_variant	0	0.142	4E-6	5.3979400086720375				Illumina [914144] (imputed)	N
2014-10-17	24493630	Ahsan H	2014-02-03	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/24493630	A genome-wide association study of early-onset breast cancer identifies PFKM as a novel breast cancer gene and supports a common genetic spectrum for breast cancer at any age.	Breast cancer (early onset)	3,523 European ancestry young female cases, 2,702 European ancestry young female controls	3,470 European ancestry young female cases, 5,475 European ancestry young female controls	3p24.1	3	27302153	SLC4A7	NEK10			152110			rs653465-?	rs653465	0	653465	intron_variant	0	0.54	5E-12	11.301029995663981		1.18	[1.12-1.23]	Illumina [1265548] (imputed)	N
2014-10-17	24493630	Ahsan H	2014-02-03	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/24493630	A genome-wide association study of early-onset breast cancer identifies PFKM as a novel breast cancer gene and supports a common genetic spectrum for breast cancer at any age.	Breast cancer (early onset)	3,523 European ancestry young female cases, 2,702 European ancestry young female controls	3,470 European ancestry young female cases, 5,475 European ancestry young female controls	5q11.2	5	56872885	MAP3K1	MAP3K1			4214			rs2229882-?	rs2229882	0	2229882	synonymous_variant	0	0.06	1E-14	14.0		1.45	[1.32-1.60]	Illumina [1265548] (imputed)	N
2014-10-17	24493630	Ahsan H	2014-02-03	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/24493630	A genome-wide association study of early-onset breast cancer identifies PFKM as a novel breast cancer gene and supports a common genetic spectrum for breast cancer at any age.	Breast cancer (early onset)	3,523 European ancestry young female cases, 2,702 European ancestry young female controls	3,470 European ancestry young female cases, 5,475 European ancestry young female controls	8q24.21	8	127375779	intergenic	CASC21, CASC8			103021164, 727677			rs2392780-?	rs2392780	0	2392780	intron_variant	0	0.6	1E-8	8.0		1.15	[1.10-1.20]	Illumina [1265548] (imputed)	N
2014-10-17	24493630	Ahsan H	2014-02-03	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/24493630	A genome-wide association study of early-onset breast cancer identifies PFKM as a novel breast cancer gene and supports a common genetic spectrum for breast cancer at any age.	Breast cancer (early onset)	3,523 European ancestry young female cases, 2,702 European ancestry young female controls	3,470 European ancestry young female cases, 5,475 European ancestry young female controls	10q26.13	10	121589148	FGFR2	FGFR2			2263			rs2912774-?	rs2912774	0	2912774	intron_variant	0	0.44	3E-27	26.522878745280337		1.29	[1.23-1.35]	Illumina [1265548] (imputed)	N
2014-10-17	24493630	Ahsan H	2014-02-03	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/24493630	A genome-wide association study of early-onset breast cancer identifies PFKM as a novel breast cancer gene and supports a common genetic spectrum for breast cancer at any age.	Breast cancer (early onset)	3,523 European ancestry young female cases, 2,702 European ancestry young female controls	3,470 European ancestry young female cases, 5,475 European ancestry young female controls	11q13.3	11	69492927	CCND1	LINC01488			101928292			rs537626-?	rs537626	0	537626	intergenic_variant	0	0.18	2E-15	14.698970004336019		1.29	[1.21-1.37]	Illumina [1265548] (imputed)	N
2014-10-17	24493630	Ahsan H	2014-02-03	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/24493630	A genome-wide association study of early-onset breast cancer identifies PFKM as a novel breast cancer gene and supports a common genetic spectrum for breast cancer at any age.	Breast cancer (early onset)	3,523 European ancestry young female cases, 2,702 European ancestry young female controls	3,470 European ancestry young female cases, 5,475 European ancestry young female controls	16q12.1	16	52541995	TOX3	TOX3			27324			rs4784223-?	rs4784223	0	4784223	intron_variant	0	0.29	6E-21	20.221848749616356		1.27	[1.21-1.34]	Illumina [1265548] (imputed)	N
2014-10-17	24493630	Ahsan H	2014-02-03	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/24493630	A genome-wide association study of early-onset breast cancer identifies PFKM as a novel breast cancer gene and supports a common genetic spectrum for breast cancer at any age.	Breast cancer (early onset)	3,523 European ancestry young female cases, 2,702 European ancestry young female controls	3,470 European ancestry young female cases, 5,475 European ancestry young female controls	5q11.2	5	56733416	MAP3K1	LOC101928448 - LOC105378979	101928448	105378979		127184	32979	rs16886181-?	rs16886181	0	16886181	intergenic_variant	1	0.18	9E-14	13.045757490560675		1.26	[1.18-1.34]	Illumina [1265548] (imputed)	N
2014-10-17	24493630	Ahsan H	2014-02-03	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/24493630	A genome-wide association study of early-onset breast cancer identifies PFKM as a novel breast cancer gene and supports a common genetic spectrum for breast cancer at any age.	Breast cancer (early onset)	3,523 European ancestry young female cases, 2,702 European ancestry young female controls	3,470 European ancestry young female cases, 5,475 European ancestry young female controls	5q11.2	5	56874986	MAP3K1	MAP3K1			4214			rs16886448-?	rs16886448	0	16886448	intron_variant	0	0.07	2E-12	11.698970004336019		1.37	[1.25-1.49]	Illumina [1265548] (imputed)	N
2014-10-17	24493630	Ahsan H	2014-02-03	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/24493630	A genome-wide association study of early-onset breast cancer identifies PFKM as a novel breast cancer gene and supports a common genetic spectrum for breast cancer at any age.	Breast cancer (early onset)	3,523 European ancestry young female cases, 2,702 European ancestry young female controls	3,470 European ancestry young female cases, 5,475 European ancestry young female controls	5q11.2	5	56838449	MAP3K1	MAP3K1			4214			rs16886397-?	rs16886397	0	16886397	intron_variant	0	0.07	4E-12	11.397940008672037		1.36	[1.25-1.49]	Illumina [1265548] (imputed)	N
2014-10-17	24493630	Ahsan H	2014-02-03	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/24493630	A genome-wide association study of early-onset breast cancer identifies PFKM as a novel breast cancer gene and supports a common genetic spectrum for breast cancer at any age.	Breast cancer (early onset)	3,523 European ancestry young female cases, 2,702 European ancestry young female controls	3,470 European ancestry young female cases, 5,475 European ancestry young female controls	5q11.2	5	56882284	MAP3K1	MAP3K1			4214			rs3822625-?	rs3822625	0	3822625	synonymous_variant	0	0.07	5E-12	11.301029995663981		1.36	[1.24-1.48]	Illumina [1265548] (imputed)	N
2014-10-17	24493630	Ahsan H	2014-02-03	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/24493630	A genome-wide association study of early-onset breast cancer identifies PFKM as a novel breast cancer gene and supports a common genetic spectrum for breast cancer at any age.	Breast cancer (early onset)	3,523 European ancestry young female cases, 2,702 European ancestry young female controls	3,470 European ancestry young female cases, 5,475 European ancestry young female controls	5q11.2	5	56826517	MAP3K1	MAP3K1			4214			rs16886364-?	rs16886364	0	16886364	intron_variant	0	0.07	5E-12	11.301029995663981		1.36	[1.25-1.48]	Illumina [1265548] (imputed)	N
2014-10-17	24493630	Ahsan H	2014-02-03	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/24493630	A genome-wide association study of early-onset breast cancer identifies PFKM as a novel breast cancer gene and supports a common genetic spectrum for breast cancer at any age.	Breast cancer (early onset)	3,523 European ancestry young female cases, 2,702 European ancestry young female controls	3,470 European ancestry young female cases, 5,475 European ancestry young female controls	5q11.2	5	56699208	MAP3K1	LOC101928448 - LOC105378979	101928448	105378979		92976	67187	rs16886113-?	rs16886113	0	16886113	intergenic_variant	1	0.08	4E-11	10.397940008672037		1.35	[1.23-1.47]	Illumina [1265548] (imputed)	N
2014-10-17	24493630	Ahsan H	2014-02-03	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/24493630	A genome-wide association study of early-onset breast cancer identifies PFKM as a novel breast cancer gene and supports a common genetic spectrum for breast cancer at any age.	Breast cancer (early onset)	3,523 European ancestry young female cases, 2,702 European ancestry young female controls	3,470 European ancestry young female cases, 5,475 European ancestry young female controls	5q11.2	5	56857565	MAP3K1	MAP3K1			4214			rs1017226-?	rs1017226	0	1017226	intron_variant	0	0.08	6E-11	10.221848749616356		1.33	[1.22-1.45]	Illumina [1265548] (imputed)	N
2014-10-17	24493630	Ahsan H	2014-02-03	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/24493630	A genome-wide association study of early-onset breast cancer identifies PFKM as a novel breast cancer gene and supports a common genetic spectrum for breast cancer at any age.	Breast cancer (early onset)	3,523 European ancestry young female cases, 2,702 European ancestry young female controls	3,470 European ancestry young female cases, 5,475 European ancestry young female controls	5q11.2	5	56960656	MAP3K1	MIER3 - LOC100130001	166968	100130001		8526	14828	rs7726354-?	rs7726354	0	7726354	intron_variant	1	0.06	7E-11	10.154901959985743		1.37	[1.24-1.50]	Illumina [1265548] (imputed)	N
2014-10-17	24493630	Ahsan H	2014-02-03	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/24493630	A genome-wide association study of early-onset breast cancer identifies PFKM as a novel breast cancer gene and supports a common genetic spectrum for breast cancer at any age.	Breast cancer (early onset)	3,523 European ancestry young female cases, 2,702 European ancestry young female controls	3,470 European ancestry young female cases, 5,475 European ancestry young female controls	5q11.2	5	56899963	MAP3K1	LOC105378980			105378980			rs12655019-?	rs12655019	0	12655019	downstream_gene_variant	0	0.1	3E-10	9.522878745280337		1.27	[1.18-1.37]	Illumina [1265548] (imputed)	N
2014-10-17	24493630	Ahsan H	2014-02-03	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/24493630	A genome-wide association study of early-onset breast cancer identifies PFKM as a novel breast cancer gene and supports a common genetic spectrum for breast cancer at any age.	Breast cancer (early onset)	3,523 European ancestry young female cases, 2,702 European ancestry young female controls	3,470 European ancestry young female cases, 5,475 European ancestry young female controls	5q11.2	5	56688029	MAP3K1	LOC101928448 - LOC105378979	101928448	105378979		81797	78366	rs16886034-?	rs16886034	0	16886034	regulatory_region_variant	1	0.08	2E-9	8.698970004336019		1.36	[1.23-1.51]	Illumina [1265548] (imputed)	N
2014-10-17	24493630	Ahsan H	2014-02-03	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/24493630	A genome-wide association study of early-onset breast cancer identifies PFKM as a novel breast cancer gene and supports a common genetic spectrum for breast cancer at any age.	Breast cancer (early onset)	3,523 European ancestry young female cases, 2,702 European ancestry young female controls	3,470 European ancestry young female cases, 5,475 European ancestry young female controls	5q11.2	5	56736057	MAP3K1	LOC101928448 - LOC105378979	101928448	105378979		129825	30338	rs889312-?	rs889312	0	889312	regulatory_region_variant	1	0.29	1E-8	8.0		1.29	[NR]	Illumina [1265548] (imputed)	N
2014-10-17	24493630	Ahsan H	2014-02-03	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/24493630	A genome-wide association study of early-onset breast cancer identifies PFKM as a novel breast cancer gene and supports a common genetic spectrum for breast cancer at any age.	Breast cancer (early onset)	3,523 European ancestry young female cases, 2,702 European ancestry young female controls	3,470 European ancestry young female cases, 5,475 European ancestry young female controls	11q13.3	11	69513996	CCND1	LINC01488 - CCND1	101928292	595		20453	127109	rs614367-?	rs614367	0	614367	intergenic_variant	1	0.16	1E-8	8.0		1.34	[NR]	Illumina [1265548] (imputed)	N
2012-01-14	22180457	Kiyotani K	2011-12-16	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/22180457	A genome-wide association study identifies locus at 10q22 associated with clinical outcomes of adjuvant tamoxifen therapy for breast cancer patients in Japanese.	Response to tamoxifen in breast cancer	240 Japanese ancestry female cases	222 Japanese ancestry female cases	10q22.3	10	76397814	C10orf11	C10orf11			83938			rs10509373-C	rs10509373	0	10509373	intron_variant	0	0.024	6E-9	8.221848749616356		4.51	[2.72-7.51]	Illumina [470796]	N
2008-06-16	18326623	Gold B	2008-03-11	Proc Natl Acad Sci U S A	www.ncbi.nlm.nih.gov/pubmed/18326623	Genome-wide association study provides evidence for a breast cancer risk locus at 6q22.33.	Breast cancer	249 Ashkenazi Jewish non-BRCA1/2 carriers cases, 299 Ashkenazi Jewish non-BRCA1/2 carriers controls	1,193 Ashkenazi Jewish non-BRCA1/2 carriers  cases,1,166 Ashkenazi Jewish non-BRCA1/2 carriers controls	6q22.33	6	127279485	ECHDC1, RNF146	RNF146			81847			rs2180341-G	rs2180341	0	2180341	intron_variant	0	0.21	3E-8	7.522878745280337		1.41	[1.25-1.59]	Affymetrix [150080]	N
2008-06-16	17529967	Easton DF	2007-05-27	Nature	www.ncbi.nlm.nih.gov/pubmed/17529967	Genome-wide association study identifies novel breast cancer susceptibility loci.	Breast cancer	390 European ancestry cases, 364 European ancestry controls	4,364 East Asian ancestry cases, 24,174 European ancestry controls, 3,564 East Asian ancestry controls, 24,391 European ancestry controls	10q26.13	10	121592803	FGFR2	FGFR2			2263			rs2981582-A	rs2981582	0	2981582	intron_variant	0	0.38	2E-76	75.69897000433602		1.26	[1.23-1.30]	Perlegen [205586]	N
2008-06-16	17529967	Easton DF	2007-05-27	Nature	www.ncbi.nlm.nih.gov/pubmed/17529967	Genome-wide association study identifies novel breast cancer susceptibility loci.	Breast cancer	390 European ancestry cases, 364 European ancestry controls	4,364 East Asian ancestry cases, 24,174 European ancestry controls, 3,564 East Asian ancestry controls, 24,391 European ancestry controls	16q12.1	16	52552429	TNRC9, LOC643714	CASC16			643714			rs3803662-T	rs3803662	0	3803662	non_coding_transcript_exon_variant	0	0.25	1E-36	36.0		1.2	[1.16-1.24]	Perlegen [205586]	N
2008-06-16	17529967	Easton DF	2007-05-27	Nature	www.ncbi.nlm.nih.gov/pubmed/17529967	Genome-wide association study identifies novel breast cancer susceptibility loci.	Breast cancer	390 European ancestry cases, 364 European ancestry controls	4,364 East Asian ancestry cases, 24,174 European ancestry controls, 3,564 East Asian ancestry controls, 24,391 European ancestry controls	5q11.2	5	56736057	MAP3K1	LOC101928448 - LOC105378979	101928448	105378979		129825	30338	rs889312-C	rs889312	0	889312	regulatory_region_variant	1	0.28	7E-20	19.154901959985743		1.13	[1.10-1.16]	Perlegen [205586]	N
2008-06-16	17529967	Easton DF	2007-05-27	Nature	www.ncbi.nlm.nih.gov/pubmed/17529967	Genome-wide association study identifies novel breast cancer susceptibility loci.	Breast cancer	390 European ancestry cases, 364 European ancestry controls	4,364 East Asian ancestry cases, 24,174 European ancestry controls, 3,564 East Asian ancestry controls, 24,391 European ancestry controls	8q24.21	8	127343372	intergenic	CASC8, CASC21			727677, 103021164			rs13281615-C	rs13281615	0	13281615	intron_variant	0	0.40	5E-12	11.301029995663981		1.08	[1.05-1.11]	Perlegen [205586]	N
2008-06-16	17529967	Easton DF	2007-05-27	Nature	www.ncbi.nlm.nih.gov/pubmed/17529967	Genome-wide association study identifies novel breast cancer susceptibility loci.	Breast cancer	390 European ancestry cases, 364 European ancestry controls	4,364 East Asian ancestry cases, 24,174 European ancestry controls, 3,564 East Asian ancestry controls, 24,391 European ancestry controls	11p15.5	11	1887776	LSP1	LSP1			4046			rs3817198-C	rs3817198	0	3817198	intron_variant	0	0.30	3E-9	8.522878745280337		1.07	[1.04-1.11]	Perlegen [205586]	N
2008-06-16	17529973	Hunter DJ	2007-05-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/17529973	A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer.	Breast cancer	1,145 European ancestry cases, 1,142 European ancestry controls	874 European ancestry cases, 1,478 European ancestry controls, 302 cases, 594 controls	10q26.13	10	121586676	FGFR2	FGFR2			2263			rs1219648-G	rs1219648	0	1219648	intron_variant	0	0.40	1E-10	10.0		1.2	[1.07-1.42]	Illumina [528173]	N
2008-06-16	17529967	Easton DF	2007-05-27	Nature	www.ncbi.nlm.nih.gov/pubmed/17529967	Genome-wide association study identifies novel breast cancer susceptibility loci.	Breast cancer	390 European ancestry cases, 364 European ancestry controls	4,364 East Asian ancestry cases, 24,174 European ancestry controls, 3,564 East Asian ancestry controls, 24,391 European ancestry controls	5p12	5	45285616	intergenic	HCN1			348980			rs981782-C	rs981782	0	981782	intron_variant	0	0.53	9E-6	5.045757490560675		1.04	[1.01-1.08]	Perlegen [205586]	N
2009-02-28	19219042	Zheng W	2009-02-15	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19219042	Genome-wide association study identifies a new breast cancer susceptibility locus at 6q25.1.	Breast cancer	1,505 Chinese ancestry cases, 1,522 Chinese ancestry controls	5,026 Chinese ancestry cases, 2,476 Chinese ancestry controls, 1,591 European ancestry cases, 1,466 European ancestry controls	6q25.1	6	151627231	ESR1, C6orf97	CCDC170 - ESR1	80129	2099		6038	26917	rs2046210-A	rs2046210	0	2046210	intergenic_variant	1	0.37	2E-15	14.698970004336019		1.29	[1.21-1.37]	Affymetrix [up to 607728]	N
2009-04-03	19330030	Thomas G	2009-03-29	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19330030	A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1).	Breast cancer	1,145 European ancestry cases, 1,142 European ancestry controls	8,625 European ancestry cases, 9,657 European ancestry controls	10q26.13	10	121577821	FGFR2	FGFR2			2263			rs2981579-T	rs2981579	0	2981579	intron_variant	0	0.41	2E-10	9.698970004336019		1.17	[1.07-1.27] (Het)	Illumina [528173]	N
2009-04-03	19330030	Thomas G	2009-03-29	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19330030	A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1).	Breast cancer	1,145 European ancestry cases, 1,142 European ancestry controls	8,625 European ancestry cases, 9,657 European ancestry controls	16q12.1	16	52552429	TOX3	CASC16			643714			rs3803662-T	rs3803662	0	3803662	non_coding_transcript_exon_variant	0	0.27	1E-9	9.0		1.16	[1.07-1.27] (Het)	Illumina [528173]	N
2009-04-03	19330030	Thomas G	2009-03-29	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19330030	A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1).	Breast cancer	1,145 European ancestry cases, 1,142 European ancestry controls	8,625 European ancestry cases, 9,657 European ancestry controls	5q11.2	5	56727256	MAP3K1	LOC101928448 - LOC105378979	101928448	105378979		121024	39139	rs16886165-G	rs16886165	0	16886165	intergenic_variant	1	0.15	5E-7	6.301029995663981		1.23	[1.12-1.35] (Het)	Illumina [528173]	N
2009-04-03	19330030	Thomas G	2009-03-29	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19330030	A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1).	Breast cancer	1,145 European ancestry cases, 1,142 European ancestry controls	8,625 European ancestry cases, 9,657 European ancestry controls	2q35	2	217041109	intergenic	LOC105373874, LOC101928278			105373874, 101928278			rs13387042-A	rs13387042	0	13387042	intergenic_variant	0	0.51	2E-8	7.698970004336019		1.25	[1.15-1.37] (Het)	Illumina [528173]	N
2009-04-03	19330030	Thomas G	2009-03-29	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19330030	A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1).	Breast cancer	1,145 European ancestry cases, 1,142 European ancestry controls	8,625 European ancestry cases, 9,657 European ancestry controls	1p11.2	1	121538815	intergenic	EMBP1			647121			rs11249433-C	rs11249433	0	11249433	intron_variant	0	0.39	7E-10	9.154901959985743		1.16	[1.09-1.24] (Het)	Illumina [528173]	N
2009-04-03	19330030	Thomas G	2009-03-29	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19330030	A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1).	Breast cancer	1,145 European ancestry cases, 1,142 European ancestry controls	8,625 European ancestry cases, 9,657 European ancestry controls	14q24.1	14	68567965	RAD51L1	RAD51B			5890			rs999737-C	rs999737	0	999737	intron_variant	0	0.76	2E-7	6.698970004336019		1.06	[1.01-1.14] (Het)	Illumina [528173]	N
2010-12-09	21060860	Gaudet MM	2010-10-28	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/21060860	Common genetic variants and modification of penetrance of BRCA2-associated breast cancer.	Breast cancer in BRCA2 mutation carriers	899 European ancestry cases, 804 European ancestry controls	1,264 European ancestry cases, 1,222 European ancestry controls	10q26.13	10	121586602	FGFR2	FGFR2			2263			rs2981575-?	rs2981575	0	2981575	intron_variant	0	0.42	1E-8	8.0		1.28	[1.18-1.39]	Affymetrix [592163]	N
2015-04-19	21263130	Fletcher O	2011-01-24	J Natl Cancer Inst	www.ncbi.nlm.nih.gov/pubmed/21263130	Novel breast cancer susceptibility locus at 9q31.2: results of a genome-wide association study.	Breast cancer	2,839 European ancestry cases, 3,507 European ancestry controls	9,041 European ancestry cases, 8,980 European ancestry controls	2q35	2	217041109	intergenic	LOC105373874, LOC101928278			105373874, 101928278			rs13387042-A	rs13387042	0	13387042	intergenic_variant	0	0.52	2E-10	9.698970004336019		1.16	[1.11-1.22]	Illumina [~ 296114]	N
2015-04-19	21263130	Fletcher O	2011-01-24	J Natl Cancer Inst	www.ncbi.nlm.nih.gov/pubmed/21263130	Novel breast cancer susceptibility locus at 9q31.2: results of a genome-wide association study.	Breast cancer	2,839 European ancestry cases, 3,507 European ancestry controls	9,041 European ancestry cases, 8,980 European ancestry controls	3p24.1	3	27374522	SLC4A7	SLC4A7			9497			rs4973768-C	rs4973768	0	4973768	3_prime_UTR_variant	0	0.49	2E-8	7.698970004336019		1.14	[1.09-1.19]	Illumina [~ 296114]	N
2015-04-19	21263130	Fletcher O	2011-01-24	J Natl Cancer Inst	www.ncbi.nlm.nih.gov/pubmed/21263130	Novel breast cancer susceptibility locus at 9q31.2: results of a genome-wide association study.	Breast cancer	2,839 European ancestry cases, 3,507 European ancestry controls	9,041 European ancestry cases, 8,980 European ancestry controls	5p12	5	44662413	intergenic	LOC102723839 - RN7SL383P	102723839	106479363		152131	53780	rs4415084-T	rs4415084	0	4415084	intergenic_variant	1	0.42	8E-11	10.096910013008056		1.17	[1.11-1.22]	Illumina [~ 296114]	N
2015-04-19	21263130	Fletcher O	2011-01-24	J Natl Cancer Inst	www.ncbi.nlm.nih.gov/pubmed/21263130	Novel breast cancer susceptibility locus at 9q31.2: results of a genome-wide association study.	Breast cancer	2,839 European ancestry cases, 3,507 European ancestry controls	9,041 European ancestry cases, 8,980 European ancestry controls	8q24.21	8	127375606	intergenic	CASC21, CASC8			103021164, 727677			rs1562430-A	rs1562430	0	1562430	intron_variant	0	0.60	3E-11	10.522878745280337		1.16	[1.11-1.22]	Illumina [~ 296114]	N
2015-04-19	21263130	Fletcher O	2011-01-24	J Natl Cancer Inst	www.ncbi.nlm.nih.gov/pubmed/21263130	Novel breast cancer susceptibility locus at 9q31.2: results of a genome-wide association study.	Breast cancer	2,839 European ancestry cases, 3,507 European ancestry controls	9,041 European ancestry cases, 8,980 European ancestry controls	10q26.13	10	121586676	FGFR2	FGFR2			2263			rs1219648-?	rs1219648	0	1219648	intron_variant	0	0.42	1E-30	30.0		1.31	[1.25-1.37]	Illumina [~ 296114]	N
2015-04-19	21263130	Fletcher O	2011-01-24	J Natl Cancer Inst	www.ncbi.nlm.nih.gov/pubmed/21263130	Novel breast cancer susceptibility locus at 9q31.2: results of a genome-wide association study.	Breast cancer	2,839 European ancestry cases, 3,507 European ancestry controls	9,041 European ancestry cases, 8,980 European ancestry controls	16q12.2	16	52601252	TOX3	CASC16			643714			rs3112612-T	rs3112612	0	3112612	intron_variant	0	0.43	4E-10	9.397940008672037		1.15	[1.10-1.21]	Illumina [~ 296114]	N
2012-02-14	22232737	Shu XO	2012-01-09	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/22232737	Novel genetic markers of breast cancer survival identified by a genome-wide association study.	Breast cancer (survival)	1,950 Chinese ancestry cases	4,160 Chinese ancestry cases	14q24.1	14	68283210	RAD51L1	RAD51B			5890			rs3784099-A	rs3784099	0	3784099	intron_variant	0	NR	1E-7	7.0	(Total Mortality)	1.49	[1.28-1.72]	Affymetrix [613031]	N
2012-02-14	22232737	Shu XO	2012-01-09	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/22232737	Novel genetic markers of breast cancer survival identified by a genome-wide association study.	Breast cancer (survival)	1,950 Chinese ancestry cases	4,160 Chinese ancestry cases	14q24.1	14	68283210	RAD51L1	RAD51B			5890			rs3784099-A	rs3784099	0	3784099	intron_variant	0	NR	3E-7	6.522878745280337	(Recurrence)	1.43	[1.25-1.64]	Affymetrix [613031]	N
2012-02-14	22232737	Shu XO	2012-01-09	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/22232737	Novel genetic markers of breast cancer survival identified by a genome-wide association study.	Breast cancer (survival)	1,950 Chinese ancestry cases	4,160 Chinese ancestry cases	16q22.3	16	73405456	intergenic	C16orf47, LINC01568			388289, 100506172			rs9934948-C	rs9934948	0	9934948	intron_variant	0	NR	6E-6	5.221848749616356	(Total Mortality)	1.29	[1.16-1.44]	Affymetrix [613031]	N
2012-03-17	22383897	Long J	2012-02-23	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/22383897	Genome-wide association study in east Asians identifies novel susceptibility loci for breast cancer.	Breast cancer	2,918 Chinese ancestry cases, 2,324 Chinese ancestry controls	up to 16,173 East Asian ancestry cases, up to 18,282 East Asian ancestry controls	6q25.1	6	149287738	TAB2	TAB2			23118			rs9485372-G	rs9485372	0	9485372	intron_variant	0	0.55	4E-12	11.397940008672037		1.11	[1.09-1.15]	Affymetrix [690947]	N
2012-03-17	22383897	Long J	2012-02-23	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/22383897	Genome-wide association study in east Asians identifies novel susceptibility loci for breast cancer.	Breast cancer	2,918 Chinese ancestry cases, 2,324 Chinese ancestry controls	up to 16,173 East Asian ancestry cases, up to 18,282 East Asian ancestry controls	6q25.1	6	151974478	ESR1	ESR1			2099			rs9383951-G	rs9383951	0	9383951	intron_variant	0	0.90	2E-6	5.698970004336019		1.14	[1.08-1.19]	Affymetrix [690947]	N
2012-03-17	22383897	Long J	2012-02-23	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/22383897	Genome-wide association study in east Asians identifies novel susceptibility loci for breast cancer.	Breast cancer	2,918 Chinese ancestry cases, 2,324 Chinese ancestry controls	up to 16,173 East Asian ancestry cases, up to 18,282 East Asian ancestry controls	11q24.3	11	129603795	TMEM45B, BARX2	RPS27P20 - LINC01395	100271581	101929557		65622	8321	rs7107217-C	rs7107217	0	7107217	intron_variant	1	0.36	5E-7	6.301029995663981		1.08	[1.05-1.11]	Affymetrix [690947]	N
2015-04-19	21263130	Fletcher O	2011-01-24	J Natl Cancer Inst	www.ncbi.nlm.nih.gov/pubmed/21263130	Novel breast cancer susceptibility locus at 9q31.2: results of a genome-wide association study.	Breast cancer	2,839 European ancestry cases, 3,507 European ancestry controls	9,041 European ancestry cases, 8,980 European ancestry controls	9q31.2	9	108126198	KLF4, ACTL7A, RAD23B	LOC105376214			105376214			rs865686-T	rs865686	0	865686	intergenic_variant	0	0.61	2E-10	9.698970004336019		1.12	[1.09-1.18]	Illumina [~ 296114]	N
2015-04-19	21263130	Fletcher O	2011-01-24	J Natl Cancer Inst	www.ncbi.nlm.nih.gov/pubmed/21263130	Novel breast cancer susceptibility locus at 9q31.2: results of a genome-wide association study.	Breast cancer	2,839 European ancestry cases, 3,507 European ancestry controls	9,041 European ancestry cases, 8,980 European ancestry controls	6q25.1	6	151618215	ESR1	CCDC170			80129			rs3734805-C	rs3734805	0	3734805	3_prime_UTR_variant	0	0.08	1E-7	7.0		1.19	[1.11-1.27]	Illumina [~ 296114]	N
2015-04-19	21263130	Fletcher O	2011-01-24	J Natl Cancer Inst	www.ncbi.nlm.nih.gov/pubmed/21263130	Novel breast cancer susceptibility locus at 9q31.2: results of a genome-wide association study.	Breast cancer	2,839 European ancestry cases, 3,507 European ancestry controls	9,041 European ancestry cases, 8,980 European ancestry controls	10q26.13	10	121865675	FGFR2	ATE1			11101			rs10510102-G	rs10510102	0	10510102	intron_variant	0	0.17	2E-6	5.698970004336019		1.12	[1.07-1.17]	Illumina [~ 296114]	N
2011-04-13	21424380	Sehrawat B	2011-03-19	Hum Genet	www.ncbi.nlm.nih.gov/pubmed/21424380	Potential novel candidate polymorphisms identified in genome-wide association study for breast cancer susceptibility.	Breast cancer	302 European ancestry female cases, 321 European ancestry female controls	1,153 European ancestry female cases, 1,215 European ancestry female controls	5p15.2	5	10467590	ROPN1L	ROPN1L			83853			rs1092913-T	rs1092913	0	1092913	intron_variant	0	0.13	2E-6	5.698970004336019		1.45	[1.24-1.69]	Affymetrix [782838]	N
2011-04-13	21424380	Sehrawat B	2011-03-19	Hum Genet	www.ncbi.nlm.nih.gov/pubmed/21424380	Potential novel candidate polymorphisms identified in genome-wide association study for breast cancer susceptibility.	Breast cancer	302 European ancestry female cases, 321 European ancestry female controls	1,153 European ancestry female cases, 1,215 European ancestry female controls	19q13.41	19	51869723	ZNF577	ZNF577			84765			rs10411161-T	rs10411161	0	10411161	intron_variant	0	0.13	7E-6	5.154901959985743		1.42	[1.22-1.65]	Affymetrix [782838]	N
2010-06-02	20453838	Turnbull C	2010-05-09	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20453838	Genome-wide association study identifies five new breast cancer susceptibility loci.	Breast cancer	3,659 European ancestry cases, 4,897 European ancestry controls	12,576 European ancestry cases, 12,223 European ancestry controls	10q26.13	10	121577821	FGFR2	FGFR2			2263			rs2981579-A	rs2981579	0	2981579	intron_variant	0	0.42	4E-31	30.397940008672037		1.43	[1.35-1.53]	Illumina [582886]	N
2010-06-02	20453838	Turnbull C	2010-05-09	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20453838	Genome-wide association study identifies five new breast cancer susceptibility loci.	Breast cancer	3,659 European ancestry cases, 4,897 European ancestry controls	12,576 European ancestry cases, 12,223 European ancestry controls	16q12.1	16	52552429	TOX3	CASC16			643714			rs3803662-A	rs3803662	0	3803662	non_coding_transcript_exon_variant	0	0.26	3E-15	14.522878745280337		1.3	[1.22-1.39]	Illumina [582886]	N
2010-06-02	20453838	Turnbull C	2010-05-09	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20453838	Genome-wide association study identifies five new breast cancer susceptibility loci.	Breast cancer	3,659 European ancestry cases, 4,897 European ancestry controls	12,576 European ancestry cases, 12,223 European ancestry controls	5q11.2	5	56736057	MAP3K1	LOC101928448 - LOC105378979	101928448	105378979		129825	30338	rs889312-C	rs889312	0	889312	regulatory_region_variant	1	0.28	5E-9	8.301029995663981		1.22	[1.14-1.30]	Illumina [582886]	N
2010-06-02	20453838	Turnbull C	2010-05-09	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20453838	Genome-wide association study identifies five new breast cancer susceptibility loci.	Breast cancer	3,659 European ancestry cases, 4,897 European ancestry controls	12,576 European ancestry cases, 12,223 European ancestry controls	8q24.21	8	127375606	intergenic	CASC21, CASC8			103021164, 727677			rs1562430-T	rs1562430	0	1562430	intron_variant	0	0.58	6E-7	6.221848749616356		1.17	[1.10-1.25]	Illumina [582886]	N
2010-06-02	20453838	Turnbull C	2010-05-09	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20453838	Genome-wide association study identifies five new breast cancer susceptibility loci.	Breast cancer	3,659 European ancestry cases, 4,897 European ancestry controls	12,576 European ancestry cases, 12,223 European ancestry controls	2q35	2	217041109	intergenic	LOC105373874, LOC101928278			105373874, 101928278			rs13387042-A	rs13387042	0	13387042	intergenic_variant	0	0.49	2E-10	9.698970004336019		1.21	[1.14-1.29]	Illumina [582886]	N
2010-06-02	20453838	Turnbull C	2010-05-09	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20453838	Genome-wide association study identifies five new breast cancer susceptibility loci.	Breast cancer	3,659 European ancestry cases, 4,897 European ancestry controls	12,576 European ancestry cases, 12,223 European ancestry controls	11p15.5	11	1920716	LSP1	TNNT3			7140			rs909116-T	rs909116	0	909116	intron_variant	0	0.53	7E-7	6.154901959985743		1.17	[1.10-1.24]	Illumina [582886]	N
2010-06-02	20453838	Turnbull C	2010-05-09	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20453838	Genome-wide association study identifies five new breast cancer susceptibility loci.	Breast cancer	3,659 European ancestry cases, 4,897 European ancestry controls	12,576 European ancestry cases, 12,223 European ancestry controls	6q25.1	6	151592978	ESR1, C6orf97	CCDC170			80129			rs3757318-A	rs3757318	0	3757318	intron_variant	0	0.07	3E-6	5.522878745280337		1.3	[1.17-1.46]	Illumina [582886]	N
2010-06-02	20453838	Turnbull C	2010-05-09	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20453838	Genome-wide association study identifies five new breast cancer susceptibility loci.	Breast cancer	3,659 European ancestry cases, 4,897 European ancestry controls	12,576 European ancestry cases, 12,223 European ancestry controls	3p24.1	3	27374522	SLC4A7	SLC4A7			9497			rs4973768-T	rs4973768	0	4973768	3_prime_UTR_variant	0	0.47	6E-7	6.221848749616356		1.16	[1.10-1.24]	Illumina [582886]	N
2010-06-02	20453838	Turnbull C	2010-05-09	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20453838	Genome-wide association study identifies five new breast cancer susceptibility loci.	Breast cancer	3,659 European ancestry cases, 4,897 European ancestry controls	12,576 European ancestry cases, 12,223 European ancestry controls	9p21.3	9	22062135	CDKN2A, CDKN2B	CDKN2B-AS1			100048912			rs1011970-T	rs1011970	0	1011970	intron_variant	0	0.17	3E-8	7.522878745280337		1.09	[1.04-1.14]	Illumina [582886]	N
2010-06-02	20453838	Turnbull C	2010-05-09	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20453838	Genome-wide association study identifies five new breast cancer susceptibility loci.	Breast cancer	3,659 European ancestry cases, 4,897 European ancestry controls	12,576 European ancestry cases, 12,223 European ancestry controls	10p15.1	10	5844771	ANKRD16, FBXO18	GDI2 - TRV-TAC3-1	2665	100189342		31222	8940	rs2380205-C	rs2380205	0	2380205	upstream_gene_variant	1	0.57	5E-7	6.301029995663981		1.06	[1.02-1.10]	Illumina [582886]	N
2010-06-02	20453838	Turnbull C	2010-05-09	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20453838	Genome-wide association study identifies five new breast cancer susceptibility loci.	Breast cancer	3,659 European ancestry cases, 4,897 European ancestry controls	12,576 European ancestry cases, 12,223 European ancestry controls	10q21.2	10	62518923	ZNF365	ZNF365			22891			rs10995190-G	rs10995190	0	10995190	intron_variant	0	0.85	5E-15	14.301029995663981		1.16	[1.10-1.22]	Illumina [582886]	N
2010-06-02	20453838	Turnbull C	2010-05-09	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20453838	Genome-wide association study identifies five new breast cancer susceptibility loci.	Breast cancer	3,659 European ancestry cases, 4,897 European ancestry controls	12,576 European ancestry cases, 12,223 European ancestry controls	10q22.3	10	79081391	ZMIZ1	ZMIZ1			57178			rs704010-A	rs704010	0	704010	intron_variant	0	0.39	4E-9	8.397940008672037		1.07	[1.03-1.11]	Illumina [582886]	N
2010-06-02	20453838	Turnbull C	2010-05-09	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20453838	Genome-wide association study identifies five new breast cancer susceptibility loci.	Breast cancer	3,659 European ancestry cases, 4,897 European ancestry controls	12,576 European ancestry cases, 12,223 European ancestry controls	11q13.3	11	69513996	FGF3, MYEOV, CCND1, ORAOV1, FGF19, FGF4	LINC01488 - CCND1	101928292	595		20453	127109	rs614367-T	rs614367	0	614367	intergenic_variant	1	0.15	3E-15	14.522878745280337		1.15	[1.10-1.20]	Illumina [582886]	N
2012-10-13	22923054	Chen F	2012-08-25	Hum Genet	www.ncbi.nlm.nih.gov/pubmed/22923054	A genome-wide association study of breast cancer in women of African ancestry.	Breast cancer	3,016 African American cases, 2,745 African American controls	3,533 African ancestry cases, 11,046 African ancestry controls	14q31.3	14	87829256	GALC	LOC105370611 - GALC	105370611	2581		173962	103758	rs4322600-G	rs4322600	0	4322600	intron_variant	1	0.78	4E-6	5.3979400086720375		1.18	[1.10-1.27]	Illumina [2067098] (imputed)	N
2013-04-24	23354978	Rinella ES	2013-01-25	Hum Genet	www.ncbi.nlm.nih.gov/pubmed/23354978	Genetic variants associated with breast cancer risk for Ashkenazi Jewish women with strong family histories but no identifiable BRCA1/2 mutation.	Breast cancer	477 Ashkenazi Jewish cases, 524 Ashkenazi Jewish controls	203 Ashkenazi Jewish cases, 263 Ashkenazi Jewish contols	10q26.13	10	121579461	FGFR2	FGFR2			2263			rs1078806-C	rs1078806	0	1078806	intron_variant	0	0.39	2E-6	5.698970004336019	(Pooled P value)	1.43	[NR]	Affymetrix [435632]	N
2013-06-06	23468962	Song C	2013-02-28	PLoS One	www.ncbi.nlm.nih.gov/pubmed/23468962	A genome-wide scan for breast cancer risk haplotypes among African American women.	Breast cancer	3,016 African American cases, 2,745 African American controls	NA	1p36.23	1;1;1;1;1	8335381;8335500;8326670;8334176;8330828	SLC45A1	SLC45A1; SLC45A1; SLC45A1; SLC45A1; SLC45A1						rs2305016-?; rs7535752-?; rs9628987-?; rs12711517-?; rs2289731-?	rs2305016; rs7535752; rs9628987; rs12711517; rs2289731	0		intron_variant; missense_variant; intron_variant; intron_variant; synonymous_variant		NR	5E-6	5.301029995663981		1.23	[1.12-1.35]	Illumina [1006480]	N
2013-06-06	23468962	Song C	2013-02-28	PLoS One	www.ncbi.nlm.nih.gov/pubmed/23468962	A genome-wide scan for breast cancer risk haplotypes among African American women.	Breast cancer	3,016 African American cases, 2,745 African American controls	NA	4q27	4;4	121200339;121205653	TNIP3	TNIP3; TNIP3						rs17435444-A; rs13116936-G	rs17435444; rs13116936	0		intron_variant; intron_variant		0.64	3E-7	6.522878745280337		1.23	[1.13-1.33]	Illumina [1006480]	N
2013-06-06	23468962	Song C	2013-02-28	PLoS One	www.ncbi.nlm.nih.gov/pubmed/23468962	A genome-wide scan for breast cancer risk haplotypes among African American women.	Breast cancer	3,016 African American cases, 2,745 African American controls	NA	10p15.1	10;10;10	5630056;5628312;5623811		LOC107984199; LOC107984199; LOC102723629 - LOC107984199						rs4414128-?; rs2386661-?; rs17141741-?	rs4414128; rs2386661; rs17141741	0		upstream_gene_variant; upstream_gene_variant; upstream_gene_variant		NR	5E-6	5.301029995663981		1.27	[1.14-1.39]	Illumina [1006480]	N
2013-06-06	23468962	Song C	2013-02-28	PLoS One	www.ncbi.nlm.nih.gov/pubmed/23468962	A genome-wide scan for breast cancer risk haplotypes among African American women.	Breast cancer	3,016 African American cases, 2,745 African American controls	NA	14q24.1	14;14;14;14;14;14	68497029;68506829;68507560;68505059;68500665;68508657		RAD51B; RAD51B; RAD51B; RAD51B; RAD51B; RAD51B						rs765899-?; rs757369-?; rs10132579-?; rs2842347-?; rs737387-?; rs2842346-?	rs765899; rs757369; rs10132579; rs2842347; rs737387; rs2842346	0		intron_variant; intron_variant; intron_variant; intron_variant; intron_variant; intron_variant		NR	2E-6	5.698970004336019		1.67	[1.35-2.08]	Illumina [1006480]	N
2013-09-12	23535733	Garcia-Closas M	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535733	Genome-wide association studies identify four ER negative-specific breast cancer risk loci.	Breast cancer	4,193 European ancestry cases, 35,194 European ancestry controls	6,514 European ancestry cases, 41,455 European ancestry controls	1q32.1	1	204549714	LRRN2, PIK3C2B, MDM4	MDM4			4194			rs4245739-?	rs4245739	0	4245739	3_prime_UTR_variant	0	0.26	2E-12	11.698970004336019		1.14	[1.10-1.18]	Illumina [NR]	N
2013-09-12	23535733	Garcia-Closas M	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535733	Genome-wide association studies identify four ER negative-specific breast cancer risk loci.	Breast cancer	4,193 European ancestry cases, 35,194 European ancestry controls	6,514 European ancestry cases, 41,455 European ancestry controls	1q32.1	1	202218048	LGR6, UBE2T, PTPN7	LGR6			59352			rs6678914-?	rs6678914	0	6678914	intron_variant	0	0.59	1E-8	8.0		1.1	[1.06-1.13]	Illumina [NR]	N
2013-09-12	23535733	Garcia-Closas M	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535733	Genome-wide association studies identify four ER negative-specific breast cancer risk loci.	Breast cancer	4,193 European ancestry cases, 35,194 European ancestry controls	6,514 European ancestry cases, 41,455 European ancestry controls	2p24.1	2	19121042	intergenic	LOC105373455 - MIR4757	105373455	100616307		54972	227387	rs12710696-?	rs12710696	0	12710696	intron_variant	1	0.36	5E-8	7.301029995663981		1.1	[1.06-1.13]	Illumina [NR]	N
2013-09-12	23535733	Garcia-Closas M	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535733	Genome-wide association studies identify four ER negative-specific breast cancer risk loci.	Breast cancer	4,193 European ancestry cases, 35,194 European ancestry controls	6,514 European ancestry cases, 41,455 European ancestry controls	16q12.2	16	53821379	FTO, KIAA1752	FTO			79068			rs11075995-?	rs11075995	0	11075995	intron_variant	0	0.24	4E-8	7.3979400086720375		1.11	[1.07-1.15]	Illumina [NR]	N
2014-04-10	24143190	Low SK	2013-10-15	PLoS One	www.ncbi.nlm.nih.gov/pubmed/24143190	Genome-wide association study of breast cancer in the Japanese population.	Breast cancer	2,642 Japanese ancestry cases, 2,099 Japanese ancestry controls	2,885 Japanese ancestry cases, 3,395 Japanese ancestry controls	10q26.13	10	121580797	FGFR2	FGFR2			2263			rs2981578-C	rs2981578	0	2981578	intron_variant	0	0.514	1E-12	12.0		1.225	[1.158-1.296]	Illumina [5335291] (imputed)	N
2014-04-10	24143190	Low SK	2013-10-15	PLoS One	www.ncbi.nlm.nih.gov/pubmed/24143190	Genome-wide association study of breast cancer in the Japanese population.	Breast cancer	2,642 Japanese ancestry cases, 2,099 Japanese ancestry controls	2,885 Japanese ancestry cases, 3,395 Japanese ancestry controls	16q12.2	16	52601088	TOX3, LOC643714	CASC16			643714			rs12922061-T	rs12922061	0	12922061	intron_variant	0	0.241	4E-10	9.397940008672037		1.231	[1.153-1.314]	Illumina [5335291] (imputed)	N
2014-04-10	24143190	Low SK	2013-10-15	PLoS One	www.ncbi.nlm.nih.gov/pubmed/24143190	Genome-wide association study of breast cancer in the Japanese population.	Breast cancer	2,642 Japanese ancestry cases, 2,099 Japanese ancestry controls	2,885 Japanese ancestry cases, 3,395 Japanese ancestry controls	16q12.1	16	52552429	TOX3, LOC643714	CASC16			643714			rs3803662-T	rs3803662	0	3803662	non_coding_transcript_exon_variant	0	0.522	3E-11	10.522878745280337		1.213	[1.146-1.284]	Illumina [5335291] (imputed)	N
2014-04-10	24143190	Low SK	2013-10-15	PLoS One	www.ncbi.nlm.nih.gov/pubmed/24143190	Genome-wide association study of breast cancer in the Japanese population.	Breast cancer	2,642 Japanese ancestry cases, 2,099 Japanese ancestry controls	2,885 Japanese ancestry cases, 3,395 Japanese ancestry controls	12p13.1	12	14257551	ATF7IP	GNAI2P1 - RPL30P11	2772	100271303		2065	99314	rs17221259-G	rs17221259	0	17221259	downstream_gene_variant	1	0.204	7E-6	5.154901959985743		1.252	[1.136-1.381]	Illumina [5335291] (imputed)	N
2013-09-12	23535733	Garcia-Closas M	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535733	Genome-wide association studies identify four ER negative-specific breast cancer risk loci.	Breast cancer	4,193 European ancestry cases, 35,194 European ancestry controls	6,514 European ancestry cases, 41,455 European ancestry controls	5p15.33	5	1279675	TERT	TERT			7015			rs10069690-T	rs10069690	0	10069690	intron_variant	0	0.321	5E-12	11.301029995663981		1.15	[1.11-1.20]	Illumina [NR]	N
2013-09-12	23535733	Garcia-Closas M	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535733	Genome-wide association studies identify four ER negative-specific breast cancer risk loci.	Breast cancer	4,193 European ancestry cases, 35,194 European ancestry controls	6,514 European ancestry cases, 41,455 European ancestry controls	6q14.1	6	81483392	intergenic	LOC105377871			105377871			rs17530068-C	rs17530068	0	17530068	intergenic_variant	0	0.237	3E-6	5.522878745280337		1.09	[1.05-1.13]	Illumina [NR]	N
2013-09-12	23535733	Garcia-Closas M	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535733	Genome-wide association studies identify four ER negative-specific breast cancer risk loci.	Breast cancer	4,193 European ancestry cases, 35,194 European ancestry controls	6,514 European ancestry cases, 41,455 European ancestry controls	6q25.1	6	151627231	ESR1	CCDC170 - ESR1	80129	2099		6038	26917	rs2046210-A	rs2046210	0	2046210	intergenic_variant	1	0.423	5E-16	15.301029995663981		1.15	[1.11-1.19]	Illumina [NR]	N
2013-09-12	23535733	Garcia-Closas M	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535733	Genome-wide association studies identify four ER negative-specific breast cancer risk loci.	Breast cancer	4,193 European ancestry cases, 35,194 European ancestry controls	6,514 European ancestry cases, 41,455 European ancestry controls	10q21.2	10	62518923	ZNF365	ZNF365			22891			rs10995190-G	rs10995190	0	10995190	intron_variant	0	0.846	1E-7	7.0		1.12	[1.08-1.18]	Illumina [NR]	N
2013-09-12	23535733	Garcia-Closas M	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535733	Genome-wide association studies identify four ER negative-specific breast cancer risk loci.	Breast cancer	4,193 European ancestry cases, 35,194 European ancestry controls	6,514 European ancestry cases, 41,455 European ancestry controls	12p11.22	12	28002147	PTHLH	PTHLH - LOC105369710	5744	105369710		27960	59494	rs10771399-T	rs10771399	0	10771399	intergenic_variant	1	0.895	2E-12	11.698970004336019		1.2	[1.15-1.27]	Illumina [NR]	N
2013-09-12	23535733	Garcia-Closas M	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535733	Genome-wide association studies identify four ER negative-specific breast cancer risk loci.	Breast cancer	4,193 European ancestry cases, 35,194 European ancestry controls	6,514 European ancestry cases, 41,455 European ancestry controls	16q12.1	16	52552429	TOX3	CASC16			643714			rs3803662-T	rs3803662	0	3803662	non_coding_transcript_exon_variant	0	0.267	6E-13	12.221848749616356		1.14	[1.10-1.18]	Illumina [NR]	N
2013-09-12	23535733	Garcia-Closas M	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535733	Genome-wide association studies identify four ER negative-specific breast cancer risk loci.	Breast cancer	4,193 European ancestry cases, 35,194 European ancestry controls	6,514 European ancestry cases, 41,455 European ancestry controls	19p13.11	19	17278895	MERIT40	BABAM1			29086			rs8170-A	rs8170	0	8170	synonymous_variant	0	0.191	9E-13	12.045757490560675		1.15	[1.11-1.20]	Illumina [NR]	N
2013-09-12	23535733	Garcia-Closas M	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535733	Genome-wide association studies identify four ER negative-specific breast cancer risk loci.	Breast cancer	4,193 European ancestry cases, 35,194 European ancestry controls	6,514 European ancestry cases, 41,455 European ancestry controls	1p36.22	1	10506158	PEX14	PEX14			5195			rs616488-A	rs616488	0	616488	intron_variant	0	0.665	1E-8	8.0		1.1	[1.06-1.14]	Illumina [NR]	N
2013-09-12	23535733	Garcia-Closas M	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535733	Genome-wide association studies identify four ER negative-specific breast cancer risk loci.	Breast cancer	4,193 European ancestry cases, 35,194 European ancestry controls	6,514 European ancestry cases, 41,455 European ancestry controls	5q33.3	5	158817075	EBF1	EBF1			1879			rs1432679-C	rs1432679	0	1432679	intron_variant	0	0.435	7E-6	5.154901959985743		1.08	[1.04-1.11]	Illumina [NR]	N
2013-09-12	23535733	Garcia-Closas M	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535733	Genome-wide association studies identify four ER negative-specific breast cancer risk loci.	Breast cancer	4,193 European ancestry cases, 35,194 European ancestry controls	6,514 European ancestry cases, 41,455 European ancestry controls	12q22	12	95633983	NTN4	USP44 - PGAM1P5	84101	100132594		82454	15272	rs17356907-A	rs17356907	0	17356907	intron_variant	1	0.702	9E-6	5.045757490560675		1.09	[1.04-1.12]	Illumina [NR]	N
2013-09-12	23535733	Garcia-Closas M	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535733	Genome-wide association studies identify four ER negative-specific breast cancer risk loci.	Breast cancer	4,193 European ancestry cases, 35,194 European ancestry controls	6,514 European ancestry cases, 41,455 European ancestry controls	13q13.1	13	32398489	BRCA2, N4BP2L1	BRCA2			675			rs11571833-T	rs11571833	0	11571833	stop_gained	0	0.496	6E-6	5.221848749616356		1.52	[1.31-1.77]	Illumina [NR]	N
2013-09-12	23535733	Garcia-Closas M	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535733	Genome-wide association studies identify four ER negative-specific breast cancer risk loci.	Breast cancer	4,193 European ancestry cases, 35,194 European ancestry controls	6,514 European ancestry cases, 41,455 European ancestry controls	16q12.2	16	53779455	FTO, MIR1972-2	FTO			79068			rs17817449-T	rs17817449	0	17817449	intron_variant	0	0.526	6E-7	6.221848749616356		1.09	[1.05-1.12]	Illumina [NR]	N
2013-09-12	23535733	Garcia-Closas M	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535733	Genome-wide association studies identify four ER negative-specific breast cancer risk loci.	Breast cancer	4,193 European ancestry cases, 35,194 European ancestry controls	6,514 European ancestry cases, 41,455 European ancestry controls	22q13.1	22	40480230	MKL1	MKL1			57591			rs6001930-C	rs6001930	0	6001930	intron_variant	0	0.107	2E-6	5.698970004336019		1.14	[1.08-1.20]	Illumina [NR]	N
2014-03-26	24025145	Chung S	2013-09-11	Breast Cancer Res	www.ncbi.nlm.nih.gov/pubmed/24025145	A genome-wide association study of chemotherapy-induced alopecia in breast cancer patients.	Adverse response to chemotherapy in breast cancer (alopecia) (cyclophosphamide+epirubicin+/-5FU)	116 Japanese ancestry cases, 108 Japanese ancestry controls	NA	13q12.3	13	30740318	ALOX5AP	ALOX5AP			241			rs3885907-G	rs3885907	0	3885907	intron_variant	0	0.18	1E-6	6.0	(Dominant)	2.66	[1.71-4.13]	Illumina [555600]	N
2014-03-26	24025145	Chung S	2013-09-11	Breast Cancer Res	www.ncbi.nlm.nih.gov/pubmed/24025145	A genome-wide association study of chemotherapy-induced alopecia in breast cancer patients.	Adverse response to chemotherapy in breast cancer (alopecia) (cyclophosphamide+epirubicin+/-5FU)	116 Japanese ancestry cases, 108 Japanese ancestry controls	NA	1p21.3	1	94615889	LOC100130235	LOC105378861			105378861			rs4474258-A	rs4474258	0	4474258	non_coding_transcript_exon_variant	0	0.43	5E-6	5.301029995663981	(Recessive)	1.89	[1.29-2.75]	Illumina [555600]	N
2014-03-26	24025145	Chung S	2013-09-11	Breast Cancer Res	www.ncbi.nlm.nih.gov/pubmed/24025145	A genome-wide association study of chemotherapy-induced alopecia in breast cancer patients.	Adverse response to chemotherapy in breast cancer (alopecia) (cyclophosphamide+epirubicin+/-5FU)	116 Japanese ancestry cases, 108 Japanese ancestry controls	NA	10p13	10	13625731	PRPF18	PRPF18			8559			rs7089227-G	rs7089227	0	7089227	intron_variant	0	0.41	7E-6	5.154901959985743	(Dominant)	1.99	[1.37-2.90]	Illumina [555600]	N
2014-03-27	24025145	Chung S	2013-09-11	Breast Cancer Res	www.ncbi.nlm.nih.gov/pubmed/24025145	A genome-wide association study of chemotherapy-induced alopecia in breast cancer patients.	Adverse response to chemotherapy in breast cancer (alopecia) (cyclophosphamide+doxorubicin+/-5FU)	64 Japanese ancestry cases, 27 Japanese ancestry controls	NA	1q21.2	1	147548685	BCL9	BCL9			607			rs594206-A	rs594206	0	594206	intron_variant	0	0.78	6E-7	6.221848749616356	(Dominant)	36.3	[4.58-287]	Illumina [555600]	N
2014-03-27	24025145	Chung S	2013-09-11	Breast Cancer Res	www.ncbi.nlm.nih.gov/pubmed/24025145	A genome-wide association study of chemotherapy-induced alopecia in breast cancer patients.	Adverse response to chemotherapy in breast cancer (alopecia) (cyclophosphamide+doxorubicin+/-5FU)	64 Japanese ancestry cases, 27 Japanese ancestry controls	NA	1p31.1	1	70421416	CTH	CTH			1491			rs672203-A	rs672203	0	672203	intron_variant	0	0.52	2E-6	5.698970004336019	(Dominant)	5.33	[2.59-11.0]	Illumina [555600]	N
2014-03-27	24025145	Chung S	2013-09-11	Breast Cancer Res	www.ncbi.nlm.nih.gov/pubmed/24025145	A genome-wide association study of chemotherapy-induced alopecia in breast cancer patients.	Adverse response to chemotherapy in breast cancer (alopecia) (cyclophosphamide+doxorubicin+/-5FU)	64 Japanese ancestry cases, 27 Japanese ancestry controls	NA	9p24.2	9	2203938	SMARCA2	LOC107987043			107987043			rs6475600-C	rs6475600	0	6475600	intergenic_variant	0	0.63	2E-6	5.698970004336019	(Allelic)	7.78	3.25-18.6]	Illumina [555600]	N
2014-03-27	24025145	Chung S	2013-09-11	Breast Cancer Res	www.ncbi.nlm.nih.gov/pubmed/24025145	A genome-wide association study of chemotherapy-induced alopecia in breast cancer patients.	Adverse response to chemotherapy in breast cancer (alopecia) (cyclophosphamide+doxorubicin+/-5FU)	64 Japanese ancestry cases, 27 Japanese ancestry controls	NA	4p15.31	4	18864546	LCORL	LOC105374510 - LOC107986263	105374510	107986263		27483	103950	rs6845621-C	rs6845621	0	6845621	intergenic_variant	1	0.20	2E-6	5.698970004336019	(Allelic)	5.53	[2.61-11.7]	Illumina [555600]	N
2014-03-27	24025145	Chung S	2013-09-11	Breast Cancer Res	www.ncbi.nlm.nih.gov/pubmed/24025145	A genome-wide association study of chemotherapy-induced alopecia in breast cancer patients.	Adverse response to chemotherapy in breast cancer (alopecia) (cyclophosphamide+doxorubicin+/-5FU)	64 Japanese ancestry cases, 27 Japanese ancestry controls	NA	9q33.3	9	123933491	DENND1A	DENND1A - LOC105376267	57706	105376267		3333	62581	rs10818894-G	rs10818894	0	10818894	upstream_gene_variant	1	0.70	2E-6	5.698970004336019	(Dominant)	10.4	[3.56-30.1]	Illumina [555600]	N
2014-03-27	24025145	Chung S	2013-09-11	Breast Cancer Res	www.ncbi.nlm.nih.gov/pubmed/24025145	A genome-wide association study of chemotherapy-induced alopecia in breast cancer patients.	Adverse response to chemotherapy in breast cancer (alopecia) (cyclophosphamide+doxorubicin+/-5FU)	64 Japanese ancestry cases, 27 Japanese ancestry controls	NA	8p23.2	8	5017650	LOC100129861	CSMD1 - RSL24D1P7	64478	100129861		22615	53639	rs10112481-A	rs10112481	0	10112481	intergenic_variant	1	0.22	4E-6	5.3979400086720375	(Allelic)	5.12	[2.46-10.6]	Illumina [555600]	N
2014-03-27	24025145	Chung S	2013-09-11	Breast Cancer Res	www.ncbi.nlm.nih.gov/pubmed/24025145	A genome-wide association study of chemotherapy-induced alopecia in breast cancer patients.	Adverse response to chemotherapy in breast cancer (alopecia) (cyclophosphamide+doxorubicin+/-5FU)	64 Japanese ancestry cases, 27 Japanese ancestry controls	NA	18q22.1	18	65231430	CDH7	LOC105372168 - LOC107985128	105372168	107985128		87223	192598	rs637644-G	rs637644	0	637644	intergenic_variant	1	0.80	7E-6	5.154901959985743	(Allelic)	32.5	[4.08-259]	Illumina [555600]	N
2014-03-27	24025145	Chung S	2013-09-11	Breast Cancer Res	www.ncbi.nlm.nih.gov/pubmed/24025145	A genome-wide association study of chemotherapy-induced alopecia in breast cancer patients.	Adverse response to chemotherapy in breast cancer (alopecia) (cyclophosphamide+doxorubicin+/-5FU)	64 Japanese ancestry cases, 27 Japanese ancestry controls	NA	16q23.3	16	83292454	CDH13	CDH13			1012			rs11644424-T	rs11644424	0	11644424	intron_variant	0	0.44	8E-6	5.096910013008056	(Dominant)	3.32	[1.71-6.44]	Illumina [555600]	N
2013-06-06	23468962	Song C	2013-02-28	PLoS One	www.ncbi.nlm.nih.gov/pubmed/23468962	A genome-wide scan for breast cancer risk haplotypes among African American women.	Breast cancer	3,016 African American cases, 2,745 African American controls	NA	10q22.3	10	79295869		ZMIZ1			57178			rs12355688-T	rs12355688	0	12355688	non_coding_transcript_exon_variant	0	0.22	6E-6	5.221848749616356		1.24	[1.13-1.36]	Illumina [1006480]	N
2013-06-06	23468962	Song C	2013-02-28	PLoS One	www.ncbi.nlm.nih.gov/pubmed/23468962	A genome-wide scan for breast cancer risk haplotypes among African American women.	Breast cancer	3,016 African American cases, 2,745 African American controls	NA	1p36.23	1;1	8326670;8335500		SLC45A1; SLC45A1						rs9628987-?; rs7535752-?	rs9628987; rs7535752	0		intron_variant; missense_variant		NR	5E-6	5.301029995663981				Illumina [1006480]	N
2013-06-06	23468962	Song C	2013-02-28	PLoS One	www.ncbi.nlm.nih.gov/pubmed/23468962	A genome-wide scan for breast cancer risk haplotypes among African American women.	Breast cancer	3,016 African American cases, 2,745 African American controls	NA	3p26.1	3;3	7220327;7242282		GRM7; GRM7						rs6797852-?; rs1810320-?	rs6797852; rs1810320	0		intron_variant; intron_variant		NR	3E-6	5.522878745280337				Illumina [1006480]	N
2013-06-06	23468962	Song C	2013-02-28	PLoS One	www.ncbi.nlm.nih.gov/pubmed/23468962	A genome-wide scan for breast cancer risk haplotypes among African American women.	Breast cancer	3,016 African American cases, 2,745 African American controls	NA	4q27	4;4	121185138;121205653		TNIP3; TNIP3						rs17051310-?; rs13116936-?	rs17051310; rs13116936	0		intron_variant; intron_variant		NR	2E-6	5.698970004336019				Illumina [1006480]	N
2013-06-06	23468962	Song C	2013-02-28	PLoS One	www.ncbi.nlm.nih.gov/pubmed/23468962	A genome-wide scan for breast cancer risk haplotypes among African American women.	Breast cancer	3,016 African American cases, 2,745 African American controls	NA	4q27	4;4	121215608;121189820		TNIP3; TNIP3						rs4455437-?; rs921551-?	rs4455437; rs921551	0		intron_variant; intron_variant		NR	2E-6	5.698970004336019				Illumina [1006480]	N
2013-06-06	23468962	Song C	2013-02-28	PLoS One	www.ncbi.nlm.nih.gov/pubmed/23468962	A genome-wide scan for breast cancer risk haplotypes among African American women.	Breast cancer	3,016 African American cases, 2,745 African American controls	NA	4q27	4;4	121222509;121200339		TNIP3; TNIP3						rs6835704-?; rs17435444-?	rs6835704; rs17435444	0		intron_variant; intron_variant		NR	2E-6	5.698970004336019				Illumina [1006480]	N
2013-06-06	23468962	Song C	2013-02-28	PLoS One	www.ncbi.nlm.nih.gov/pubmed/23468962	A genome-wide scan for breast cancer risk haplotypes among African American women.	Breast cancer	3,016 African American cases, 2,745 African American controls	NA	5p15.32	5;5	5320143;5324870		ADAMTS16; LOC101929200; LOC101929200						rs3806872-?; rs16875333-?	rs3806872; rs16875333	0		3_prime_UTR_variant; downstream_gene_variant		NR	3E-6	5.522878745280337				Illumina [1006480]	N
2013-06-06	23468962	Song C	2013-02-28	PLoS One	www.ncbi.nlm.nih.gov/pubmed/23468962	A genome-wide scan for breast cancer risk haplotypes among African American women.	Breast cancer	3,016 African American cases, 2,745 African American controls	NA	12q22	12;12	94138989;94149730		LOC105369913 - LOC441644; PLXNC1						rs11613298-?; rs2230754-?	rs11613298; rs2230754	0		upstream_gene_variant; synonymous_variant		NR	5E-6	5.301029995663981				Illumina [1006480]	N
2013-06-06	23468962	Song C	2013-02-28	PLoS One	www.ncbi.nlm.nih.gov/pubmed/23468962	A genome-wide scan for breast cancer risk haplotypes among African American women.	Breast cancer	3,016 African American cases, 2,745 African American controls	NA	17q23.2	17;17	61319088;61314018		BCAS3; BCAS3						rs10853029-?; rs3785856-?	rs10853029; rs3785856	0		intron_variant; intron_variant		NR	8E-6	5.096910013008056	(Haplotype-?????)			Illumina [1006480]	N
2012-11-06	22951594	Elgazzar S	2012-09-06	J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/22951594	A genome-wide association study identifies a genetic variant in the SIAH2 locus associated with hormonal receptor-positive breast cancer in Japanese.	Breast cancer	1,086 Japanese ancestry cases, 1,816 Japanese ancestry controls	1,653 Japanese ancestry cases, 2,797 Japanese ancestry controls	3q25.1	3	150750021	SIAH2	SIAH2			6478			rs6788895-G	rs6788895	0	6788895	intron_variant	0	0.65	9E-8	7.045757490560675		1.22	[1.13-1.31]	Illumina [453627]	N
2012-11-06	22951594	Elgazzar S	2012-09-06	J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/22951594	A genome-wide association study identifies a genetic variant in the SIAH2 locus associated with hormonal receptor-positive breast cancer in Japanese.	Breast cancer	1,086 Japanese ancestry cases, 1,816 Japanese ancestry controls	1,653 Japanese ancestry cases, 2,797 Japanese ancestry controls	10q26.13	10	121573063	FGFR2	FGFR2			2263			rs3750817-T	rs3750817	0	3750817	intron_variant	0	0.49	8E-8	7.096910013008056		1.22	[NR]	Illumina [453627]	N
2012-12-02	23001122	Orr N	2012-09-23	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23001122	Genome-wide association study identifies a common variant in RAD51B associated with male breast cancer risk.	Breast cancer (male)	823 European ancestry cases, 2,795 European ancestry controls	438 European ancestry cases, 474 European ancestry controls	1p31.1	1	84156830	PRKACB	LOC107985046, PRKACB			107985046, 5567			rs903263-?	rs903263	0	903263	intron_variant	0	NR	1E-6	6.0		1.27	[1.10-1.34]	Illumina [447760]	N
2012-12-02	23001122	Orr N	2012-09-23	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23001122	Genome-wide association study identifies a common variant in RAD51B associated with male breast cancer risk.	Breast cancer (male)	823 European ancestry cases, 2,795 European ancestry controls	438 European ancestry cases, 474 European ancestry controls	14q24.1	14	68232877	RAD51B	RAD51B			5890			rs1314913-?	rs1314913	0	1314913	intron_variant	0	NR	3E-13	12.522878745280337		1.57	[1.39-1.77]	Illumina [447760]	N
2012-12-02	23001122	Orr N	2012-09-23	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23001122	Genome-wide association study identifies a common variant in RAD51B associated with male breast cancer risk.	Breast cancer (male)	823 European ancestry cases, 2,795 European ancestry controls	438 European ancestry cases, 474 European ancestry controls	16q12.1	16	52552429	LOC643174, TOX3	CASC16			643714			rs3803662-?	rs3803662	0	3803662	non_coding_transcript_exon_variant	0	NR	4E-15	14.397940008672037		1.5	[1.35-1.66]	Illumina [447760]	N
2013-03-26	23319801	Rafiq S	2013-01-14	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/23319801	Identification of inherited genetic variations influencing prognosis in early-onset breast cancer.	Breast cancer (prognosis)	536 European ancestry early-onset cases	1,516 European ancestry early-onset cases	5q14.3	5	91979496	ARRDC3	PCBP2P3 - LOC105379080	100131236	105379080		134968	347656	rs421379-?	rs421379	0	421379	intergenic_variant	1	0.05	1E-6	6.0		1.61	[1.33-1.96]	Illumina [487496]	N
2013-03-26	23319801	Rafiq S	2013-01-14	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/23319801	Identification of inherited genetic variations influencing prognosis in early-onset breast cancer.	Breast cancer (prognosis)	536 European ancestry early-onset cases	1,516 European ancestry early-onset cases	15q22.2	15	61410580	RORa	LOC105370847			105370847			rs3884558-?	rs3884558	0	3884558	intron_variant	0	0.07	4E-6	5.3979400086720375		1.46	[1.24-1.72]	Illumina [487496]	N
2013-03-26	23319801	Rafiq S	2013-01-14	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/23319801	Identification of inherited genetic variations influencing prognosis in early-onset breast cancer.	Breast cancer (prognosis)	536 European ancestry early-onset cases	1,516 European ancestry early-onset cases	17p13.1	17	9186907	NTN1	NTN1			9423			rs3785982-?	rs3785982	0	3785982	intron_variant	0	0.12	8E-6	5.096910013008056		1.4	[1.21-1.62]	Illumina [487496]	N
2013-03-26	23319801	Rafiq S	2013-01-14	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/23319801	Identification of inherited genetic variations influencing prognosis in early-onset breast cancer.	Breast cancer (prognosis)	536 European ancestry early-onset cases	1,516 European ancestry early-onset cases	1p13.2	1	114128347	SYT6	SYT6			148281			rs2774307-?	rs2774307	0	2774307	intron_variant	0	0.26	8E-6	5.096910013008056		1.3	[1.16-1.47]	Illumina [487496]	N
2013-03-26	23319801	Rafiq S	2013-01-14	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/23319801	Identification of inherited genetic variations influencing prognosis in early-onset breast cancer.	Breast cancer (prognosis)	536 European ancestry early-onset cases	1,516 European ancestry early-onset cases	1q23.3	1	164720525	PBX1	PBX1			5087			rs1387389-?	rs1387389	0	1387389	intron_variant	0	0.36	4E-6	5.3979400086720375		1.28	[1.16-1.43]	Illumina [487496]	N
2013-04-24	23354978	Rinella ES	2013-01-25	Hum Genet	www.ncbi.nlm.nih.gov/pubmed/23354978	Genetic variants associated with breast cancer risk for Ashkenazi Jewish women with strong family histories but no identifiable BRCA1/2 mutation.	Breast cancer	477 Ashkenazi Jewish cases, 524 Ashkenazi Jewish controls	203 Ashkenazi Jewish cases, 263 Ashkenazi Jewish contols	6p22.3	6	19443704	intergenic	RNA5SP205 - LOC105374960	100873466	105374960		5286	6117	rs16882214-?	rs16882214	0	16882214	intron_variant	1	0.81	2E-6	5.698970004336019	(Meta P value)	1.43	[NR]	Affymetrix [435632]	N
2013-04-24	23354978	Rinella ES	2013-01-25	Hum Genet	www.ncbi.nlm.nih.gov/pubmed/23354978	Genetic variants associated with breast cancer risk for Ashkenazi Jewish women with strong family histories but no identifiable BRCA1/2 mutation.	Breast cancer	477 Ashkenazi Jewish cases, 524 Ashkenazi Jewish controls	203 Ashkenazi Jewish cases, 263 Ashkenazi Jewish contols	15q24.3	15	77977130	intergenic	ADAMTS7P3			400406			rs12906542-?	rs12906542	0	12906542	intron_variant	0	0.93	7E-7	6.154901959985743	(Meta P value)	2.0	[NR]	Affymetrix [435632]	N
2015-05-16	25327703	Fejerman L	2014-10-20	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25327703	Genome-wide association study of breast cancer in Latinas identifies novel protective variants on 6q25.	Breast cancer	1,497 Latino cases, 3,213 Latino controls	1,643 Latino cases, 4,971 Latino controls	6q25.1	6	151633699	ESR1	CCDC170 - ESR1	80129	2099		12506	20449	rs140068132-A	rs140068132	0	140068132	intergenic_variant	1	0.93	9E-18	17.045757490560675		1.67	[1.49-1.89]	Affymetrix, Illumina [7229558] (imputed)	N
2015-05-16	25327703	Fejerman L	2014-10-20	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25327703	Genome-wide association study of breast cancer in Latinas identifies novel protective variants on 6q25.	Breast cancer	1,497 Latino cases, 3,213 Latino controls	1,643 Latino cases, 4,971 Latino controls	16q12.1	16	52565276	TOX3	CASC16			643714			rs4784227-T	rs4784227	0	4784227	intron_variant	0	0.31	3E-9	8.522878745280337		1.38	[1.24-1.54]	Affymetrix, Illumina [7229558] (imputed)	N
2015-09-22	25526632	Rafiq S	2014-12-19	PLoS One	www.ncbi.nlm.nih.gov/pubmed/25526632	A genome wide meta-analysis study for identification of common variation associated with breast cancer prognosis.	Breast cancer (survival)	1,341 European ancestry cases	1,523 European ancestry cases	10p14	10	11806793	C10orf47, ECHDC3	LOC105376415 - PROSER2	105376415	254427		21461	16548	rs12358475-?	rs12358475	0	12358475	intergenic_variant	1	NR	2E-6	5.698970004336019		1.33	[1.19-1.49]	Illumina [6500000] (imputed)	N
2015-09-22	25526632	Rafiq S	2014-12-19	PLoS One	www.ncbi.nlm.nih.gov/pubmed/25526632	A genome wide meta-analysis study for identification of common variation associated with breast cancer prognosis.	Breast cancer (survival)	1,341 European ancestry cases	1,523 European ancestry cases	16q24.1	16	86400840	LOC732275, FOXF1	LINC00917 - LOC401864	732275	401864		55161	34004	rs1728400-?	rs1728400	0	1728400	intergenic_variant	1	NR	6E-6	5.221848749616356		1.25	[1.13-1.39]	Illumina [6500000] (imputed)	N
2016-03-24	25987243	Parham LR	2015-05-19	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/25987243	Comprehensive genome-wide evaluation of lapatinib-induced liver injury yields a single genetic signal centered on known risk allele HLA-DRB1*07:01.	Lapatinib-induced hepatotoxicity	775 European ancestry treated breast cancer cases, 236 East Asian ancestry treated breast cancer cases, 247 treated breast cancer cases	NA				HLA-DRB1							HLA-DRB1*07:01	HLA-DRB1*07:01	0			1	NR	8E-11	10.096910013008056	(case/control)			Illumina [1085881]	N
2016-03-24	25987243	Parham LR	2015-05-19	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/25987243	Comprehensive genome-wide evaluation of lapatinib-induced liver injury yields a single genetic signal centered on known risk allele HLA-DRB1*07:01.	Lapatinib-induced hepatotoxicity	775 European ancestry treated breast cancer cases, 236 East Asian ancestry treated breast cancer cases, 247 treated breast cancer cases	NA				HLA-DRB1							HLA-DRB1*07:01	HLA-DRB1*07:01	0			1	NR	2E-18	17.69897000433602	(Maximum ALT)			Illumina [1085881]	N
2015-09-22	25526632	Rafiq S	2014-12-19	PLoS One	www.ncbi.nlm.nih.gov/pubmed/25526632	A genome wide meta-analysis study for identification of common variation associated with breast cancer prognosis.	Breast cancer (survival)	1,341 European ancestry cases	1,523 European ancestry cases	5q14.3	5	91979496	ARRDC3	PCBP2P3 - LOC105379080	100131236	105379080		134968	347656	rs421379-?	rs421379	0	421379	intergenic_variant	1	NR	1E-6	6.0		1.49	[1.27-1.75]	Illumina [6500000] (imputed)	N
2016-02-05	25867717	Song N	2015-04-13	PLoS One	www.ncbi.nlm.nih.gov/pubmed/25867717	Prediction of breast cancer survival using clinical and genetic markers by tumor subtypes.	Disease-free survival in breast cancer	1,732 Korean ancestry cases	1,494 Korean ancestry cases	15q25.1	15	79777420	MTHFS	RPS12P25 - RNU6-667P	646985	106479862		25371	39929	rs166870-T	rs166870	0	166870	intergenic_variant	1	0.13	3E-7	6.522878745280337	(HR+ HER2-)	2.3	[1.67-3.15]	Affymetrix [2210580] (imputed)	N
2016-02-05	25867717	Song N	2015-04-13	PLoS One	www.ncbi.nlm.nih.gov/pubmed/25867717	Prediction of breast cancer survival using clinical and genetic markers by tumor subtypes.	Disease-free survival in breast cancer	1,732 Korean ancestry cases	1,494 Korean ancestry cases	10q21.1	10	53506471	PCDH15	RNA5SP318 - PCDH15	100873584	65217		48183	296300	rs10825036-G	rs10825036	0	10825036	intergenic_variant	1	0.32	4E-7	6.3979400086720375	(HR- HER2-)	2.26	[1.34-3.81]	Affymetrix [2210580] (imputed)	N
2015-12-07	25890600	Guo Q	2015-04-18	J Natl Cancer Inst	www.ncbi.nlm.nih.gov/pubmed/25890600	Identification of novel genetic markers of breast cancer survival.	Breast cancer (survival)	23,059 European ancestry estrogen-receptor positive cases, 6,881 European ancestry estrogen-receptor negative cases, 8,014 European ancestry cases		2q24.3	2	162922103	KCNH7, BC042876	KCNH7 - RPL7P61	90134	101929589		83356	230148	rs148760487-?	rs148760487	0	148760487	intergenic_variant	1	0.01	2E-8	7.698970004336019		1.88	[1.51-2.34]	Affymetrix, Illumina [9000000] (imputed)	N
2016-03-24	25987243	Parham LR	2015-05-19	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/25987243	Comprehensive genome-wide evaluation of lapatinib-induced liver injury yields a single genetic signal centered on known risk allele HLA-DRB1*07:01.	Lapatinib-induced hepatotoxicity	775 European ancestry treated breast cancer cases, 236 East Asian ancestry treated breast cancer cases, 247 treated breast cancer cases	NA	8q21.13	8	80146584	TPD52	TPD52			7163			rs7828135-?	rs7828135	0	7828135	intron_variant	0	NR	5E-8	7.301029995663981	(Maximum ALT, Conditioned on HLA- DRB1*07:01)			Illumina [1085881]	N
2016-02-12	25956309	Palomba G	2015-05-10	BMC Cancer	www.ncbi.nlm.nih.gov/pubmed/25956309	Genome-wide association study of susceptibility loci for breast cancer in Sardinian population.	Breast cancer	1,367 Sardinian cases, 1,658 Sardinian controls	201 Sardinian cases, 1,467 Sardinian controls, 61,485 European ancestry cases, 60,860 European ancestry controls	10q26.13	10	121577603	FGFR2	FGFR2			2263			rs2912780-?	rs2912780	0	2912780	intron_variant	0	0.506	4E-6	5.3979400086720375		1.302	(1.164-1.456)	Affymetrix [2067645] (imputed)	N
2016-02-12	25956309	Palomba G	2015-05-10	BMC Cancer	www.ncbi.nlm.nih.gov/pubmed/25956309	Genome-wide association study of susceptibility loci for breast cancer in Sardinian population.	Breast cancer	1,367 Sardinian cases, 1,658 Sardinian controls	201 Sardinian cases, 1,467 Sardinian controls, 61,485 European ancestry cases, 60,860 European ancestry controls	16q12.1	16	52532542	TOX3	TOX3			27324			rs2193094-?	rs2193094	0	2193094	intron_variant	0	0.478	2E-7	6.698970004336019		1.337	(1.198-1.491)	Affymetrix [2067645] (imputed)	N
2015-10-26	25824743	Haryono SJ	2015-01-01	Asian Pac J Cancer Prev	www.ncbi.nlm.nih.gov/pubmed/25824743	A Pilot Genome-wide Association Study of Breast Cancer Susceptibility Loci in Indonesia.	Breast cancer	89 Indonesian ancestry cases, 46 Indonesian ancestry controls	NA	18p11.22	18	8716323	SOGA2	MTCL1			23255			rs2111836-G	rs2111836	0	2111836	intron_variant	0	0.22	7E-6	5.154901959985743		1.32	[1.17-1.44]	Affymetrix [292887]	N
2015-10-26	25824743	Haryono SJ	2015-01-01	Asian Pac J Cancer Prev	www.ncbi.nlm.nih.gov/pubmed/25824743	A Pilot Genome-wide Association Study of Breast Cancer Susceptibility Loci in Indonesia.	Breast cancer	89 Indonesian ancestry cases, 46 Indonesian ancestry controls	NA	2p12	2	79716982	CTNNA2	CTNNA2			1496			rs13025833-A	rs13025833	0	13025833	intron_variant	0	0.52	1E-7	7.0		1.2	[1.13-1.33]	Affymetrix [292887]	N
2017-03-20	28171663	Huo D	2016-09-04	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/28171663	Genome-wide Association Studies in Women of African Ancestry Identified 3q26.21 as a Novel Susceptibility Locus for Estrogen Receptor Negative Breast Cancer.	Breast cancer	3962 African American cases, 711 African ancestry cases, 4,150 African ancestry controls, 624 African ancestry controls	1,984 African American cases, 2,939 African American controls	3q26.31	3	172550013	TNFSF10	TNFSF10 - LOC105374219	8743	105374219		26506	42844	rs13074711-T	rs13074711	0	13074711	intergenic_variant	1	0.69	2E-6	5.698970004336019		1.14	[1.08-1.21]	Illumina [16147413] (imputed)	N
2017-03-20	28171663	Huo D	2016-09-04	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/28171663	Genome-wide Association Studies in Women of African Ancestry Identified 3q26.21 as a Novel Susceptibility Locus for Estrogen Receptor Negative Breast Cancer.	Breast cancer	3962 African American cases, 711 African ancestry cases, 4,150 African ancestry controls, 624 African ancestry controls	1,984 African American cases, 2,939 African American controls	5p15.33	5	1279675	TERT	TERT			7015			rs10069690-T	rs10069690	0	10069690	intron_variant	0	0.6	5E-6	5.301029995663981		1.13	[1.07-1.19]	Illumina [16147413] (imputed)	N
2017-01-10	27354352	Han MR	2016-06-27	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/27354352	Genome-wide association study in East Asians identifies two novel breast cancer susceptibility loci.	Breast cancer	7,619 East Asian ancestry cases, 6,286 East Asian ancestry controls	6,605 East Asian ancestry cases, 8,543 East Asian ancestry controls	1p22.3	1	87313534	LMO4	LOC101927844 - LMO4	101927844	8543		62203	14934	rs12118297-G	rs12118297	0	12118297	intergenic_variant	1	0.62	4E-8	7.3979400086720375		1.1	[1.06-1.14]	Affymetrix, Illumina [668499] (imputed)	N
2017-01-10	27354352	Han MR	2016-06-27	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/27354352	Genome-wide association study in East Asians identifies two novel breast cancer susceptibility loci.	Breast cancer	7,619 East Asian ancestry cases, 6,286 East Asian ancestry controls	6,605 East Asian ancestry cases, 8,543 East Asian ancestry controls	21q22.12	21	34738904	LINC00160	LOC107985515			107985515			rs16992204-C	rs16992204	0	16992204	upstream_gene_variant	0	0.12	5E-8	7.301029995663981		1.13	[1.07-1.18]	Affymetrix, Illumina [668499] (imputed)	N
2017-01-10	27354352	Han MR	2016-06-27	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/27354352	Genome-wide association study in East Asians identifies two novel breast cancer susceptibility loci.	Breast cancer	7,619 East Asian ancestry cases, 6,286 East Asian ancestry controls	6,605 East Asian ancestry cases, 8,543 East Asian ancestry controls	6q25.1	6	151592978		CCDC170			80129			rs3757318-A	rs3757318	0	3757318	intron_variant	0	0.26	1E-6	6.0		1.15	[1.09-1.22]	Affymetrix, Illumina [668499] (imputed)	N
2017-01-10	27354352	Han MR	2016-06-27	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/27354352	Genome-wide association study in East Asians identifies two novel breast cancer susceptibility loci.	Breast cancer	7,619 East Asian ancestry cases, 6,286 East Asian ancestry controls	6,605 East Asian ancestry cases, 8,543 East Asian ancestry controls	6q25.1	6	151627231		CCDC170 - ESR1	80129	2099		6038	26917	rs2046210-A	rs2046210	0	2046210	intergenic_variant	1	0.35	7E-15	14.154901959985743		1.22	[1.16-1.29]	Affymetrix, Illumina [668499] (imputed)	N
2017-01-10	27354352	Han MR	2016-06-27	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/27354352	Genome-wide association study in East Asians identifies two novel breast cancer susceptibility loci.	Breast cancer	7,619 East Asian ancestry cases, 6,286 East Asian ancestry controls	6,605 East Asian ancestry cases, 8,543 East Asian ancestry controls	10q26.13	10	121577821		FGFR2			2263			rs2981579-A	rs2981579	0	2981579	intron_variant	0	0.55	3E-11	10.522878745280337		1.19	[1.11-1.23]	Affymetrix, Illumina [668499] (imputed)	N
2017-01-10	27354352	Han MR	2016-06-27	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/27354352	Genome-wide association study in East Asians identifies two novel breast cancer susceptibility loci.	Breast cancer	7,619 East Asian ancestry cases, 6,286 East Asian ancestry controls	6,605 East Asian ancestry cases, 8,543 East Asian ancestry controls	22q13.1	22	38962032		APOBEC3A			200315			rs12628403-C	rs12628403	0	12628403	intron_variant	0	0.27	4E-6	5.3979400086720375		1.17	[1.09-1.25]	Affymetrix, Illumina [668499] (imputed)	N
2017-03-31	27117709	Couch FJ	2016-04-27	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27117709	Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.	Breast cancer	4,939 European ancestry estrogen receptor-negative cases, 14,352 European ancestry controls	7,333 European ancestry estrogen receptor-negative cases, 7,797 European ancestry BRCA1 mutation carrier cases, 7,455  European ancestry BRCA1 mutation carrier controls, 42,468 European ancestry controls	1p36.22	1	10503552	PEX14	PEX14			5195			rs10864459-?	rs10864459	0	10864459	intron_variant	0	0.69	5E-10	9.301029995663981		1.0526316	[1.01-1.1] (BRCA1 carriers)	Illumina [10909381] (imputed)	N
2017-03-31	27117709	Couch FJ	2016-04-27	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27117709	Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.	Breast cancer	4,939 European ancestry estrogen receptor-negative cases, 14,352 European ancestry controls	7,333 European ancestry estrogen receptor-negative cases, 7,797 European ancestry BRCA1 mutation carrier cases, 7,455  European ancestry BRCA1 mutation carrier controls, 42,468 European ancestry controls	1q32.1	1	202209914	LGR6	LGR6			59352			rs17489300-?	rs17489300	0	17489300	intron_variant	0	0.61	2E-8	7.698970004336019		1.0309278	[0.99-1.08] (BRCA1 carriers)	Illumina [10909381] (imputed)	N
2017-03-31	27117709	Couch FJ	2016-04-27	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27117709	Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.	Breast cancer	4,939 European ancestry estrogen receptor-negative cases, 14,352 European ancestry controls	7,333 European ancestry estrogen receptor-negative cases, 7,797 European ancestry BRCA1 mutation carrier cases, 7,455  European ancestry BRCA1 mutation carrier controls, 42,468 European ancestry controls	1q32.1	1	204549714	MDM4	MDM4			4194			rs4245739-?	rs4245739	0	4245739	3_prime_UTR_variant	0	0.28	8E-18	17.096910013008056		1.09	[1.05-1.14] (BRCA1 carriers)	Illumina [10909381] (imputed)	N
2017-03-31	27117709	Couch FJ	2016-04-27	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27117709	Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.	Breast cancer	4,939 European ancestry estrogen receptor-negative cases, 14,352 European ancestry controls	7,333 European ancestry estrogen receptor-negative cases, 7,797 European ancestry BRCA1 mutation carrier cases, 7,455  European ancestry BRCA1 mutation carrier controls, 42,468 European ancestry controls	2p24.1	2	19121042	Intergenic	LOC105373455 - MIR4757	105373455	100616307		54972	227387	rs12710696-?	rs12710696	0	12710696	intron_variant	1	0.39	2E-6	5.698970004336019		1.01	[0.97-1.05] (BRCA1 carriers)	Illumina [10909381] (imputed)	N
2017-03-31	27117709	Couch FJ	2016-04-27	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27117709	Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.	Breast cancer	4,939 European ancestry estrogen receptor-negative cases, 14,352 European ancestry controls	7,333 European ancestry estrogen receptor-negative cases, 7,797 European ancestry BRCA1 mutation carrier cases, 7,455  European ancestry BRCA1 mutation carrier controls, 42,468 European ancestry controls	2q14.2	2	120330606	INHBB	LOC105373584 - LOC105373989	105373584	105373989		11282	11844	rs11903787-?	rs11903787	0	11903787	downstream_gene_variant	1	0.74	7E-10	9.154901959985743		1.098901	[1.04-1.15] (BRCA1 carriers)	Illumina [10909381] (imputed)	N
2017-03-31	27117709	Couch FJ	2016-04-27	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27117709	Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.	Breast cancer	4,939 European ancestry estrogen receptor-negative cases, 14,352 European ancestry controls	7,333 European ancestry estrogen receptor-negative cases, 7,797 European ancestry BRCA1 mutation carrier cases, 7,455  European ancestry BRCA1 mutation carrier controls, 42,468 European ancestry controls	5p15.33	5	1279913	TERT	TERT			7015			rs2242652-?	rs2242652	0	2242652	intron_variant	0	0.22	8E-28	27.096910013008056		1.22	[1.16-1.28] (BRCA1 carriers)	Illumina [10909381] (imputed)	N
2017-03-31	27117709	Couch FJ	2016-04-27	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27117709	Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.	Breast cancer	4,939 European ancestry estrogen receptor-negative cases, 14,352 European ancestry controls	7,333 European ancestry estrogen receptor-negative cases, 7,797 European ancestry BRCA1 mutation carrier cases, 7,455  European ancestry BRCA1 mutation carrier controls, 42,468 European ancestry controls	5p15.33	5	1282204	TERT	TERT			7015			rs7726159-?	rs7726159	0	7726159	intron_variant	0	0.35	3E-8	7.522878745280337		1.07	[1.02-1.11] (BRCA1 carriers)	Illumina [10909381] (imputed)	N
2017-03-31	27117709	Couch FJ	2016-04-27	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27117709	Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.	Breast cancer	4,939 European ancestry estrogen receptor-negative cases, 14,352 European ancestry controls	7,333 European ancestry estrogen receptor-negative cases, 7,797 European ancestry BRCA1 mutation carrier cases, 7,455  European ancestry BRCA1 mutation carrier controls, 42,468 European ancestry controls	5p15.33	5	1297373	TERT	TERT - MIR4457	7015	100616235		1747	11937	rs2736108-?	rs2736108	0	2736108	upstream_gene_variant	1	0.71	3E-14	13.522878745280337		1.1235955	[1.08-1.16] (BRCA1 carriers)	Illumina [10909381] (imputed)	N
2017-03-31	27117709	Couch FJ	2016-04-27	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27117709	Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.	Breast cancer	4,939 European ancestry estrogen receptor-negative cases, 14,352 European ancestry controls	7,333 European ancestry estrogen receptor-negative cases, 7,797 European ancestry BRCA1 mutation carrier cases, 7,455  European ancestry BRCA1 mutation carrier controls, 42,468 European ancestry controls	6q25.1	6	151597721	ESR1	CCDC170			80129			rs12662670-?	rs12662670	0	12662670	intron_variant	0	0.09	1E-19	19.0		1.19	[1.11-1.27] (BRCA1 carriers)	Illumina [10909381] (imputed)	N
2017-03-31	27117709	Couch FJ	2016-04-27	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27117709	Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.	Breast cancer	4,939 European ancestry estrogen receptor-negative cases, 14,352 European ancestry controls	7,333 European ancestry estrogen receptor-negative cases, 7,797 European ancestry BRCA1 mutation carrier cases, 7,455  European ancestry BRCA1 mutation carrier controls, 42,468 European ancestry controls	6q25.1	6	151625017	ESR1	CCDC170 - ESR1	80129	2099		3824	29131	rs11155804-?	rs11155804	0	11155804	downstream_gene_variant	1	0.36	4E-28	27.397940008672037		1.15	[1.11-1.20] (BRCA1 carriers)	Illumina [10909381] (imputed)	N
2017-03-31	27117709	Couch FJ	2016-04-27	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27117709	Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.	Breast cancer	4,939 European ancestry estrogen receptor-negative cases, 14,352 European ancestry controls	7,333 European ancestry estrogen receptor-negative cases, 7,797 European ancestry BRCA1 mutation carrier cases, 7,455  European ancestry BRCA1 mutation carrier controls, 42,468 European ancestry controls	10q21.2	10	62518923	ZNF365	ZNF365			22891			rs10995190-?	rs10995190	0	10995190	intron_variant	0	0.84	8E-6	5.096910013008056		1.010101	[0.96-1.06] (BRCA1 carriers)	Illumina [10909381] (imputed)	N
2017-03-31	27117709	Couch FJ	2016-04-27	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27117709	Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.	Breast cancer	4,939 European ancestry estrogen receptor-negative cases, 14,352 European ancestry controls	7,333 European ancestry estrogen receptor-negative cases, 7,797 European ancestry BRCA1 mutation carrier cases, 7,455  European ancestry BRCA1 mutation carrier controls, 42,468 European ancestry controls	10q25.2	10	113023044	TCF7L2	TCF7L2			6934			rs6585202-?	rs6585202	0	6585202	intron_variant	0	0.47	1E-9	9.0		1.1	[1.05-1.14] (BRCA1 carriers)	Illumina [10909381] (imputed)	N
2017-03-31	27117709	Couch FJ	2016-04-27	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27117709	Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.	Breast cancer	4,939 European ancestry estrogen receptor-negative cases, 14,352 European ancestry controls	7,333 European ancestry estrogen receptor-negative cases, 7,797 European ancestry BRCA1 mutation carrier cases, 7,455  European ancestry BRCA1 mutation carrier controls, 42,468 European ancestry controls	11p15.5	11	1880867	LSP1	LSP1			4046			rs4980383-?	rs4980383	0	4980383	non_coding_transcript_exon_variant	0	0.45	9E-9	8.045757490560675		1.07	[1.03-1.11] (BRCA1 carriers)	Illumina [10909381] (imputed)	N
2017-03-31	27117709	Couch FJ	2016-04-27	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27117709	Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.	Breast cancer	4,939 European ancestry estrogen receptor-negative cases, 14,352 European ancestry controls	7,333 European ancestry estrogen receptor-negative cases, 7,797 European ancestry BRCA1 mutation carrier cases, 7,455  European ancestry BRCA1 mutation carrier controls, 42,468 European ancestry controls	12p11.22	12	28021884	PTHLH	PTHLH - LOC105369710	5744	105369710		47697	39757	rs7297051-?	rs7297051	0	7297051	regulatory_region_variant	1	0.77	3E-20	19.522878745280337		1.1235955	[1.08-1.18] (BRCA1 carriers)	Illumina [10909381] (imputed)	N
2017-03-31	27117709	Couch FJ	2016-04-27	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27117709	Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.	Breast cancer	4,939 European ancestry estrogen receptor-negative cases, 14,352 European ancestry controls	7,333 European ancestry estrogen receptor-negative cases, 7,797 European ancestry BRCA1 mutation carrier cases, 7,455  European ancestry BRCA1 mutation carrier controls, 42,468 European ancestry controls	12p11.22	12	28002147	PTHLH	PTHLH - LOC105369710	5744	105369710		27960	59494	rs10771399-?	rs10771399	0	10771399	intergenic_variant	1	0.9	7E-18	17.154901959985743		1.1627907	[1.1-1.25] (BRCA1 carriers)	Illumina [10909381] (imputed)	N
2017-03-31	27117709	Couch FJ	2016-04-27	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27117709	Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.	Breast cancer	4,939 European ancestry estrogen receptor-negative cases, 14,352 European ancestry controls	7,333 European ancestry estrogen receptor-negative cases, 7,797 European ancestry BRCA1 mutation carrier cases, 7,455  European ancestry BRCA1 mutation carrier controls, 42,468 European ancestry controls	16q12.1	16	52565276	TOX3	CASC16			643714			rs4784227-?	rs4784227	0	4784227	intron_variant	0	0.26	6E-15	14.221848749616356		1.07	[1.02-1.12] (BRCA1 carriers)	Illumina [10909381] (imputed)	N
2017-03-31	27117709	Couch FJ	2016-04-27	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27117709	Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.	Breast cancer	4,939 European ancestry estrogen receptor-negative cases, 14,352 European ancestry controls	7,333 European ancestry estrogen receptor-negative cases, 7,797 European ancestry BRCA1 mutation carrier cases, 7,455  European ancestry BRCA1 mutation carrier controls, 42,468 European ancestry controls	16q12.2	16	53779455	FTO	FTO			79068			rs17817449-?	rs17817449	0	17817449	intron_variant	0	0.59	5E-8	7.301029995663981		1.0526316	[1.01-1.09] (BRCA1 carriers)	Illumina [10909381] (imputed)	N
2017-03-31	27117709	Couch FJ	2016-04-27	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27117709	Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.	Breast cancer	4,939 European ancestry estrogen receptor-negative cases, 14,352 European ancestry controls	7,333 European ancestry estrogen receptor-negative cases, 7,797 European ancestry BRCA1 mutation carrier cases, 7,455  European ancestry BRCA1 mutation carrier controls, 42,468 European ancestry controls	16q12.2	16	53821379	FTO	FTO			79068			rs11075995-?	rs11075995	0	11075995	intron_variant	0	0.24	2E-6	5.698970004336019		1.01	[0.97-1.06] (BRCA1 carriers)	Illumina [10909381] (imputed)	N
2017-03-31	27117709	Couch FJ	2016-04-27	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27117709	Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.	Breast cancer	4,939 European ancestry estrogen receptor-negative cases, 14,352 European ancestry controls	7,333 European ancestry estrogen receptor-negative cases, 7,797 European ancestry BRCA1 mutation carrier cases, 7,455  European ancestry BRCA1 mutation carrier controls, 42,468 European ancestry controls	19p13.11	19	17278895	MERIT40	BABAM1			29086			rs8170-?	rs8170	0	8170	synonymous_variant	0	0.19	7E-21	20.154901959985743		1.17	[1.11-1.23] (BRCA1 carriers)	Illumina [10909381] (imputed)	N
2017-03-31	27117709	Couch FJ	2016-04-27	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27117709	Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.	Breast cancer	4,939 European ancestry estrogen receptor-negative cases, 14,352 European ancestry controls	7,333 European ancestry estrogen receptor-negative cases, 7,797 European ancestry BRCA1 mutation carrier cases, 7,455  European ancestry BRCA1 mutation carrier controls, 42,468 European ancestry controls	19p13.11	19	17283116	ADHB8	ANKLE1			126549			rs56069439-?	rs56069439	0	56069439	non_coding_transcript_exon_variant	0	0.3	1E-32	32.0		1.19	[1.14-1.24] (BRCA1 carriers)	Illumina [10909381] (imputed)	N
2017-03-31	27117709	Couch FJ	2016-04-27	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27117709	Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.	Breast cancer	4,939 European ancestry estrogen receptor-negative cases, 14,352 European ancestry controls	7,333 European ancestry estrogen receptor-negative cases, 7,797 European ancestry BRCA1 mutation carrier cases, 7,455  European ancestry BRCA1 mutation carrier controls, 42,468 European ancestry controls	2p23.2	2	28896719	WDR43	WDR43			23160			rs67073037-?	rs67073037	0	67073037	intron_variant	0	0.8	5E-9	8.301029995663981		1.0869565	[1.04-1.15] (BRCA1 carriers)	Illumina [10909381] (imputed)	N
2017-03-31	27117709	Couch FJ	2016-04-27	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27117709	Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.	Breast cancer	4,939 European ancestry estrogen receptor-negative cases, 14,352 European ancestry controls	7,333 European ancestry estrogen receptor-negative cases, 7,797 European ancestry BRCA1 mutation carrier cases, 7,455  European ancestry BRCA1 mutation carrier controls, 42,468 European ancestry controls	2q33.1	2	201071148	FAM126B, NDUFB3, CLK1, PPIL3	FAM126B			285172			rs114962751-?	rs114962751	0	114962751	intron_variant	0	0.02	7E-8	7.154901959985743		1.22	[1.05-1.42] (BRCA1 carriers)	Illumina [10909381] (imputed)	N
2017-03-31	27117709	Couch FJ	2016-04-27	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27117709	Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.	Breast cancer	4,939 European ancestry estrogen receptor-negative cases, 14,352 European ancestry controls	7,333 European ancestry estrogen receptor-negative cases, 7,797 European ancestry BRCA1 mutation carrier cases, 7,455  European ancestry BRCA1 mutation carrier controls, 42,468 European ancestry controls	13q22.1	13	73383544	KLF5, KLF12	RNY1P8 - MARK2P12	100873807	100421565		156284	24245	rs6562760-?	rs6562760	0	6562760	intergenic_variant	1	0.8	5E-10	9.301029995663981		1.1235955	[1.06-1.18] (BRCA1 carriers)	Illumina [10909381] (imputed)	N
2017-03-31	27117709	Couch FJ	2016-04-27	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27117709	Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.	Breast cancer	4,939 European ancestry estrogen receptor-negative cases, 14,352 European ancestry controls	7,333 European ancestry estrogen receptor-negative cases, 7,797 European ancestry BRCA1 mutation carrier cases, 7,455  European ancestry BRCA1 mutation carrier controls, 42,468 European ancestry controls	13q22.1	13	73232845	KLF12, KLF5	RNY1P8 - MARK2P12	100873807	100421565		5585	174944	rs12870942-?	rs12870942	0	12870942	intergenic_variant	1	0.3	4E-8	7.3979400086720375		1.06	[1.01-1.10] (BRCA1 carriers)	Illumina [10909381] (imputed)	N
2017-03-31	27117709	Couch FJ	2016-04-27	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27117709	Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.	Breast cancer	4,939 European ancestry estrogen receptor-negative cases, 14,352 European ancestry controls	7,333 European ancestry estrogen receptor-negative cases, 7,797 European ancestry BRCA1 mutation carrier cases, 7,455  European ancestry BRCA1 mutation carrier controls, 42,468 European ancestry controls	2q35	2	217431785	NR	DIRC3			729582			rs16857609-?	rs16857609	0	16857609	intron_variant	0	0.26	7E-6	5.154901959985743		1.04	[1.00-1.09] (BRCA1 carriers)	Illumina [10909381] (imputed)	N
2017-03-31	27117709	Couch FJ	2016-04-27	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27117709	Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.	Breast cancer	4,939 European ancestry estrogen receptor-negative cases, 14,352 European ancestry controls	7,333 European ancestry estrogen receptor-negative cases, 7,797 European ancestry BRCA1 mutation carrier cases, 7,455  European ancestry BRCA1 mutation carrier controls, 42,468 European ancestry controls	5q33.3	5	158817075	NR	EBF1			1879			rs1432679-?	rs1432679	0	1432679	intron_variant	0	0.44	2E-6	5.698970004336019		1.04	[1.00-1.08] (BRCA1 carriers)	Illumina [10909381] (imputed)	N
2017-03-31	27117709	Couch FJ	2016-04-27	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27117709	Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.	Breast cancer	4,939 European ancestry estrogen receptor-negative cases, 14,352 European ancestry controls	7,333 European ancestry estrogen receptor-negative cases, 7,797 European ancestry BRCA1 mutation carrier cases, 7,455  European ancestry BRCA1 mutation carrier controls, 42,468 European ancestry controls	8p11.23	8	37000965	NR	RPL26P25 - LOC105379377	100270966	105379377		12467	65169	rs13365225-?	rs13365225	0	13365225	intergenic_variant	1	0.81	7E-6	5.154901959985743		1.0416667	[0.99-1.1] (BRCA1 carriers)	Illumina [10909381] (imputed)	N
2017-03-31	27117709	Couch FJ	2016-04-27	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27117709	Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.	Breast cancer	4,939 European ancestry estrogen receptor-negative cases, 14,352 European ancestry controls	7,333 European ancestry estrogen receptor-negative cases, 7,797 European ancestry BRCA1 mutation carrier cases, 7,455  European ancestry BRCA1 mutation carrier controls, 42,468 European ancestry controls	11q24.3	11	129591276	NR	RPS27P20 - LINC01395	100271581	101929557		53103	20840	rs11820646-?	rs11820646	0	11820646	upstream_gene_variant	1	0.62	9E-6	5.045757490560675		1.0752687	[1.03-1.14] (BRCA1 carriers)	Illumina [10909381] (imputed)	N
2017-03-31	27117709	Couch FJ	2016-04-27	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27117709	Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.	Breast cancer	4,939 European ancestry estrogen receptor-negative cases, 14,352 European ancestry controls	7,333 European ancestry estrogen receptor-negative cases, 7,797 European ancestry BRCA1 mutation carrier cases, 7,455  European ancestry BRCA1 mutation carrier controls, 42,468 European ancestry controls	12q22	12	95633983	NR	USP44 - PGAM1P5	84101	100132594		82454	15272	rs17356907-?	rs17356907	0	17356907	intron_variant	1	0.71	5E-7	6.301029995663981		1.0526316	[1-1.1] (BRCA1 carriers)	Illumina [10909381] (imputed)	N
2017-03-31	27117709	Couch FJ	2016-04-27	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27117709	Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.	Breast cancer	4,939 European ancestry estrogen receptor-negative cases, 14,352 European ancestry controls	7,333 European ancestry estrogen receptor-negative cases, 7,797 European ancestry BRCA1 mutation carrier cases, 7,455  European ancestry BRCA1 mutation carrier controls, 42,468 European ancestry controls	17q25.3	17	79807926	NR	CBX8 - LOC102723961	57332	102723961		10810	8017	rs745570-?	rs745570	0	745570	intergenic_variant	1	0.51	6E-6	5.221848749616356		1.0416667	[1-1.09] (BRCA1 carriers)	Illumina [10909381] (imputed)	N
2017-03-31	27117709	Couch FJ	2016-04-27	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27117709	Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.	Breast cancer	4,939 European ancestry estrogen receptor-negative cases, 14,352 European ancestry controls	7,333 European ancestry estrogen receptor-negative cases, 7,797 European ancestry BRCA1 mutation carrier cases, 7,455  European ancestry BRCA1 mutation carrier controls, 42,468 European ancestry controls	22q13.1	22	40480230	NR	MKL1			57591			rs6001930-?	rs6001930	0	6001930	intron_variant	0	0.11	2E-6	5.698970004336019		1.07	[1.01-1.14] (BRCA1 carriers)	Illumina [10909381] (imputed)	N
2017-01-10	27354352	Han MR	2016-06-27	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/27354352	Genome-wide association study in East Asians identifies two novel breast cancer susceptibility loci.	Breast cancer	7,619 East Asian ancestry cases, 6,286 East Asian ancestry controls	6,605 East Asian ancestry cases, 8,543 East Asian ancestry controls	10q26.13	10	121586676	NR	FGFR2			2263			rs1219648-G	rs1219648	0	1219648	intron_variant	0	0.39	6E-9	8.221848749616356		1.17	[1.11-1.23]	Affymetrix, Illumina [668499] (imputed)	N
2017-01-10	27354352	Han MR	2016-06-27	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/27354352	Genome-wide association study in East Asians identifies two novel breast cancer susceptibility loci.	Breast cancer	7,619 East Asian ancestry cases, 6,286 East Asian ancestry controls	6,605 East Asian ancestry cases, 8,543 East Asian ancestry controls	10q26.13	10	121592803	NR	FGFR2			2263			rs2981582-A	rs2981582	0	2981582	intron_variant	0	0.68	2E-8	7.698970004336019		1.18	[1.11-1.23]	Affymetrix, Illumina [668499] (imputed)	N
2017-11-14	25751625	Michailidou K	2015-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer.	Breast cancer	15,748 European ancestry cases, 18,084 European ancestry controls	46,785 European ancestry cases, 42,892 European ancestry controls	1q21.1	1	145790097	LOC10028814, NBPF10, RNF115	RNF115			27246			rs12405132-C	rs12405132	0	12405132	intron_variant	0	0.64	8E-9	8.096910013008056		1.0526316	[1.03-1.08]	Affymetrix, Illumina [~ 11600000] (imputed)	N
2017-11-14	25751625	Michailidou K	2015-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer.	Breast cancer	15,748 European ancestry cases, 18,084 European ancestry controls	46,785 European ancestry cases, 42,892 European ancestry controls	1q21.2	1	149955122	Intergenic	OTUD7B			56957			rs12048493-C	rs12048493	0	12048493	intron_variant	0	0.34	1E-9	9.0		1.07	[1.05-1.10]	Affymetrix, Illumina [~ 11600000] (imputed)	N
2017-11-14	25751625	Michailidou K	2015-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer.	Breast cancer	15,748 European ancestry cases, 18,084 European ancestry controls	46,785 European ancestry cases, 42,892 European ancestry controls	1q43	1	241870961	EXO1	EXO1			9156			rs72755295-G	rs72755295	0	72755295	intron_variant	0	0.03	2E-8	7.698970004336019		1.15	[1.09-1.22]	Affymetrix, Illumina [~ 11600000] (imputed)	N
2017-11-14	25751625	Michailidou K	2015-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer.	Breast cancer	15,748 European ancestry cases, 18,084 European ancestry controls	46,785 European ancestry cases, 42,892 European ancestry controls	3p21.31	3	46825376	Intergenic	PRSS43 - PRSS42	100288960	339906		12686	5028	rs6796502-G	rs6796502	0	6796502	downstream_gene_variant	1	0.91	2E-8	7.698970004336019		1.0869565	[1.05-1.12]	Affymetrix, Illumina [~ 11600000] (imputed)	N
2017-11-14	25751625	Michailidou K	2015-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer.	Breast cancer	15,748 European ancestry cases, 18,084 European ancestry controls	46,785 European ancestry cases, 42,892 European ancestry controls	5p15.1	5	16187419	intergenic	LOC401176 - NACAP6	401176	100132778		355	4679	rs13162653-G	rs13162653	0	13162653	downstream_gene_variant	1	0.55	1E-10	10.0		1.0526316	[1.03-1.08]	Affymetrix, Illumina [~ 11600000] (imputed)	N
2017-11-14	25751625	Michailidou K	2015-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer.	Breast cancer	15,748 European ancestry cases, 18,084 European ancestry controls	46,785 European ancestry cases, 42,892 European ancestry controls	5p13.3	5	32567626	Intergenic	SUB1			10923			rs2012709-T	rs2012709	0	2012709	intron_variant	0	0.46	6E-9	8.221848749616356		1.05	[1.03-1.08]	Affymetrix, Illumina [~ 11600000] (imputed)	N
2017-11-14	25751625	Michailidou K	2015-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer.	Breast cancer	15,748 European ancestry cases, 18,084 European ancestry controls	46,785 European ancestry cases, 42,892 European ancestry controls	5q14.2	5	82242227	ATG10	ATG10			83734			rs7707921-A	rs7707921	0	7707921	intron_variant	0	0.77	5E-11	10.301029995663981		1.0752687	[1.05-1.1]	Affymetrix, Illumina [~ 11600000] (imputed)	N
2017-11-14	25751625	Michailidou K	2015-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer.	Breast cancer	15,748 European ancestry cases, 18,084 European ancestry controls	46,785 European ancestry cases, 42,892 European ancestry controls	6p22.1	6	28958443	Intergenic	TRM-CAT3-2 - KRT18P1	100189111	3879		5106	10629	rs9257408-C	rs9257408	0	9257408	regulatory_region_variant	1	0.38	5E-8	7.301029995663981		1.05	[1.03-1.08]	Affymetrix, Illumina [~ 11600000] (imputed)	N
2017-11-14	25751625	Michailidou K	2015-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer.	Breast cancer	15,748 European ancestry cases, 18,084 European ancestry controls	46,785 European ancestry cases, 42,892 European ancestry controls	7q32.3	7	130982362	FLJ43663	LINC-PINT			378805			rs4593472-C	rs4593472	0	4593472	intron_variant	0	0.65	2E-9	8.698970004336019		1.0526316	[1.03-1.06]	Affymetrix, Illumina [~ 11600000] (imputed)	N
2017-11-14	25751625	Michailidou K	2015-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer.	Breast cancer	15,748 European ancestry cases, 18,084 European ancestry controls	46,785 European ancestry cases, 42,892 European ancestry controls	8p11.23	8	37000965	Intergenic	RPL26P25 - LOC105379377	100270966	105379377		12467	65169	rs13365225-A	rs13365225	0	13365225	intergenic_variant	1	0.83	1E-8	8.0		1.0526316	[1.02-1.08]	Affymetrix, Illumina [~ 11600000] (imputed)	N
2017-11-14	25751625	Michailidou K	2015-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer.	Breast cancer	15,748 European ancestry cases, 18,084 European ancestry controls	46,785 European ancestry cases, 42,892 European ancestry controls	8q23.3	8	116197325	LINC00536	LINC00536			100859921			rs13267382-A	rs13267382	0	13267382	intron_variant	0	0.36	2E-8	7.698970004336019		1.05	[1.03-1.07]	Affymetrix, Illumina [~ 11600000] (imputed)	N
2017-11-14	25751625	Michailidou K	2015-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer.	Breast cancer	15,748 European ancestry cases, 18,084 European ancestry controls	46,785 European ancestry cases, 42,892 European ancestry controls	14q32.12	14	92637727	RIN3	RIN3			79890			rs11627032-T	rs11627032	0	11627032	intron_variant	0	0.74	4E-9	8.397940008672037		1.0638298	[1.04-1.09]	Affymetrix, Illumina [~ 11600000] (imputed)	N
2017-11-14	25751625	Michailidou K	2015-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer.	Breast cancer	15,748 European ancestry cases, 18,084 European ancestry controls	46,785 European ancestry cases, 42,892 European ancestry controls				ATAD5							chr17:29230520-GGT	chr17:29230520	0			1	0.8	3E-8	7.522878745280337		1.0752687	[1.04-1.1]	Affymetrix, Illumina [~ 11600000] (imputed)	N
2017-11-14	25751625	Michailidou K	2015-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer.	Breast cancer	15,748 European ancestry cases, 18,084 European ancestry controls	46,785 European ancestry cases, 42,892 European ancestry controls	17q25.3	17	79807926	Intergenic	CBX8 - LOC102723961	57332	102723961		10810	8017	rs745570-A	rs745570	0	745570	intergenic_variant	1	0.5	1E-9	9.0		1.0526316	[1.03-1.08]	Affymetrix, Illumina [~ 11600000] (imputed)	N
2017-11-14	25751625	Michailidou K	2015-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer.	Breast cancer	15,748 European ancestry cases, 18,084 European ancestry controls	46,785 European ancestry cases, 42,892 European ancestry controls	18q12.3	18	44819625	SETBP1	SETBP1			26040			rs6507583-A	rs6507583	0	6507583	intron_variant	0	0.93	3E-8	7.522878745280337		1.098901	[1.05-1.14]	Affymetrix, Illumina [~ 11600000] (imputed)	N
2017-11-14	25751625	Michailidou K	2015-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer.	Breast cancer	15,748 European ancestry cases, 18,084 European ancestry controls	46,785 European ancestry cases, 42,892 European ancestry controls	1p36.22	1	10506158	NR	PEX14			5195			rs616488-A	rs616488	0	616488	intron_variant	0	0.67	4E-11	10.397940008672037		1.0638298	[1.04-1.09]	Affymetrix, Illumina [~ 11600000] (imputed)	N
2017-11-14	25751625	Michailidou K	2015-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer.	Breast cancer	15,748 European ancestry cases, 18,084 European ancestry controls	46,785 European ancestry cases, 42,892 European ancestry controls	1p13.2	1	113905767	NR	DCLRE1B			64858			rs11552449-T	rs11552449	0	11552449	missense_variant	0	0.16	3E-9	8.522878745280337		1.07	[1.04-1.09]	Affymetrix, Illumina [~ 11600000] (imputed)	N
2017-11-14	25751625	Michailidou K	2015-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer.	Breast cancer	15,748 European ancestry cases, 18,084 European ancestry controls	46,785 European ancestry cases, 42,892 European ancestry controls	1p11.2	1	121538815	NR	EMBP1			647121			rs11249433-G	rs11249433	0	11249433	intron_variant	0	0.4	3E-27	26.522878745280337		1.09	[1.07-1.12]	Affymetrix, Illumina [~ 11600000] (imputed)	N
2017-11-14	25751625	Michailidou K	2015-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer.	Breast cancer	15,748 European ancestry cases, 18,084 European ancestry controls	46,785 European ancestry cases, 42,892 European ancestry controls	2p24.1	2	19121042	NR	LOC105373455 - MIR4757	105373455	100616307		54972	227387	rs12710696-T	rs12710696	0	12710696	intron_variant	1	0.36	4E-7	6.3979400086720375		1.04	[1.02-1.06]	Affymetrix, Illumina [~ 11600000] (imputed)	N
2017-11-14	25751625	Michailidou K	2015-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer.	Breast cancer	15,748 European ancestry cases, 18,084 European ancestry controls	46,785 European ancestry cases, 42,892 European ancestry controls	2q14.2	2	120487546	NR	LINC01101 - LOC105373585	84931	105373585		21197	55312	rs4849887-C	rs4849887	0	4849887	intergenic_variant	1	0.9	2E-11	10.698970004336019		1.098901	[1.06-1.14]	Affymetrix, Illumina [~ 11600000] (imputed)	N
2017-11-14	25751625	Michailidou K	2015-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer.	Breast cancer	15,748 European ancestry cases, 18,084 European ancestry controls	46,785 European ancestry cases, 42,892 European ancestry controls	2q31.1	2	172108243	NR	DLX2-AS1			104326193			rs2016394-G	rs2016394	0	2016394	intron_variant	0	0.52	8E-6	5.096910013008056		1.0526316	[1.03-1.06]	Affymetrix, Illumina [~ 11600000] (imputed)	N
2017-11-14	25751625	Michailidou K	2015-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer.	Breast cancer	15,748 European ancestry cases, 18,084 European ancestry controls	46,785 European ancestry cases, 42,892 European ancestry controls	2q31.1	2	173348166	NR	LOC100289479 - CDCA7	100289479	83879		9705	5851	rs1550623-A	rs1550623	0	1550623	intron_variant	1	0.84	1E-6	6.0		1.0526316	[1.03-1.09]	Affymetrix, Illumina [~ 11600000] (imputed)	N
2017-11-14	25751625	Michailidou K	2015-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer.	Breast cancer	15,748 European ancestry cases, 18,084 European ancestry controls	46,785 European ancestry cases, 42,892 European ancestry controls	2q35	2	217041109	NR	LOC105373874, LOC101928278			105373874, 101928278			rs13387042-A	rs13387042	0	13387042	intergenic_variant	0	0.51	1E-55	55.0		1.1363636	[1.11-1.16]	Affymetrix, Illumina [~ 11600000] (imputed)	N
2017-11-14	25751625	Michailidou K	2015-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer.	Breast cancer	15,748 European ancestry cases, 18,084 European ancestry controls	46,785 European ancestry cases, 42,892 European ancestry controls	2q35	2	217431785	NR	DIRC3			729582			rs16857609-T	rs16857609	0	16857609	intron_variant	0	0.26	1E-17	17.0		1.08	[1.06-1.11]	Affymetrix, Illumina [~ 11600000] (imputed)	N
2017-11-14	25751625	Michailidou K	2015-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer.	Breast cancer	15,748 European ancestry cases, 18,084 European ancestry controls	46,785 European ancestry cases, 42,892 European ancestry controls	3p26.1	3	4700592	NR	ITPR1			3708			rs6762644-G	rs6762644	0	6762644	intron_variant	0	0.4	9E-12	11.045757490560675		1.07	[1.05-1.09]	Affymetrix, Illumina [~ 11600000] (imputed)	N
2017-11-14	25751625	Michailidou K	2015-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer.	Breast cancer	15,748 European ancestry cases, 18,084 European ancestry controls	46,785 European ancestry cases, 42,892 European ancestry controls	3p24.1	3	27374522	NR	SLC4A7			9497			rs4973768-T	rs4973768	0	4973768	3_prime_UTR_variant	0	0.47	3E-30	29.522878745280337		1.1	[1.08-1.12]	Affymetrix, Illumina [~ 11600000] (imputed)	N
2017-11-14	25751625	Michailidou K	2015-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer.	Breast cancer	15,748 European ancestry cases, 18,084 European ancestry controls	46,785 European ancestry cases, 42,892 European ancestry controls	3p24.1	3	30641447	NR	TGFBR2			7048			rs12493607-C	rs12493607	0	12493607	intron_variant	0	0.34	1E-8	8.0		1.06	[1.04-1.08]	Affymetrix, Illumina [~ 11600000] (imputed)	N
2017-11-14	25751625	Michailidou K	2015-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer.	Breast cancer	15,748 European ancestry cases, 18,084 European ancestry controls	46,785 European ancestry cases, 42,892 European ancestry controls	3p14.1	3	63982224	NR	ATXN7			6314			rs1053338-G	rs1053338	0	1053338	missense_variant	0	0.13	9E-9	8.045757490560675		1.08	[1.05-1.11]	Affymetrix, Illumina [~ 11600000] (imputed)	N
2017-11-14	25751625	Michailidou K	2015-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer.	Breast cancer	15,748 European ancestry cases, 18,084 European ancestry controls	46,785 European ancestry cases, 42,892 European ancestry controls	4q24	4	105163621	NR	TET2			54790			rs9790517-T	rs9790517	0	9790517	intron_variant	0	0.22	1E-9	9.0		1.05	[1.03-1.08]	Affymetrix, Illumina [~ 11600000] (imputed)	N
2017-11-14	25751625	Michailidou K	2015-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer.	Breast cancer	15,748 European ancestry cases, 18,084 European ancestry controls	46,785 European ancestry cases, 42,892 European ancestry controls	4q34.1	4	174925275	NR	ADAM29			11086			rs6828523-C	rs6828523	0	6828523	intron_variant	0	0.88	1E-15	15.0		1.1111112	[1.08-1.15]	Affymetrix, Illumina [~ 11600000] (imputed)	N
2017-11-14	25751625	Michailidou K	2015-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer.	Breast cancer	15,748 European ancestry cases, 18,084 European ancestry controls	46,785 European ancestry cases, 42,892 European ancestry controls	5p15.33	5	1279675	NR	TERT			7015			rs10069690-T	rs10069690	0	10069690	intron_variant	0	0.26	1E-8	8.0		1.06	[1.04-1.09]	Affymetrix, Illumina [~ 11600000] (imputed)	N
2017-11-14	25751625	Michailidou K	2015-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer.	Breast cancer	15,748 European ancestry cases, 18,084 European ancestry controls	46,785 European ancestry cases, 42,892 European ancestry controls	5p15.33	5	1297373	NR	TERT - MIR4457	7015	100616235		1747	11937	rs2736108-C	rs2736108	0	2736108	upstream_gene_variant	1	0.71	2E-9	8.698970004336019		1.0638298	[1.04-1.09]	Affymetrix, Illumina [~ 11600000] (imputed)	N
2017-11-14	25751625	Michailidou K	2015-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer.	Breast cancer	15,748 European ancestry cases, 18,084 European ancestry controls	46,785 European ancestry cases, 42,892 European ancestry controls	5p12	5	44706396	NR	LOC102723839 - RN7SL383P	102723839	106479363		196114	9797	rs10941679-G	rs10941679	0	10941679	intergenic_variant	1	0.25	5E-32	31.30102999566398		1.12	[1.1-1.15]	Affymetrix, Illumina [~ 11600000] (imputed)	N
2017-11-14	25751625	Michailidou K	2015-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer.	Breast cancer	15,748 European ancestry cases, 18,084 European ancestry controls	46,785 European ancestry cases, 42,892 European ancestry controls	5q11.2	5	56736057	NR	LOC101928448 - LOC105378979	101928448	105378979		129825	30338	rs889312-C	rs889312	0	889312	regulatory_region_variant	1	0.28	1E-39	39.0		1.12	[1.1-1.15]	Affymetrix, Illumina [~ 11600000] (imputed)	N
2017-11-14	25751625	Michailidou K	2015-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer.	Breast cancer	15,748 European ancestry cases, 18,084 European ancestry controls	46,785 European ancestry cases, 42,892 European ancestry controls	5q11.2	5	58888234	NR	RAB3C - PDE4D	115827	5144		28840	80804	rs10472076-C	rs10472076	0	10472076	intergenic_variant	1	0.38	2E-8	7.698970004336019		1.05	[1.03-1.07]	Affymetrix, Illumina [~ 11600000] (imputed)	N
2017-11-14	25751625	Michailidou K	2015-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer.	Breast cancer	15,748 European ancestry cases, 18,084 European ancestry controls	46,785 European ancestry cases, 42,892 European ancestry controls	5q11.2	5	59041654	NR	PDE4D			5144			rs1353747-T	rs1353747	0	1353747	intron_variant	0	0.9	3E-8	7.522878745280337		1.0869565	[1.05-1.12]	Affymetrix, Illumina [~ 11600000] (imputed)	N
2017-11-14	25751625	Michailidou K	2015-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer.	Breast cancer	15,748 European ancestry cases, 18,084 European ancestry controls	46,785 European ancestry cases, 42,892 European ancestry controls	5q33.3	5	158817075	NR	EBF1			1879			rs1432679-C	rs1432679	0	1432679	intron_variant	0	0.43	4E-16	15.397940008672037		1.07	[1.05-1.09]	Affymetrix, Illumina [~ 11600000] (imputed)	N
2017-11-14	25751625	Michailidou K	2015-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer.	Breast cancer	15,748 European ancestry cases, 18,084 European ancestry controls	46,785 European ancestry cases, 42,892 European ancestry controls	6p25.3	6	1318643	NR	FOXQ1 - LINC01394	94234	106144586		3885	2566	rs11242675-T	rs11242675	0	11242675	downstream_gene_variant	1	0.62	1E-7	7.0		1.0416667	[1.02-1.06]	Affymetrix, Illumina [~ 11600000] (imputed)	N
2017-11-14	25751625	Michailidou K	2015-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer.	Breast cancer	15,748 European ancestry cases, 18,084 European ancestry controls	46,785 European ancestry cases, 42,892 European ancestry controls	6p23	6	13722291	NR	RANBP9 - MCUR1	10048	63933		10709	64258	rs204247-G	rs204247	0	204247	intergenic_variant	1	0.44	4E-10	9.397940008672037		1.05	[1.03-1.07]	Affymetrix, Illumina [~ 11600000] (imputed)	N
2017-11-14	25751625	Michailidou K	2015-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer.	Breast cancer	15,748 European ancestry cases, 18,084 European ancestry controls	46,785 European ancestry cases, 42,892 European ancestry controls	6q14.1	6	81418669	NR	LOC648934 - LOC105377871	648934	105377871		861480	26120	rs17529111-C	rs17529111	0	17529111	intergenic_variant	1	0.22	2E-10	9.698970004336019		1.06	[1.04-1.08]	Affymetrix, Illumina [~ 11600000] (imputed)	N
2017-11-14	25751625	Michailidou K	2015-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer.	Breast cancer	15,748 European ancestry cases, 18,084 European ancestry controls	46,785 European ancestry cases, 42,892 European ancestry controls	6q25.1	6	151597721	NR	CCDC170			80129			rs12662670-G	rs12662670	0	12662670	intron_variant	0	0.07	7E-27	26.154901959985743		1.17	[1.13-1.22]	Affymetrix, Illumina [~ 11600000] (imputed)	N
2017-11-14	25751625	Michailidou K	2015-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer.	Breast cancer	15,748 European ancestry cases, 18,084 European ancestry controls	46,785 European ancestry cases, 42,892 European ancestry controls	6q25.1	6	151627231	NR	CCDC170 - ESR1	80129	2099		6038	26917	rs2046210-A	rs2046210	0	2046210	intergenic_variant	1	0.34	6E-24	23.221848749616356		1.08	[1.06-1.1]	Affymetrix, Illumina [~ 11600000] (imputed)	N
2017-11-14	25751625	Michailidou K	2015-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer.	Breast cancer	15,748 European ancestry cases, 18,084 European ancestry controls	46,785 European ancestry cases, 42,892 European ancestry controls	7q21.2	7	92001306	NR	AKAP9			10142			rs6964587-T	rs6964587	0	6964587	missense_variant	0	0.39	5E-7	6.301029995663981		1.05	[1.03-1.07]	Affymetrix, Illumina [~ 11600000] (imputed)	N
2017-11-14	25751625	Michailidou K	2015-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer.	Breast cancer	15,748 European ancestry cases, 18,084 European ancestry controls	46,785 European ancestry cases, 42,892 European ancestry controls	7q35	7	144377836	NR	ARHGEF5			7984			rs720475-G	rs720475	0	720475	intron_variant	0	0.75	4E-10	9.397940008672037		1.0638298	[1.04-1.09]	Affymetrix, Illumina [~ 11600000] (imputed)	N
2017-11-14	25751625	Michailidou K	2015-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer.	Breast cancer	15,748 European ancestry cases, 18,084 European ancestry controls	46,785 European ancestry cases, 42,892 European ancestry controls	8p12	8	29652100	NR	RPL17P33 - LINC00589	646909	619351		19417	69159	rs9693444-A	rs9693444	0	9693444	intergenic_variant	1	0.32	1E-12	12.0		1.07	[1.05-1.09]	Affymetrix, Illumina [~ 11600000] (imputed)	N
2017-11-14	25751625	Michailidou K	2015-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer.	Breast cancer	15,748 European ancestry cases, 18,084 European ancestry controls	46,785 European ancestry cases, 42,892 European ancestry controls	8q21.13	8	75318066	NR	HIGD1AP6 - PKMP4	100874436	106480443		15492	58643	rs6472903-T	rs6472903	0	6472903	intron_variant	1	0.82	1E-16	16.0		1.098901	[1.08-1.12]	Affymetrix, Illumina [~ 11600000] (imputed)	N
2017-11-14	25751625	Michailidou K	2015-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer.	Breast cancer	15,748 European ancestry cases, 18,084 European ancestry controls	46,785 European ancestry cases, 42,892 European ancestry controls	8q21.13	8	75505702	NR	HNF4G			3174			rs2943559-G	rs2943559	0	2943559	intron_variant	0	0.07	1E-16	16.0		1.13	[1.09-1.17]	Affymetrix, Illumina [~ 11600000] (imputed)	N
2017-11-14	25751625	Michailidou K	2015-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer.	Breast cancer	15,748 European ancestry cases, 18,084 European ancestry controls	46,785 European ancestry cases, 42,892 European ancestry controls	8q24.21	8	127343372	NR	CASC8, CASC21			727677, 103021164			rs13281615-G	rs13281615	0	13281615	intron_variant	0	0.4	6E-31	30.221848749616356		1.1	[1.08-1.12]	Affymetrix, Illumina [~ 11600000] (imputed)	N
2017-11-14	25751625	Michailidou K	2015-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer.	Breast cancer	15,748 European ancestry cases, 18,084 European ancestry controls	46,785 European ancestry cases, 42,892 European ancestry controls	8q24.21	8	128182395	NR	MIR1208 - RN7SKP226	100302281	106480903		32207	38109	rs11780156-T	rs11780156	0	11780156	regulatory_region_variant	1	0.16	2E-9	8.698970004336019		1.07	[1.04-1.09]	Affymetrix, Illumina [~ 11600000] (imputed)	N
2017-11-14	25751625	Michailidou K	2015-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer.	Breast cancer	15,748 European ancestry cases, 18,084 European ancestry controls	46,785 European ancestry cases, 42,892 European ancestry controls	9p21.3	9	22062135	NR	CDKN2B-AS1			100048912			rs1011970-T	rs1011970	0	1011970	intron_variant	0	0.17	4E-9	8.397940008672037		1.06	[1.03-1.08]	Affymetrix, Illumina [~ 11600000] (imputed)	N
2017-11-14	25751625	Michailidou K	2015-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer.	Breast cancer	15,748 European ancestry cases, 18,084 European ancestry controls	46,785 European ancestry cases, 42,892 European ancestry controls	9q31.2	9	107543834	NR	LOC105376206 - LOC105376205	105376206	105376205		28619	22955	rs10759243-A	rs10759243	0	10759243	upstream_gene_variant	1	0.29	3E-9	8.522878745280337		1.05	[1.03-1.08]	Affymetrix, Illumina [~ 11600000] (imputed)	N
2017-11-14	25751625	Michailidou K	2015-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer.	Breast cancer	15,748 European ancestry cases, 18,084 European ancestry controls	46,785 European ancestry cases, 42,892 European ancestry controls	9q31.2	9	108126198	NR	LOC105376214			105376214			rs865686-T	rs865686	0	865686	intergenic_variant	0	0.62	6E-34	33.221848749616356		1.1111112	[1.09-1.14]	Affymetrix, Illumina [~ 11600000] (imputed)	N
2017-11-14	25751625	Michailidou K	2015-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer.	Breast cancer	15,748 European ancestry cases, 18,084 European ancestry controls	46,785 European ancestry cases, 42,892 European ancestry controls	10p12.31	10	21744013	NR	LOC107984214			107984214			rs7072776-A	rs7072776	0	7072776	downstream_gene_variant	0	0.29	1E-14	14.0		1.07	[1.05-1.09]	Affymetrix, Illumina [~ 11600000] (imputed)	N
2017-11-14	25751625	Michailidou K	2015-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer.	Breast cancer	15,748 European ancestry cases, 18,084 European ancestry controls	46,785 European ancestry cases, 42,892 European ancestry controls	10p12.31	10	22026914	NR	DNAJC1 - ADIPOR1P1	64215	645220		23146	137662	rs11814448-C	rs11814448	0	11814448	intergenic_variant	1	0.02	6E-17	16.221848749616356		1.27	[1.19-1.36]	Affymetrix, Illumina [~ 11600000] (imputed)	N
2017-11-14	25751625	Michailidou K	2015-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer.	Breast cancer	15,748 European ancestry cases, 18,084 European ancestry controls	46,785 European ancestry cases, 42,892 European ancestry controls	10q21.2	10	62518923	NR	ZNF365			22891			rs10995190-G	rs10995190	0	10995190	intron_variant	0	0.84	2E-37	36.69897000433602		1.1627907	[1.14-1.2]	Affymetrix, Illumina [~ 11600000] (imputed)	N
2017-11-14	25751625	Michailidou K	2015-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer.	Breast cancer	15,748 European ancestry cases, 18,084 European ancestry controls	46,785 European ancestry cases, 42,892 European ancestry controls	10q22.3	10	79081391	NR	ZMIZ1			57178			rs704010-T	rs704010	0	704010	intron_variant	0	0.38	3E-23	22.522878745280337		1.08	[1.06-1.1]	Affymetrix, Illumina [~ 11600000] (imputed)	N
2017-11-14	25751625	Michailidou K	2015-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer.	Breast cancer	15,748 European ancestry cases, 18,084 European ancestry controls	46,785 European ancestry cases, 42,892 European ancestry controls	10q25.2	10	113014168	NR	TCF7L2			6934			rs7904519-G	rs7904519	0	7904519	intron_variant	0	0.46	9E-13	12.045757490560675		1.05	[1.03-1.07]	Affymetrix, Illumina [~ 11600000] (imputed)	N
2017-11-14	25751625	Michailidou K	2015-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer.	Breast cancer	15,748 European ancestry cases, 18,084 European ancestry controls	46,785 European ancestry cases, 42,892 European ancestry controls	10q26.12	10	121334387	NR	LOC105378523 - RN7SKP167	105378523	106479169		11442	76529	rs11199914-C	rs11199914	0	11199914	intergenic_variant	1	0.68	8E-9	8.096910013008056		1.0526316	[1.03-1.08]	Affymetrix, Illumina [~ 11600000] (imputed)	N
2017-11-14	25751625	Michailidou K	2015-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer.	Breast cancer	15,748 European ancestry cases, 18,084 European ancestry controls	46,785 European ancestry cases, 42,892 European ancestry controls	10q26.13	10	121577821	NR	FGFR2			2263			rs2981579-A	rs2981579	0	2981579	intron_variant	0	0.4	6E-164	163.22184874961636		1.27	[1.24-1.29]	Affymetrix, Illumina [~ 11600000] (imputed)	N
2017-11-14	25751625	Michailidou K	2015-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer.	Breast cancer	15,748 European ancestry cases, 18,084 European ancestry controls	46,785 European ancestry cases, 42,892 European ancestry controls	11p15.5	11	1887776	NR	LSP1			4046			rs3817198-C	rs3817198	0	3817198	intron_variant	0	0.31	2E-13	12.698970004336019		1.07	[1.05-1.09]	Affymetrix, Illumina [~ 11600000] (imputed)	N
2017-11-14	25751625	Michailidou K	2015-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer.	Breast cancer	15,748 European ancestry cases, 18,084 European ancestry controls	46,785 European ancestry cases, 42,892 European ancestry controls	11q13.1	11	65815595	NR	OVOL1 - SNX32	5017	254122		18376	18041	rs3903072-G	rs3903072	0	3903072	regulatory_region_variant	1	0.53	1E-10	10.0		1.0526316	[1.03-1.08]	Affymetrix, Illumina [~ 11600000] (imputed)	N
2017-11-14	25751625	Michailidou K	2015-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer.	Breast cancer	15,748 European ancestry cases, 18,084 European ancestry controls	46,785 European ancestry cases, 42,892 European ancestry controls	11q13.3	11	69516650	NR	LINC01488 - CCND1	101928292	595		23107	124455	rs78540526-T	rs78540526	0	78540526	regulatory_region_variant	1	0.08	2E-86	85.69897000433602		1.34	[1.29-1.38]	Affymetrix, Illumina [~ 11600000] (imputed)	N
2017-11-14	25751625	Michailidou K	2015-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer.	Breast cancer	15,748 European ancestry cases, 18,084 European ancestry controls	46,785 European ancestry cases, 42,892 European ancestry controls	11q13.3	11	69516874	NR	LINC01488 - CCND1	101928292	595		23331	124231	rs554219-G	rs554219	0	554219	regulatory_region_variant	1	0.12	2E-81	80.69897000433602		1.26	[1.23-1.3]	Affymetrix, Illumina [~ 11600000] (imputed)	N
2017-11-14	25751625	Michailidou K	2015-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer.	Breast cancer	15,748 European ancestry cases, 18,084 European ancestry controls	46,785 European ancestry cases, 42,892 European ancestry controls	11q13.3	11	69564393	NR	LINC01488 - CCND1	101928292	595		70850	76712	rs75915166-A	rs75915166	0	75915166	intergenic_variant	1	0.06	1E-57	57.0		1.31	[1.26-1.36]	Affymetrix, Illumina [~ 11600000] (imputed)	N
2017-11-14	25751625	Michailidou K	2015-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer.	Breast cancer	15,748 European ancestry cases, 18,084 European ancestry controls	46,785 European ancestry cases, 42,892 European ancestry controls	11q24.3	11	129591276	NR	RPS27P20 - LINC01395	100271581	101929557		53103	20840	rs11820646-C	rs11820646	0	11820646	upstream_gene_variant	1	0.59	1E-10	10.0		1.0526316	[1.03-1.08]	Affymetrix, Illumina [~ 11600000] (imputed)	N
2017-11-14	25751625	Michailidou K	2015-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer.	Breast cancer	15,748 European ancestry cases, 18,084 European ancestry controls	46,785 European ancestry cases, 42,892 European ancestry controls	12p13.1	12	14260997	NR	GNAI2P1 - RPL30P11	2772	100271303		5511	95868	rs12422552-C	rs12422552	0	12422552	regulatory_region_variant	1	0.26	1E-7	7.0		1.04	[1.02-1.07]	Affymetrix, Illumina [~ 11600000] (imputed)	N
2017-11-14	25751625	Michailidou K	2015-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer.	Breast cancer	15,748 European ancestry cases, 18,084 European ancestry controls	46,785 European ancestry cases, 42,892 European ancestry controls	12p11.22	12	28002147	NR	PTHLH - LOC105369710	5744	105369710		27960	59494	rs10771399-A	rs10771399	0	10771399	intergenic_variant	1	0.88	5E-34	33.30102999566398		1.1627907	[1.12-1.2]	Affymetrix, Illumina [~ 11600000] (imputed)	N
2017-11-14	25751625	Michailidou K	2015-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer.	Breast cancer	15,748 European ancestry cases, 18,084 European ancestry controls	46,785 European ancestry cases, 42,892 European ancestry controls	12q22	12	95633983	NR	USP44 - PGAM1P5	84101	100132594		82454	15272	rs17356907-A	rs17356907	0	17356907	intron_variant	1	0.7	7E-21	20.154901959985743		1.098901	[1.08-1.11]	Affymetrix, Illumina [~ 11600000] (imputed)	N
2017-11-14	25751625	Michailidou K	2015-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer.	Breast cancer	15,748 European ancestry cases, 18,084 European ancestry controls	46,785 European ancestry cases, 42,892 European ancestry controls	12q24.21	12	115398717	NR	LOC105370003			105370003			rs1292011-A	rs1292011	0	1292011	regulatory_region_variant	0	0.58	2E-21	20.69897000433602		1.0869565	[1.06-1.11]	Affymetrix, Illumina [~ 11600000] (imputed)	N
2017-11-14	25751625	Michailidou K	2015-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer.	Breast cancer	15,748 European ancestry cases, 18,084 European ancestry controls	46,785 European ancestry cases, 42,892 European ancestry controls	13q13.1	13	32398489	NR	BRCA2			675			rs11571833-T	rs11571833	0	11571833	stop_gained	0	0.01	6E-7	6.221848749616356		1.27	[1.15-1.4]	Affymetrix, Illumina [~ 11600000] (imputed)	N
2017-11-14	25751625	Michailidou K	2015-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer.	Breast cancer	15,748 European ancestry cases, 18,084 European ancestry controls	46,785 European ancestry cases, 42,892 European ancestry controls	14q13.3	14	36663564	NR	PAX9			5083			rs2236007-G	rs2236007	0	2236007	intron_variant	0	0.79	9E-13	12.045757490560675		1.0752687	[1.05-1.1]	Affymetrix, Illumina [~ 11600000] (imputed)	N
2017-11-14	25751625	Michailidou K	2015-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer.	Breast cancer	15,748 European ancestry cases, 18,084 European ancestry controls	46,785 European ancestry cases, 42,892 European ancestry controls	14q24.1	14	68193711	NR	RAD51B			5890			rs2588809-T	rs2588809	0	2588809	intron_variant	0	0.16	2E-8	7.698970004336019		1.08	[1.05-1.11]	Affymetrix, Illumina [~ 11600000] (imputed)	N
2017-11-14	25751625	Michailidou K	2015-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer.	Breast cancer	15,748 European ancestry cases, 18,084 European ancestry controls	46,785 European ancestry cases, 42,892 European ancestry controls	14q24.1	14	68567965	NR	RAD51B			5890			rs999737-C	rs999737	0	999737	intron_variant	0	0.77	2E-21	20.69897000433602		1.0869565	[1.06-1.11]	Affymetrix, Illumina [~ 11600000] (imputed)	N
2017-11-14	25751625	Michailidou K	2015-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer.	Breast cancer	15,748 European ancestry cases, 18,084 European ancestry controls	46,785 European ancestry cases, 42,892 European ancestry controls	14q32.11	14	91374725	NR	CCDC88C			440193			rs941764-G	rs941764	0	941764	intron_variant	0	0.34	6E-11	10.221848749616356		1.07	[1.05-1.09]	Affymetrix, Illumina [~ 11600000] (imputed)	N
2017-11-14	25751625	Michailidou K	2015-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer.	Breast cancer	15,748 European ancestry cases, 18,084 European ancestry controls	46,785 European ancestry cases, 42,892 European ancestry controls	16q12.1	16	52552429	NR	CASC16			643714			rs3803662-A	rs3803662	0	3803662	non_coding_transcript_exon_variant	0	0.26	4E-117	116.39794000867204		1.24	[1.21-1.26]	Affymetrix, Illumina [~ 11600000] (imputed)	N
2017-11-14	25751625	Michailidou K	2015-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer.	Breast cancer	15,748 European ancestry cases, 18,084 European ancestry controls	46,785 European ancestry cases, 42,892 European ancestry controls	16q12.2	16	53779455	NR	FTO			79068			rs17817449-T	rs17817449	0	17817449	intron_variant	0	0.6	2E-14	13.698970004336019		1.0752687	[1.05-1.1]	Affymetrix, Illumina [~ 11600000] (imputed)	N
2017-11-14	25751625	Michailidou K	2015-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer.	Breast cancer	15,748 European ancestry cases, 18,084 European ancestry controls	46,785 European ancestry cases, 42,892 European ancestry controls	16q12.2	16	53821379	NR	FTO			79068			rs11075995-A	rs11075995	0	11075995	intron_variant	0	0.24	1E-6	6.0		1.04	[1.02-1.06]	Affymetrix, Illumina [~ 11600000] (imputed)	N
2017-11-14	25751625	Michailidou K	2015-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer.	Breast cancer	15,748 European ancestry cases, 18,084 European ancestry controls	46,785 European ancestry cases, 42,892 European ancestry controls	16q23.2	16	80616908	NR	CDYL2			124359			rs13329835-G	rs13329835	0	13329835	intron_variant	0	0.22	2E-17	16.69897000433602		1.08	[1.06-1.11]	Affymetrix, Illumina [~ 11600000] (imputed)	N
2017-11-14	25751625	Michailidou K	2015-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer.	Breast cancer	15,748 European ancestry cases, 18,084 European ancestry controls	46,785 European ancestry cases, 42,892 European ancestry controls	17q22	17	54979110	NR	STXBP4			252983			rs6504950-G	rs6504950	0	6504950	intron_variant	0	0.72	5E-12	11.301029995663981		1.0638298	[1.04-1.09]	Affymetrix, Illumina [~ 11600000] (imputed)	N
2017-11-14	25751625	Michailidou K	2015-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer.	Breast cancer	15,748 European ancestry cases, 18,084 European ancestry controls	46,785 European ancestry cases, 42,892 European ancestry controls	18q11.2	18	26757460	NR	PCAT18 - LOC105372035	728606	105372035		53822	65353	rs527616-G	rs527616	0	527616	intron_variant	1	0.62	8E-13	12.096910013008056		1.0526316	[1.03-1.08]	Affymetrix, Illumina [~ 11600000] (imputed)	N
2017-11-14	25751625	Michailidou K	2015-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer.	Breast cancer	15,748 European ancestry cases, 18,084 European ancestry controls	46,785 European ancestry cases, 42,892 European ancestry controls	18q11.2	18	26990703	NR	CHST9			83539			rs1436904-T	rs1436904	0	1436904	intron_variant	0	0.6	3E-8	7.522878745280337		1.0416667	[1.03-1.06]	Affymetrix, Illumina [~ 11600000] (imputed)	N
2017-11-14	25751625	Michailidou K	2015-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer.	Breast cancer	15,748 European ancestry cases, 18,084 European ancestry controls	46,785 European ancestry cases, 42,892 European ancestry controls	19p13.11	19	17278895	NR	BABAM1			29086			rs8170-A	rs8170	0	8170	synonymous_variant	0	0.19	2E-6	5.698970004336019		1.04	[1.02-1.07]	Affymetrix, Illumina [~ 11600000] (imputed)	N
2017-11-14	25751625	Michailidou K	2015-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer.	Breast cancer	15,748 European ancestry cases, 18,084 European ancestry controls	46,785 European ancestry cases, 42,892 European ancestry controls	19p13.11	19	17283315	NR	ANKLE1			126549			rs2363956-T	rs2363956	0	2363956	missense_variant	0	0.49	2E-6	5.698970004336019		1.03	[1.01-1.05]	Affymetrix, Illumina [~ 11600000] (imputed)	N
2017-11-14	25751625	Michailidou K	2015-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer.	Breast cancer	15,748 European ancestry cases, 18,084 European ancestry controls	46,785 European ancestry cases, 42,892 European ancestry controls	19p13.11	19	18460331	NR	ELL			8178			rs4808801-A	rs4808801	0	4808801	intron_variant	0	0.65	4E-15	14.397940008672037		1.0752687	[1.06-1.1]	Affymetrix, Illumina [~ 11600000] (imputed)	N
2017-11-14	25751625	Michailidou K	2015-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer.	Breast cancer	15,748 European ancestry cases, 18,084 European ancestry controls	46,785 European ancestry cases, 42,892 European ancestry controls	19q13.31	19	43782361	NR	KCNN4 - LOC107987268	3783	107987268		222	1931	rs3760982-A	rs3760982	0	3760982	upstream_gene_variant	1	0.46	8E-9	8.096910013008056		1.05	[1.03-1.07]	Affymetrix, Illumina [~ 11600000] (imputed)	N
2017-11-14	25751625	Michailidou K	2015-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer.	Breast cancer	15,748 European ancestry cases, 18,084 European ancestry controls	46,785 European ancestry cases, 42,892 European ancestry controls	21q21.1	21	15148511	NR	LOC107985483 - LOC105372739	107985483	105372739		26075	40082	rs2823093-G	rs2823093	0	2823093	intergenic_variant	1	0.73	3E-13	12.522878745280337		1.0752687	[1.05-1.1]	Affymetrix, Illumina [~ 11600000] (imputed)	N
2017-11-14	25751625	Michailidou K	2015-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer.	Breast cancer	15,748 European ancestry cases, 18,084 European ancestry controls	46,785 European ancestry cases, 42,892 European ancestry controls	22q12.2	22	29225488	NR	EMID1			129080			rs132390-C	rs132390	0	132390	intron_variant	0	0.04	3E-9	8.522878745280337		1.14	[1.08-1.2]	Affymetrix, Illumina [~ 11600000] (imputed)	N
2017-11-14	25751625	Michailidou K	2015-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer.	Breast cancer	15,748 European ancestry cases, 18,084 European ancestry controls	46,785 European ancestry cases, 42,892 European ancestry controls	22q13.1	22	40480230	NR	MKL1			57591			rs6001930-C	rs6001930	0	6001930	intron_variant	0	0.11	2E-20	19.69897000433602		1.12	[1.09-1.16]	Affymetrix, Illumina [~ 11600000] (imputed)	N
2017-11-13	19330027	Ahmed S	2009-05-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19330027	Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2.	Breast cancer	390 European ancestry cases, 364 European ancestry controls	38,430 European ancestry cases, 2,572 East Asian ancestry cases, 41,926 European ancestry controls, 2,059 East Asian ancestry controls	3p24.1	3	27374522	SLC4A7, NEK10	SLC4A7			9497			rs4973768-T	rs4973768	0	4973768	3_prime_UTR_variant	0	0.46	4E-23	22.397940008672037		1.11	[1.08-1.13]	Illumina, Perlegen [up to 206586]	N
2017-11-13	19330027	Ahmed S	2009-05-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19330027	Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2.	Breast cancer	390 European ancestry cases, 364 European ancestry controls	38,430 European ancestry cases, 2,572 East Asian ancestry cases, 41,926 European ancestry controls, 2,059 East Asian ancestry controls	17q22	17	54979110	COX11	STXBP4			252983			rs6504950-G	rs6504950	0	6504950	intron_variant	0	0.73	1E-8	8.0		1.05	[1.03-1.09]	Illumina, Perlegen [up to 206586]	N
2017-11-13	19330027	Ahmed S	2009-05-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19330027	Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2.	Breast cancer	390 European ancestry cases, 364 European ancestry controls	11,645 European ancestry cases, 12,015 European ancestry controls	3p24.1	3	27145111	SLC4A7, NEK10	NEK10			152110			rs1357245-G	rs1357245	0	1357245	intron_variant	0	0.54	2E-7	6.698970004336019		1.06	NR	Perlegen [up to 206586]	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-cancer genome-wide analysis of lung, ovary, breast, prostate and colorectal cancer reveals novel pleiotropic associations.	Cancer	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	1q22	1	155212052	MTX1	MTX1			4580			rs2974935-T	rs2974935	0	2974935	non_coding_transcript_exon_variant	0	NR	2E-7	6.698970004336019		1.1	[NR]	Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-cancer genome-wide analysis of lung, ovary, breast, prostate and colorectal cancer reveals novel pleiotropic associations.	Cancer	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	1q22	1	155216951	GBAP1	GBAP1			2630			rs1057941-A	rs1057941	0	1057941	non_coding_transcript_exon_variant	0	NR	2E-7	6.698970004336019		1.1	[NR]	Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-cancer genome-wide analysis of lung, ovary, breast, prostate and colorectal cancer reveals novel pleiotropic associations.	Cancer	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	1q32.2	1	210816167	KCNH1	KCNH1			3756			rs11119608-T	rs11119608	0	11119608	intron_variant	0	NR	1E-7	7.0		1.1111112	[NR]	Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-cancer genome-wide analysis of lung, ovary, breast, prostate and colorectal cancer reveals novel pleiotropic associations.	Cancer	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	3q26.2	3	169043635	Intergenic	LOC107986051			107986051			rs75316749-G	rs75316749	0	75316749	intergenic_variant	0	NR	2E-7	6.698970004336019		1.1	[NR]	Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-cancer genome-wide analysis of lung, ovary, breast, prostate and colorectal cancer reveals novel pleiotropic associations.	Cancer	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	6p22.1	6	30374976	Intergenic	UBQLN1P1 - MICC	387117	100129192		10865	39737	rs115707823-A	rs115707823	1	3129817	intergenic_variant	1	NR	2E-6	5.698970004336019		1.1	[NR]	Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-cancer genome-wide analysis of lung, ovary, breast, prostate and colorectal cancer reveals novel pleiotropic associations.	Cancer	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	6p21.33	6	31347004	HLA-C	LOC105375015 - HLA-B	105375015	3106		38409	6862	rs115392158-G	rs115392158	1	2507997	intron_variant	1	NR	9E-6	5.045757490560675		1.1	[NR]	Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-cancer genome-wide analysis of lung, ovary, breast, prostate and colorectal cancer reveals novel pleiotropic associations.	Cancer	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	6p21.32	6	32699696	Intergenic	HLA-DQB1 - MTCO3P1	3119	404026		33007	6448	rs147527678-C	rs147527678	1	1794514	intergenic_variant	1	NR	5E-7	6.301029995663981		1.1	[NR]	Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-cancer genome-wide analysis of lung, ovary, breast, prostate and colorectal cancer reveals novel pleiotropic associations.	Cancer	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	6q14.1	6	80398959	Intergenic	BCKDHB			594			rs4604234-C	rs4604234	0	4604234	intergenic_variant	0	NR	6E-6	5.221848749616356		1.1	[NR]	Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-cancer genome-wide analysis of lung, ovary, breast, prostate and colorectal cancer reveals novel pleiotropic associations.	Cancer	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	9p21.3	9	21951903	Intergenic	ERVFRD-3 - CDKN2A-AS1	100533725	51198		20630	15236	rs12349081-A	rs12349081	0	12349081	intron_variant	1	NR	6E-6	5.221848749616356		1.1	[NR]	Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-cancer genome-wide analysis of lung, ovary, breast, prostate and colorectal cancer reveals novel pleiotropic associations.	Cancer	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	9p21.3	9	22062135	CDKN2B, AS1	CDKN2B-AS1			100048912			rs1011970-T	rs1011970	0	1011970	intron_variant	0	NR	2E-7	6.698970004336019		1.1	[NR]	Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-cancer genome-wide analysis of lung, ovary, breast, prostate and colorectal cancer reveals novel pleiotropic associations.	Cancer	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	12q24.12	12	111446804	SH2B3	SH2B3			10019			rs3184504-C	rs3184504	0	3184504	missense_variant	0	NR	2E-6	5.698970004336019		1.1	[NR]	Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-cancer genome-wide analysis of lung, ovary, breast, prostate and colorectal cancer reveals novel pleiotropic associations.	Cancer	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	13q13.1	13	32398489	BRCA2	BRCA2			675			rs11571833-T	rs11571833	0	11571833	stop_gained	0	NR	8E-12	11.096910013008056		1.6	[NR]	Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-cancer genome-wide analysis of lung, ovary, breast, prostate and colorectal cancer reveals novel pleiotropic associations.	Cancer	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	17q12	17	37741642	HNF1B	HNF1B			6928			rs12601991-T	rs12601991	0	12601991	intron_variant	0	NR	1E-9	9.0		1.1	[NR]	Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-cancer genome-wide analysis of lung, ovary, breast, prostate and colorectal cancer reveals novel pleiotropic associations.	Cancer	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	19p13.11	19	17279482	BABAM1	BABAM1 - ANKLE1	29086	126549		129	2163	rs4808075-C	rs4808075	0	4808075	intron_variant	1	NR	4E-7	6.3979400086720375		1.1	[NR]	Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-cancer genome-wide analysis of lung, ovary, breast, prostate and colorectal cancer reveals novel pleiotropic associations.	Cancer	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	20q11.22	20	34131991	Intergenic	RPS2P1 - ASIP	140755	434		8649	54502	rs11907546-C	rs11907546	0	11907546	regulatory_region_variant	1	NR	3E-9	8.522878745280337		1.1111112	[NR]	Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-cancer genome-wide analysis of lung, ovary, breast, prostate and colorectal cancer reveals novel pleiotropic associations.	Cancer	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	13q13.1	13	32265853	FRY	FRY			10129			rs56404467-A	rs56404467	0	56404467	intron_variant	0	NR	1E-7	7.0		1.2	[NR]	Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-cancer genome-wide analysis of lung, ovary, breast, prostate and colorectal cancer reveals novel pleiotropic associations.	Cancer	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	20q11.22	20	34002002	RALY	RALY			22913			rs2300206-G	rs2300206	0	2300206	intron_variant	0	NR	2E-8	7.698970004336019		1.1111112	[NR]	Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-cancer genome-wide analysis of lung, ovary, breast, prostate and colorectal cancer reveals novel pleiotropic associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	1p36.33	1	1351675	Intergenic	DVL1 - MXRA8	1855	54587		2533	1014	rs186507655-A	rs186507655	0	186507655	upstream_gene_variant	1	NR	5E-10	9.301029995663981	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-cancer genome-wide analysis of lung, ovary, breast, prostate and colorectal cancer reveals novel pleiotropic associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	1q22	1	155212373	MTX1	MTX1			4580			rs2075570-T	rs2075570	0	2075570	intron_variant	0	NR	5E-6	5.301029995663981	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-cancer genome-wide analysis of lung, ovary, breast, prostate and colorectal cancer reveals novel pleiotropic associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	3p24.1	3	27285723	NEK10	NEK10			152110			rs481519-T	rs481519	0	481519	intron_variant	0	NR	2E-9	8.698970004336019	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-cancer genome-wide analysis of lung, ovary, breast, prostate and colorectal cancer reveals novel pleiotropic associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	4q24	4	105140377	Intergenic	LOC100288146 - TET2	100288146	54790		36383	5498	rs7679673-A	rs7679673	0	7679673	intron_variant	1	NR	1E-10	10.0	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-cancer genome-wide analysis of lung, ovary, breast, prostate and colorectal cancer reveals novel pleiotropic associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	5p15.33	5	1282299	TERT	TERT			7015			rs7725218-A	rs7725218	0	7725218	intron_variant	0	NR	2E-10	9.698970004336019	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-cancer genome-wide analysis of lung, ovary, breast, prostate and colorectal cancer reveals novel pleiotropic associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	5q11.2	5	56737113	Intergenic	LOC101928448 - LOC105378979	101928448	105378979		130881	29282	rs1862626-T	rs1862626	0	1862626	regulatory_region_variant	1	NR	4E-12	11.397940008672037	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-cancer genome-wide analysis of lung, ovary, breast, prostate and colorectal cancer reveals novel pleiotropic associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	6p22.1	6	29785031	Intergenic	3.8-1.5 - HCG4	353010	54435		18735	6000	rs147680653-G	rs147680653	1	9258375	regulatory_region_variant	1	NR	1E-6	6.0	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-cancer genome-wide analysis of lung, ovary, breast, prostate and colorectal cancer reveals novel pleiotropic associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	6p22.1	6	30374976	Intergenic	UBQLN1P1 - MICC	387117	100129192		10865	39737	rs115707823-A	rs115707823	1	3129817	intergenic_variant	1	NR	5E-7	6.301029995663981	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-cancer genome-wide analysis of lung, ovary, breast, prostate and colorectal cancer reveals novel pleiotropic associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	6p21.33	6	31347004	HLA-C	LOC105375015 - HLA-B	105375015	3106		38409	6862	rs115392158-G	rs115392158	1	2507997	intron_variant	1	NR	3E-7	6.522878745280337	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-cancer genome-wide analysis of lung, ovary, breast, prostate and colorectal cancer reveals novel pleiotropic associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	6p21.32	6	32699696	Intergenic	HLA-DQB1 - MTCO3P1	3119	404026		33007	6448	rs147527678-C	rs147527678	1	1794514	intergenic_variant	1	NR	6E-8	7.221848749616356	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-cancer genome-wide analysis of lung, ovary, breast, prostate and colorectal cancer reveals novel pleiotropic associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	9p21.3	9	22062135	CDKN2B, AS1	CDKN2B-AS1			100048912			rs1011970-T	rs1011970	0	1011970	intron_variant	0	NR	5E-6	5.301029995663981	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-cancer genome-wide analysis of lung, ovary, breast, prostate and colorectal cancer reveals novel pleiotropic associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	10q26.13	10	121575416	FGFR2	FGFR2			2263			rs11200014-A	rs11200014	0	11200014	intron_variant	0	NR	8E-35	34.096910013008056	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-cancer genome-wide analysis of lung, ovary, breast, prostate and colorectal cancer reveals novel pleiotropic associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	11q13.3	11	69227030	Intergenic	LOC105369366 - LOC105369367	105369366	105369367		49023	1719	rs7931342-G	rs7931342	0	7931342	intergenic_variant	1	NR	4E-14	13.397940008672037	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-cancer genome-wide analysis of lung, ovary, breast, prostate and colorectal cancer reveals novel pleiotropic associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	11q22.3	11	103813371	Intergenic	LOC105369463 - LOC102723862	105369463	102723862		162091	29401	rs148883465-G	rs148883465	0	148883465	intron_variant	1	NR	3E-8	7.522878745280337	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-cancer genome-wide analysis of lung, ovary, breast, prostate and colorectal cancer reveals novel pleiotropic associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	12q13.12	12	49251457	TUBA1C	TUBA1C			84790			rs11168936-C	rs11168936	0	11168936	intron_variant	0	NR	9E-7	6.045757490560675	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-cancer genome-wide analysis of lung, ovary, breast, prostate and colorectal cancer reveals novel pleiotropic associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	12q13.13	12	52918828	KRT8	KRT8			3856			rs73110464-T	rs73110464	0	73110464	intron_variant	0	NR	2E-15	14.698970004336019	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-cancer genome-wide analysis of lung, ovary, breast, prostate and colorectal cancer reveals novel pleiotropic associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	12q24.12	12	111446804	SH2B3	SH2B3			10019			rs3184504-C	rs3184504	0	3184504	missense_variant	0	NR	1E-6	6.0	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-cancer genome-wide analysis of lung, ovary, breast, prostate and colorectal cancer reveals novel pleiotropic associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	13q13.1	13	32394673	BRCA2	BRCA2			675			rs11571818-C	rs11571818	0	11571818	intron_variant	0	NR	5E-10	9.301029995663981	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-cancer genome-wide analysis of lung, ovary, breast, prostate and colorectal cancer reveals novel pleiotropic associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	14q24.1	14	68559662	RAD51B	RAD51B			5890			rs11844632-A	rs11844632	0	11844632	intron_variant	0	NR	3E-10	9.522878745280337	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-cancer genome-wide analysis of lung, ovary, breast, prostate and colorectal cancer reveals novel pleiotropic associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	17q12	17	37741642	HNF1B	HNF1B			6928			rs12601991-T	rs12601991	0	12601991	intron_variant	0	NR	7E-28	27.154901959985743	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-cancer genome-wide analysis of lung, ovary, breast, prostate and colorectal cancer reveals novel pleiotropic associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	19p13.11	19	17279482	BABAM1	BABAM1 - ANKLE1	29086	126549		129	2163	rs4808075-C	rs4808075	0	4808075	intron_variant	1	NR	2E-9	8.698970004336019	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-cancer genome-wide analysis of lung, ovary, breast, prostate and colorectal cancer reveals novel pleiotropic associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	20q11.22	20	34131991	Intergenic	RPS2P1 - ASIP	140755	434		8649	54502	rs11907546-T	rs11907546	0	11907546	regulatory_region_variant	1	NR	3E-6	5.522878745280337	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-cancer genome-wide analysis of lung, ovary, breast, prostate and colorectal cancer reveals novel pleiotropic associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	11q22.3	11	103745837	Intergenic	LOC105369463 - LOC102723862	105369463	102723862		94557	96935	rs141752671-G	rs141752671	0	141752671	intron_variant	1	NR	1E-7	7.0	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-cancer genome-wide analysis of lung, ovary, breast, prostate and colorectal cancer reveals novel pleiotropic associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	12q24.12	12	111621753	Intergenic	ATXN2 - BRAP	6311	8315		22077	20393	rs11065979-T	rs11065979	0	11065979	intergenic_variant	1	NR	5E-6	5.301029995663981	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-cancer genome-wide analysis of lung, ovary, breast, prostate and colorectal cancer reveals novel pleiotropic associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	20q11.22	20	34002002	RALY	RALY			22913			rs2300206-C	rs2300206	0	2300206	intron_variant	0	NR	6E-6	5.221848749616356	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-cancer genome-wide analysis of lung, ovary, breast, prostate and colorectal cancer reveals novel pleiotropic associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	13q13.1	13	32295727	FRY	FRY			10129			rs56084662-A	rs56084662	0	56084662	3_prime_UTR_variant	0	NR	4E-9	8.397940008672037	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N
2008-06-16	17529974	Stacey SN	2007-05-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/17529974	Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor-positive breast cancer.	Breast cancer	1,599 European ancestry cases, 11,546 European ancestry controls	2,954 European ancestry cases, 5,967 European ancestry controls, Up to 561 Japanese ancestry cases, Up to 565 Japanese ancestry control, Up to 422 African American cases, Up to 448 African American controls, Up to 418 Hispanic cases, Up to 422 Hispanic controls, Up to 148 cases, Up to 293 controls	2q35	2	217041109	intergenic	LOC105373874, LOC101928278			105373874, 101928278			rs13387042-A	rs13387042	0	13387042	intergenic_variant	0	0.50	1E-13	13.0		1.2	[1.14-1.26]	Illumina [311524]	N
2008-06-16	17529974	Stacey SN	2007-05-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/17529974	Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor-positive breast cancer.	Breast cancer	1,599 European ancestry cases, 11,546 European ancestry controls	2,954 European ancestry cases, 5,967 European ancestry controls, Up to 561 Japanese ancestry cases, Up to 565 Japanese ancestry control, Up to 422 African American cases, Up to 448 African American controls, Up to 418 Hispanic cases, Up to 422 Hispanic controls, Up to 148 cases, Up to 293 controls	16q12.1	16	52552429	TNRC9	CASC16			643714			rs3803662-T	rs3803662	0	3803662	non_coding_transcript_exon_variant	0	0.27	6E-19	18.221848749616356		1.28	[1.21-1.35]	Illumina [311524]	N
2014-04-02	24080446	Rudolph A	2013-11-04	Endocr Relat Cancer	www.ncbi.nlm.nih.gov/pubmed/24080446	Genetic modifiers of menopausal hormone replacement therapy and breast cancer risk: a genome-wide interaction study.	Breast cancer (menopausal hormone therapy interaction)	2,920 European ancestry cases	7,689 European ancestry cases, 9,266 European ancestry controls	13q12.3	13	28590646	POMP	LOC105370135 - EIF4A1P7	105370135	341784		6269	8171	rs9579199-?	rs9579199	0	9579199	intergenic_variant	1		8E-6	5.096910013008056		1.2048	[1.11-1.32]	Illumina [2500000] (imputed)	N
2014-04-02	24080446	Rudolph A	2013-11-04	Endocr Relat Cancer	www.ncbi.nlm.nih.gov/pubmed/24080446	Genetic modifiers of menopausal hormone replacement therapy and breast cancer risk: a genome-wide interaction study.	Breast cancer (menopausal hormone therapy interaction)	2,920 European ancestry cases	7,689 European ancestry cases, 9,266 European ancestry controls	16q23.3	16	81924693	PLCG2	PLCG2			5336			rs7192724-?	rs7192724	0	7192724	intron_variant	0		3E-6	5.522878745280337		1.24	[1.13-1.36]	Illumina [2500000] (imputed)	N
2014-11-12	24785509	Barnett GC	2014-04-28	Radiother Oncol	www.ncbi.nlm.nih.gov/pubmed/24785509	A genome wide association study (GWAS) providing evidence of an association between common genetic variants and late radiotherapy toxicity.	Response to radiotherapy in cancer (late toxicity)	579 European ancestry prostate cancer cases, 1,194 European ancestry breast cancer cases	516 European ancestry prostate cancer cases, 862 prostate cancer cases, 355 breast cancer cases	10p12.31	10	21147293	C10orf113	NEBL			10529			rs12243039-?	rs12243039	0	12243039	intron_variant	0	0.01	6E-6	5.221848749616356	(All samples, overall toxicity, multivariable analysis)	3.39		Illumina [2417493] (imputed)	N
2015-04-01	25038754	Cai Q	2014-07-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25038754	Genome-wide association analysis in East Asians identifies breast cancer susceptibility loci at 1q32.1, 5q14.3 and 15q26.1.	Breast cancer	2,867 Chinese ancestry cases, 2,285 Chinese ancestry controls, 2,246 Korean ancestry cases, 2,052 Korean ancestry controls	5,029 Chinese ancestry cases, 5,302 Chinese ancestry controls, 6,066 Korean ancestry cases, 8,003 Korean ancestry controls, 6,572 Japanese ancestry cases, 6,539 Japanese ancestry controls, 16,003 European ancestry cases, 41,335 European ancestry controls	1q32.1	1	203797203	ZC3H11A	ZC3H11A			9877			rs4951011-G	rs4951011	0	4951011	5_prime_UTR_variant	0	0.282	9E-9	8.045757490560675	(East Asian)	1.09	[1.06-1.12]	Affymetrix [up to 1930412] (imputed)	N
2015-04-01	25038754	Cai Q	2014-07-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25038754	Genome-wide association analysis in East Asians identifies breast cancer susceptibility loci at 1q32.1, 5q14.3 and 15q26.1.	Breast cancer	2,867 Chinese ancestry cases, 2,285 Chinese ancestry controls, 2,246 Korean ancestry cases, 2,052 Korean ancestry controls	5,029 Chinese ancestry cases, 5,302 Chinese ancestry controls, 6,066 Korean ancestry cases, 8,003 Korean ancestry controls, 6,572 Japanese ancestry cases, 6,539 Japanese ancestry controls, 16,003 European ancestry cases, 41,335 European ancestry controls	5q14.3	5	91436408	ARRDC3	ARRDC3-AS1 - RAB5CP2	100129716	133789		15693	40003	rs10474352-C	rs10474352	0	10474352	intron_variant	1	0.482	2E-9	8.698970004336019	(East Asian)	1.09	[1.06-1.12]	Affymetrix [up to 1930412] (imputed)	N
2015-04-01	25038754	Cai Q	2014-07-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25038754	Genome-wide association analysis in East Asians identifies breast cancer susceptibility loci at 1q32.1, 5q14.3 and 15q26.1.	Breast cancer	2,867 Chinese ancestry cases, 2,285 Chinese ancestry controls, 2,246 Korean ancestry cases, 2,052 Korean ancestry controls	5,029 Chinese ancestry cases, 5,302 Chinese ancestry controls, 6,066 Korean ancestry cases, 8,003 Korean ancestry controls, 6,572 Japanese ancestry cases, 6,539 Japanese ancestry controls, 16,003 European ancestry cases, 41,335 European ancestry controls	15q26.1	15	90968837	PRC1	PRC1, PRC1-AS1			9055, 100507118			rs2290203-G	rs2290203	0	2290203	intron_variant	0	0.504	4E-8	7.3979400086720375	(East Asian)	1.08	[1.05-1.11]	Affymetrix [up to 1930412] (imputed)	N
2015-04-01	25038754	Cai Q	2014-07-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25038754	Genome-wide association analysis in East Asians identifies breast cancer susceptibility loci at 1q32.1, 5q14.3 and 15q26.1.	Breast cancer	2,867 Chinese ancestry cases, 2,285 Chinese ancestry controls, 2,246 Korean ancestry cases, 2,052 Korean ancestry controls	5,029 Chinese ancestry cases, 5,302 Chinese ancestry controls, 6,066 Korean ancestry cases, 8,003 Korean ancestry controls, 6,572 Japanese ancestry cases, 6,539 Japanese ancestry controls, 16,003 European ancestry cases, 41,335 European ancestry controls	18q11.2	18	23196687	NR	CABLES1			91768			rs11082321-A	rs11082321	0	11082321	intron_variant	0	0.21	7E-7	6.154901959985743	(East Asian)	1.08	[NR]	Affymetrix [up to 1930412] (imputed)	N
2017-03-24	27758888	Ingle JN	2016-10-10	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27758888	Genetic polymorphisms in the long noncoding RNA MIR2052HG offer a pharmacogenomic basis for the response of breast cancer patients to aromatase inhibitor therapy.	Breast cancer-free interval (treatment with aromatase inhibitor)	6 African American recurrent cases, 134 African American controls without recurrence, 243 European ancestry recurrent cases, 4,216 European ancestry controls without recurrence, 3 Asian ancestry recurrent cases, 56 Asian ancestry controls without recurrence	NA	8q21.11	8	74567389	MIR2052HG, FLJ39080, LOC441355	MIR5681A - LOC105375904	100847058	105375904		18772	22751	rs13260300-?	rs13260300	0	13260300	intergenic_variant	1		2E-7	6.698970004336019		1.64	[1.35-2.00]	Illumina [~ 7400000] (imputed)	N
2015-04-22	21278746	Lindstrom S	2011-01-30	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/21278746	Common variants in ZNF365 are associated with both mammographic density and breast cancer risk.	Percent mammographic density	4,877 European ancestry females	1,145 European ancestry females, 1,690 females	10q21.2	10	62518923	ZNF365	ZNF365			22891			rs10995190-A	rs10995190	0	10995190	intron_variant	0	0.15	1E-9	9.0		0.18	[0.12-0.25] % decrease	Affymetrix, Illumina [> 2000000] (imputed)	N
2014-03-02	23900074	Pooley KA	2013-07-29	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/23900074	A genome-wide association scan (GWAS) for mean telomere length within the COGS project: identified loci show little association with hormone-related cancer risk.	Telomere length	2,240 European ancestry individuals	11,024 breast cancer cases, 15,065 controls	3q26.2	3	169810661	TERC	LRRC34			151827			rs10936601-?	rs10936601	0	10936601	intron_variant	0	0.27	4E-15	14.397940008672037		4.0E-4	[0.00029-0.00051] unit increase	Illumina, Perlegen [2448093] (imputed)	N
2008-09-10	17903305	Murabito JM	2007-09-19	BMC Med Genet	www.ncbi.nlm.nih.gov/pubmed/17903305	A genome-wide association study of breast and prostate cancer in the NHLBI's Framingham Heart Study.	Breast cancer	58 cases, 665 controls	NA	17q21.33	17	50196930	COL1A1	COL1A1			1277			rs2075555-?	rs2075555	0	2075555	intron_variant	0	NR	8E-8	7.096910013008056				Affymetrix [70897]	N
2008-09-10	17903305	Murabito JM	2007-09-19	BMC Med Genet	www.ncbi.nlm.nih.gov/pubmed/17903305	A genome-wide association study of breast and prostate cancer in the NHLBI's Framingham Heart Study.	Breast cancer	58 cases, 665 controls	NA	5q34	5	164462274	intergenic	LOC105377703, LOC101927835			105377703, 101927835			rs6556756-?	rs6556756	0	6556756	intron_variant	0	NR	5E-7	6.301029995663981				Affymetrix [70897]	N
2008-09-10	17903305	Murabito JM	2007-09-19	BMC Med Genet	www.ncbi.nlm.nih.gov/pubmed/17903305	A genome-wide association study of breast and prostate cancer in the NHLBI's Framingham Heart Study.	Breast cancer	58 cases, 665 controls	NA	12q21.1	12	73596057	intergenic	LOC105369839 - RPL31P48	105369839	645654		253086	52583	rs1154865-?	rs1154865	0	1154865	intergenic_variant	1	NR	7E-7	6.154901959985743				Affymetrix [70897]	N
2008-09-10	17903305	Murabito JM	2007-09-19	BMC Med Genet	www.ncbi.nlm.nih.gov/pubmed/17903305	A genome-wide association study of breast and prostate cancer in the NHLBI's Framingham Heart Study.	Breast cancer	58 cases, 665 controls	NA	18q21.2	18	55997051	intergenic	LOC101927273 - LOC107985164	101927273	107985164		76852	1108	rs1978503-?	rs1978503	0	1978503	intron_variant	1	NR	1E-6	6.0				Affymetrix [70897]	N
2008-09-10	17903305	Murabito JM	2007-09-19	BMC Med Genet	www.ncbi.nlm.nih.gov/pubmed/17903305	A genome-wide association study of breast and prostate cancer in the NHLBI's Framingham Heart Study.	Breast cancer	58 cases, 665 controls	NA	13q32.1	13	95222702	ABCC4	ABCC4			10257			rs1926657-?	rs1926657	0	1926657	intron_variant	0	NR	2E-6	5.698970004336019				Affymetrix [70897]	N
2008-09-10	17903305	Murabito JM	2007-09-19	BMC Med Genet	www.ncbi.nlm.nih.gov/pubmed/17903305	A genome-wide association study of breast and prostate cancer in the NHLBI's Framingham Heart Study.	Breast cancer	58 cases, 665 controls	NA	7q11.22	7	67594280	intergenic	LOC105375340			105375340			rs10263639-?	rs10263639	0	10263639	intergenic_variant	0	NR	3E-6	5.522878745280337				Affymetrix [70897]	N
2008-09-10	17903305	Murabito JM	2007-09-19	BMC Med Genet	www.ncbi.nlm.nih.gov/pubmed/17903305	A genome-wide association study of breast and prostate cancer in the NHLBI's Framingham Heart Study.	Breast cancer	58 cases, 665 controls	NA	2p16.1	2	59272212	intergenic	LOC105374754, LOC101927285			105374754, 101927285			rs10490113-?	rs10490113	0	10490113	intron_variant	0	NR	5E-6	5.301029995663981				Affymetrix [70897]	N
2008-09-10	17903305	Murabito JM	2007-09-19	BMC Med Genet	www.ncbi.nlm.nih.gov/pubmed/17903305	A genome-wide association study of breast and prostate cancer in the NHLBI's Framingham Heart Study.	Breast cancer	58 cases, 665 controls	NA	21q21.3	21	29805194	GRIK1	GRIK1			2897			rs458685-?	rs458685	0	458685	intron_variant	0	NR	6E-6	5.221848749616356				Affymetrix [70897]	N
2008-09-10	17903305	Murabito JM	2007-09-19	BMC Med Genet	www.ncbi.nlm.nih.gov/pubmed/17903305	A genome-wide association study of breast and prostate cancer in the NHLBI's Framingham Heart Study.	Breast cancer	58 cases, 665 controls	NA	15q21.1	15	48608389	FBN1	FBN1			2200			rs1876206-?	rs1876206	0	1876206	intron_variant	0	NR	6E-6	5.221848749616356				Affymetrix [70897]	N
2012-08-20	22747683	Eriksson N	2012-06-30	BMC Med Genet	www.ncbi.nlm.nih.gov/pubmed/22747683	Genetic variants associated with breast size also influence breast cancer risk.	Breast size	16,175 European ancestry female individuals	NA	12p13.31	12	9228263	LOC642846, LOC728715	KLRG1			10219			rs10771431-A	rs10771431	0	10771431	downstream_gene_variant	0	0.444	2E-6	5.698970004336019		0.073	[0.042-0.104] cup size decrease	Illumina [7422970] (imputed)	N
2012-08-20	22747683	Eriksson N	2012-06-30	BMC Med Genet	www.ncbi.nlm.nih.gov/pubmed/22747683	Genetic variants associated with breast size also influence breast cancer risk.	Breast size	16,175 European ancestry female individuals	NA	2p23.3	2	27375230	SLC4A1AP, GCKR	SNX17			9784			rs4665972-T	rs4665972	0	4665972	intron_variant	0	0.448	1E-6	6.0		0.08	[0.047-0.113] cup size increase	Illumina [7422970] (imputed)	N
2012-08-20	22747683	Eriksson N	2012-06-30	BMC Med Genet	www.ncbi.nlm.nih.gov/pubmed/22747683	Genetic variants associated with breast size also influence breast cancer risk.	Breast size	16,175 European ancestry female individuals	NA	12p11.22	12	28003148	LOC100129646, PTHLH	PTHLH - LOC105369710	5744	105369710		28961	58493	rs12371778-G	rs12371778	0	12371778	intergenic_variant	1	0.091	1E-8	8.0		0.162	[0.11-0.22] cup size decrease	Illumina [7422970] (imputed)	N
2012-08-20	22747683	Eriksson N	2012-06-30	BMC Med Genet	www.ncbi.nlm.nih.gov/pubmed/22747683	Genetic variants associated with breast size also influence breast cancer risk.	Breast size	16,175 European ancestry female individuals	NA	8p11.23	8	36988591	KCNU1, ZNF703, MRPS7P1	RPL26P25 - LOC105379377	100270966	105379377		93	77543	rs7816345-T	rs7816345	0	7816345	upstream_gene_variant	1	0.194	2E-14	13.698970004336019		0.151	[0.11-0.19] cup size decrease	Illumina [7422970] (imputed)	N
2012-08-20	22747683	Eriksson N	2012-06-30	BMC Med Genet	www.ncbi.nlm.nih.gov/pubmed/22747683	Genetic variants associated with breast size also influence breast cancer risk.	Breast size	16,175 European ancestry female individuals	NA				FAM109B, NAGA, MKL1, WBP2NL							chr22:40779964-A	chr22:40779964	0			1	0.056	5E-7	6.301029995663981		0.187	[0.11-0.26] cup size decrease	Illumina [7422970] (imputed)	N
2012-08-20	22747683	Eriksson N	2012-06-30	BMC Med Genet	www.ncbi.nlm.nih.gov/pubmed/22747683	Genetic variants associated with breast size also influence breast cancer risk.	Breast size	16,175 European ancestry female individuals	NA				TBC1D22A, LOC100128818							chr22:45895495-T	chr22:45895495	0			1	0.199	7E-6	5.154901959985743		0.115	[0.064-0.166] cup size increase	Illumina [7422970] (imputed)	N
2012-08-20	22747683	Eriksson N	2012-06-30	BMC Med Genet	www.ncbi.nlm.nih.gov/pubmed/22747683	Genetic variants associated with breast size also influence breast cancer risk.	Breast size	16,175 European ancestry female individuals	NA				DEFB112, TFAP2D							chr6:50202617-A	chr6:50202617	0			1	0.053	5E-6	5.301029995663981		0.174	[0.100-0.248] cup size decrease	Illumina [7422970] (imputed)	N
2012-08-20	22747683	Eriksson N	2012-06-30	BMC Med Genet	www.ncbi.nlm.nih.gov/pubmed/22747683	Genetic variants associated with breast size also influence breast cancer risk.	Breast size	16,175 European ancestry female individuals	NA	3p14.2	3	60777523	NPCDR1, PTPRG	FHIT			2272			rs11919041-T	rs11919041	0	11919041	intron_variant	0	0.287	2E-6	5.698970004336019		0.082	[0.049-0.115] cup size decrease	Illumina [7422970] (imputed)	N
2012-08-20	22747683	Eriksson N	2012-06-30	BMC Med Genet	www.ncbi.nlm.nih.gov/pubmed/22747683	Genetic variants associated with breast size also influence breast cancer risk.	Breast size	16,175 European ancestry female individuals	NA	3p14.2	3	62747691	CADPS	CADPS			8618			rs580384-C	rs580384	0	580384	intron_variant	0	0.089	4E-6	5.3979400086720375		0.124	[0.071-0.177] cup size decrease	Illumina [7422970] (imputed)	N
2012-08-20	22747683	Eriksson N	2012-06-30	BMC Med Genet	www.ncbi.nlm.nih.gov/pubmed/22747683	Genetic variants associated with breast size also influence breast cancer risk.	Breast size	16,175 European ancestry female individuals	NA	10q21.2	10	62427805	ADO, ZNF365, ALDH7A1P4	ZNF365			22891			rs7089814-C	rs7089814	0	7089814	intron_variant	0	0.375	3E-9	8.522878745280337		0.096	[0.065-0.127] cup size increase	Illumina [7422970] (imputed)	N
2012-08-20	22747683	Eriksson N	2012-06-30	BMC Med Genet	www.ncbi.nlm.nih.gov/pubmed/22747683	Genetic variants associated with breast size also influence breast cancer risk.	Breast size	16,175 European ancestry female individuals	NA				NUFIP1P							chr6:67596834-A	chr6:67596834	0			1	0.0020	7E-6	5.154901959985743		1.008	[0.57-1.45] cup size increase	Illumina [7422970] (imputed)	N
2012-08-20	22747683	Eriksson N	2012-06-30	BMC Med Genet	www.ncbi.nlm.nih.gov/pubmed/22747683	Genetic variants associated with breast size also influence breast cancer risk.	Breast size	16,175 European ancestry female individuals	NA	11q13.3	11	69328516	IFITM9P, CCND1	IFITM9P - LOC105369370	390218	105369370		24710	38309	rs7102705-A	rs7102705	0	7102705	intron_variant	1	0.211	5E-6	5.301029995663981		0.086	[0.049-0.123] cup size increase	Illumina [7422970] (imputed)	N
2012-08-20	22747683	Eriksson N	2012-06-30	BMC Med Genet	www.ncbi.nlm.nih.gov/pubmed/22747683	Genetic variants associated with breast size also influence breast cancer risk.	Breast size	16,175 European ancestry female individuals	NA	4q13.3	4	74577305	EREG, AREGB, EPGN, AREG	LOC107986229			107986229			rs62314947-T	rs62314947	0	62314947	intron_variant	0	0.281	5E-8	7.301029995663981		0.101	[0.064-0.138] cup size decrease	Illumina [7422970] (imputed)	N
2012-08-20	22747683	Eriksson N	2012-06-30	BMC Med Genet	www.ncbi.nlm.nih.gov/pubmed/22747683	Genetic variants associated with breast size also influence breast cancer risk.	Breast size	16,175 European ancestry female individuals	NA	10q22.2	10	74943248	COMTD1, SPA17P1	KAT6B			23522			rs10466033-G	rs10466033	0	10466033	intron_variant	0	0.0080	6E-6	5.221848749616356		0.437	[0.25-0.63] cup size increase	Illumina [7422970] (imputed)	N
2012-08-20	22747683	Eriksson N	2012-06-30	BMC Med Genet	www.ncbi.nlm.nih.gov/pubmed/22747683	Genetic variants associated with breast size also influence breast cancer risk.	Breast size	16,175 European ancestry female individuals	NA	13q31.3	13	92929538	GPC6	GPC5 - LOC105370317	2262	105370317		62301	103447	rs9523848-T	rs9523848	0	9523848	intergenic_variant	1	0.293	3E-6	5.522878745280337		0.081	[0.048-0.114] cup size decrease	Illumina [7422970] (imputed)	N
2012-08-20	22747683	Eriksson N	2012-06-30	BMC Med Genet	www.ncbi.nlm.nih.gov/pubmed/22747683	Genetic variants associated with breast size also influence breast cancer risk.	Breast size	16,175 European ancestry female individuals	NA	14q32.13	14	94329847	SERPINA6, CLMN	SERPINA6 - SERPINA2	866	390502		6496	34471	rs61280460-T	rs61280460	0	61280460	intergenic_variant	1	0.199	8E-7	6.096910013008056		0.095	[0.058-0.132] cup size decrease	Illumina [7422970] (imputed)	N
2012-08-20	22747683	Eriksson N	2012-06-30	BMC Med Genet	www.ncbi.nlm.nih.gov/pubmed/22747683	Genetic variants associated with breast size also influence breast cancer risk.	Breast size	16,175 European ancestry female individuals	NA	12q22	12	95633983	NEDD1, MIR135A2	USP44 - PGAM1P5	84101	100132594		82454	15272	rs17356907-G	rs17356907	0	17356907	intron_variant	1	0.296	1E-6	6.0		0.081	[0.048-0.114] cup size increase	Illumina [7422970] (imputed)	N
2012-08-20	22747683	Eriksson N	2012-06-30	BMC Med Genet	www.ncbi.nlm.nih.gov/pubmed/22747683	Genetic variants associated with breast size also influence breast cancer risk.	Breast size	16,175 European ancestry female individuals	NA	2q14.2	2	120487546	INHBB, GLI2, LOC84931	LINC01101 - LOC105373585	84931	105373585		21197	55312	rs4849887-T	rs4849887	0	4849887	intergenic_variant	1	0.113	3E-11	10.522878745280337		0.166	[0.12-0.22] cup size increase	Illumina [7422970] (imputed)	N
2012-08-20	22747683	Eriksson N	2012-06-30	BMC Med Genet	www.ncbi.nlm.nih.gov/pubmed/22747683	Genetic variants associated with breast size also influence breast cancer risk.	Breast size	16,175 European ancestry female individuals	NA				TMCC1							chr3:130947635-A	chr3:130947635	0			1	0.0010	5E-7	6.301029995663981		2.299	[1.41-3.19] cup size increase	Illumina [7422970] (imputed)	N
2012-08-20	22747683	Eriksson N	2012-06-30	BMC Med Genet	www.ncbi.nlm.nih.gov/pubmed/22747683	Genetic variants associated with breast size also influence breast cancer risk.	Breast size	16,175 European ancestry female individuals	NA	8q24.3	8	141530825	FLJ43860	LOC105375791 - MIR1302-7	105375791	100302147		16610	255417	rs7837045-A	rs7837045	0	7837045	regulatory_region_variant	1	0.22	5E-6	5.301029995663981		0.092	[0.053-0.131] cup size decrease	Illumina [7422970] (imputed)	N
2012-08-20	22747683	Eriksson N	2012-06-30	BMC Med Genet	www.ncbi.nlm.nih.gov/pubmed/22747683	Genetic variants associated with breast size also influence breast cancer risk.	Breast size	16,175 European ancestry female individuals	NA	6q25.1	6	151636579	ESR1, C6orf97	CCDC170 - ESR1	80129	2099		15386	17569	rs12173570-T	rs12173570	0	12173570	intergenic_variant	1	0.101	6E-11	10.221848749616356		0.171	[0.12-0.22] cup size increase	Illumina [7422970] (imputed)	N
2012-08-20	22747683	Eriksson N	2012-06-30	BMC Med Genet	www.ncbi.nlm.nih.gov/pubmed/22747683	Genetic variants associated with breast size also influence breast cancer risk.	Breast size	16,175 European ancestry female individuals	NA				TLR3							chr4:187239569-T	chr4:187239569	0			1	0.013	6E-6	5.221848749616356		0.406	[0.23-0.58] cup size increase	Illumina [7422970] (imputed)	N
2012-08-20	22747683	Eriksson N	2012-06-30	BMC Med Genet	www.ncbi.nlm.nih.gov/pubmed/22747683	Genetic variants associated with breast size also influence breast cancer risk.	Breast size	16,175 European ancestry female individuals	NA	1q32.1	1	201915824	ATP2B4	LMOD1			25802			rs2819348-C	rs2819348	0	2819348	intron_variant	0	0.318	3E-6	5.522878745280337		0.078	[0.045-0.111] cup size increase	Illumina [7422970] (imputed)	N
2012-08-20	22747683	Eriksson N	2012-06-30	BMC Med Genet	www.ncbi.nlm.nih.gov/pubmed/22747683	Genetic variants associated with breast size also influence breast cancer risk.	Breast size	16,175 European ancestry female individuals	NA	2q14.2	2	119755557	EPB41L5	LOC101927764			101927764			rs13401620-A	rs13401620	0	13401620	upstream_gene_variant	0	0.224	2E-6	5.698970004336019		0.095	[0.056-0.134] cup size decrease	Illumina [7422970] (imputed)	N
2012-08-20	22747683	Eriksson N	2012-06-30	BMC Med Genet	www.ncbi.nlm.nih.gov/pubmed/22747683	Genetic variants associated with breast size also influence breast cancer risk.	Breast size	16,175 European ancestry female individuals	NA	2p14	2	64268493	RPL23AP37, LOC100128607	LOC100507006 - LOC105374768	100507006	105374768		15962	31378	rs1529102-A	rs1529102	0	1529102	intergenic_variant	1	0.495	6E-6	5.221848749616356		0.07	[0.041-0.099] cup size increase	Illumina [7422970] (imputed)	N
2012-08-20	22747683	Eriksson N	2012-06-30	BMC Med Genet	www.ncbi.nlm.nih.gov/pubmed/22747683	Genetic variants associated with breast size also influence breast cancer risk.	Breast size	16,175 European ancestry female individuals	NA	2p23.3	2	27519736	SLC4A1AP	GCKR			2646			rs780093-T	rs780093	0	780093	intron_variant	0	0.416	5E-6	5.301029995663981		0.072	[0.041-0.103] cup size increase	Illumina [7422970] (imputed)	N
2012-08-20	22747683	Eriksson N	2012-06-30	BMC Med Genet	www.ncbi.nlm.nih.gov/pubmed/22747683	Genetic variants associated with breast size also influence breast cancer risk.	Breast size	16,175 European ancestry female individuals	NA	2q31.2	2	178239571	TTN	OSBPL6			114880			rs34479159-C	rs34479159	0	34479159	intron_variant	0	0.19	6E-6	5.221848749616356		0.089	[0.050-0.128] cup size increase	Illumina [7422970] (imputed)	N
2012-08-20	22747683	Eriksson N	2012-06-30	BMC Med Genet	www.ncbi.nlm.nih.gov/pubmed/22747683	Genetic variants associated with breast size also influence breast cancer risk.	Breast size	16,175 European ancestry female individuals	NA				LOC645207, GAP43							chr3:116704634-A	chr3:116704634	0			1	0.054	8E-6	5.096910013008056		0.165	[0.092-0.238] cup size decrease	Illumina [7422970] (imputed)	N
2012-08-20	22747683	Eriksson N	2012-06-30	BMC Med Genet	www.ncbi.nlm.nih.gov/pubmed/22747683	Genetic variants associated with breast size also influence breast cancer risk.	Breast size	16,175 European ancestry female individuals	NA	3p24.1	3	29167660	MESTP4, RBMS3	MESTP4 - RBMS3-AS3	131572	100873979		78044	96534	rs6549915-T	rs6549915	0	6549915	intron_variant	1	0.444	9E-6	5.045757490560675		0.078	[0.043-0.113] cup size decrease	Illumina [7422970] (imputed)	N
2012-08-20	22747683	Eriksson N	2012-06-30	BMC Med Genet	www.ncbi.nlm.nih.gov/pubmed/22747683	Genetic variants associated with breast size also influence breast cancer risk.	Breast size	16,175 European ancestry female individuals	NA	4q34.3	4	179462158	RPL19P8	LOC105377563 - LOC105377564	105377563	105377564		644832	502288	rs2716816-C	rs2716816	0	2716816	intron_variant	1	0.149	7E-6	5.154901959985743		0.098	[0.055-0.141] cup size increase	Illumina [7422970] (imputed)	N
2012-08-20	22747683	Eriksson N	2012-06-30	BMC Med Genet	www.ncbi.nlm.nih.gov/pubmed/22747683	Genetic variants associated with breast size also influence breast cancer risk.	Breast size	16,175 European ancestry female individuals	NA	7p14.2	7	36912416	ELMO1	ELMO1			9844			rs10488023-G	rs10488023	0	10488023	intron_variant	0	0.142	8E-6	5.096910013008056		0.099	[0.056-0.142] cup size increase	Illumina [7422970] (imputed)	N
2012-08-20	22747683	Eriksson N	2012-06-30	BMC Med Genet	www.ncbi.nlm.nih.gov/pubmed/22747683	Genetic variants associated with breast size also influence breast cancer risk.	Breast size	16,175 European ancestry female individuals	NA	11q24.2	11	126003207	KIRREL3	CDON			50937			rs7104745-G	rs7104745	0	7104745	intron_variant	0	0.458	6E-6	5.221848749616356		0.07	[0.039-0.101] cup size increase	Illumina [7422970] (imputed)	N
2012-08-20	22747683	Eriksson N	2012-06-30	BMC Med Genet	www.ncbi.nlm.nih.gov/pubmed/22747683	Genetic variants associated with breast size also influence breast cancer risk.	Breast size	16,175 European ancestry female individuals	NA	13q13.3	13	35957411	FAM48A	DCLK1			9201			rs34065801-C	rs34065801	0	34065801	intron_variant	0	0.176	6E-6	5.221848749616356		0.096	[0.055-0.137] cup size increase	Illumina [7422970] (imputed)	N
2012-08-20	22747683	Eriksson N	2012-06-30	BMC Med Genet	www.ncbi.nlm.nih.gov/pubmed/22747683	Genetic variants associated with breast size also influence breast cancer risk.	Breast size	16,175 European ancestry female individuals	NA	13q21.2	13	59379332	TDRD3	LOC105370222 - RNU7-88P	105370222	100873843		87900	100738	rs12585963-A	rs12585963	0	12585963	intergenic_variant	1	0.312	2E-6	5.698970004336019		0.08	[0.047-0.113] cup size increase	Illumina [7422970] (imputed)	N
2012-08-20	22747683	Eriksson N	2012-06-30	BMC Med Genet	www.ncbi.nlm.nih.gov/pubmed/22747683	Genetic variants associated with breast size also influence breast cancer risk.	Breast size	16,175 European ancestry female individuals	NA	18q12.1	18	32399612	NOL4	GAREM			64762			rs58263042-C	rs58263042	0	58263042	intron_variant	0	0.061	9E-6	5.045757490560675		0.165	[0.092-0.238] cup size decrease	Illumina [7422970] (imputed)	N
2012-08-20	22747683	Eriksson N	2012-06-30	BMC Med Genet	www.ncbi.nlm.nih.gov/pubmed/22747683	Genetic variants associated with breast size also influence breast cancer risk.	Breast size	16,175 European ancestry female individuals	NA	2q14.2	2	120332155	INHBB	LOC105373584 - LOC105373989	105373584	105373989		12831	10295	rs17625845-C	rs17625845	0	17625845	intergenic_variant	1	.205	5E-10	9.301029995663981		0.125	[.086-.164] cup size increase	Illumina [7422970] (imputed)	N
2012-08-20	22747683	Eriksson N	2012-06-30	BMC Med Genet	www.ncbi.nlm.nih.gov/pubmed/22747683	Genetic variants associated with breast size also influence breast cancer risk.	Breast size	16,175 European ancestry female individuals	NA	22q12.1	22	28765019	MTFP1, LOC646513, SEC14L2, SDC4P, CHEK2	HSCB - CCDC117	150274	150275		7501	7655	rs4820792-T	rs4820792	0	4820792	intergenic_variant	1	.180	4E-7	6.3979400086720375		0.105	[0.065-.146] cup size increase	Illumina [7422970] (imputed)	N
2012-08-20	22747683	Eriksson N	2012-06-30	BMC Med Genet	www.ncbi.nlm.nih.gov/pubmed/22747683	Genetic variants associated with breast size also influence breast cancer risk.	Breast size	16,175 European ancestry female individuals	NA	7q31.1	7	112002591	ZNF277	DOCK4			9732			rs61159171-T	rs61159171	0	61159171	intron_variant	0	0.348	6E-6	5.221848749616356		0.075	[0.042-0.108] cup size decrease	Illumina [7422970] (imputed)	N
2014-04-02	24080446	Rudolph A	2013-11-04	Endocr Relat Cancer	www.ncbi.nlm.nih.gov/pubmed/24080446	Genetic modifiers of menopausal hormone replacement therapy and breast cancer risk: a genome-wide interaction study.	Lobular breast cancer (menopausal hormone therapy interaction)	541 European ancestry cases	676 European ancestry cases, 9,266 European ancestry controls	3q13.33	3	119542528	CD80	CD80			941			rs7648642-?	rs7648642	0	7648642	intron_variant	0		5E-6	5.301029995663981		1.5625	[1.28-1.89]	Illumina [2500000] (imputed)	N
2014-04-02	24080446	Rudolph A	2013-11-04	Endocr Relat Cancer	www.ncbi.nlm.nih.gov/pubmed/24080446	Genetic modifiers of menopausal hormone replacement therapy and breast cancer risk: a genome-wide interaction study.	Lobular breast cancer (menopausal hormone therapy interaction)	541 European ancestry cases	676 European ancestry cases, 9,266 European ancestry controls	17q12	17	34662519	TMEM132E	TMEM132E - LOC105371740	124842	105371740		23201	62990	rs11654964-?	rs11654964	0	11654964	intergenic_variant	1		3E-6	5.522878745280337		1.67	[1.35-2.06]	Illumina [2500000] (imputed)	N
2013-08-02	23544013	Couch FJ	2013-03-27	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/23544013	Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk.	Breast Cancer in BRCA1 mutation carriers	1,426 European ancestry cases, 1,301 European ancestry controls	6,031 European ancestry cases, 5,933 European ancestry controls	1q32.1	1	204546897	MDM4	MDM4			4194			rs2290854-A	rs2290854	0	2290854	intron_variant	0	0.31	1E-7	7.0		1.13	[1.08-1.18]	Illumina [2568349] (imputed)	N
2013-08-02	23544013	Couch FJ	2013-03-27	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/23544013	Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk.	Breast Cancer in BRCA1 mutation carriers	1,426 European ancestry cases, 1,301 European ancestry controls	6,031 European ancestry cases, 5,933 European ancestry controls	10q25.2	10	112974337	TCF7L2	TCF7L2			6934			rs11196174-G	rs11196174	0	11196174	intron_variant	0	0.28	8E-7	6.096910013008056		1.13	[1.07-1.18]	Illumina [2568349] (imputed)	N
2013-08-02	23544013	Couch FJ	2013-03-27	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/23544013	Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk.	Breast Cancer in BRCA1 mutation carriers	1,426 European ancestry cases, 1,301 European ancestry controls	6,031 European ancestry cases, 5,933 European ancestry controls	7p21.3	7	8512984	NR	NXPH1			30010			rs765855-?	rs765855	0	765855	intron_variant	0		4E-6	5.3979400086720375				Illumina [2568349] (imputed)	N
2013-08-02	23544013	Couch FJ	2013-03-27	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/23544013	Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk.	Breast Cancer in BRCA1 mutation carriers	1,426 European ancestry cases, 1,301 European ancestry controls	6,031 European ancestry cases, 5,933 European ancestry controls	19p13.11	19	17278895	intergenic	BABAM1			29086			rs8170-G	rs8170	0	8170	synonymous_variant	0	0.48	4E-13	12.397940008672037		1.19	[1.14-1.25]	Illumina [2568349] (imputed)	N
2013-08-02	23544013	Couch FJ	2013-03-27	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/23544013	Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk.	Breast Cancer in BRCA1 mutation carriers	1,426 European ancestry cases, 1,301 European ancestry controls	6,031 European ancestry cases, 5,933 European ancestry controls	6q25.1	6	151627231	intergenic	CCDC170 - ESR1	80129	2099		6038	26917	rs2046210-C	rs2046210	0	2046210	intergenic_variant	1	0.08	5E-9	8.301029995663981		1.28	[1.18-1.39]	Illumina [2568349] (imputed)	N
2013-08-02	23544013	Couch FJ	2013-03-27	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/23544013	Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk.	Breast Cancer in BRCA1 mutation carriers	1,426 European ancestry cases, 1,301 European ancestry controls	6,031 European ancestry cases, 5,933 European ancestry controls	12p11.22	12	28002147	intergenic	PTHLH - LOC105369710	5744	105369710		27960	59494	rs10771399-A	rs10771399	0	10771399	intergenic_variant	1	0.86	8E-6	5.096910013008056		1.18	[1.1-1.27]	Illumina [2568349] (imputed)	N
2014-11-12	24785509	Barnett GC	2014-04-28	Radiother Oncol	www.ncbi.nlm.nih.gov/pubmed/24785509	A genome wide association study (GWAS) providing evidence of an association between common genetic variants and late radiotherapy toxicity.	Response to radiotherapy in cancer (late toxicity)	579 European ancestry prostate cancer cases, 1,194 European ancestry breast cancer cases	516 European ancestry prostate cancer cases, 862 prostate cancer cases, 355 breast cancer cases	1p13.2	1	111873741	KCND3	KCND3			3752			rs2788612-?	rs2788612	0	2788612	intron_variant	0	0.05	6E-16	15.221848749616356	(Prostate cancer, rectal incontinence, univariable analysis)	0.18	[NR] unit increase	Illumina [2417493] (imputed)	N
2014-11-12	24785509	Barnett GC	2014-04-28	Radiother Oncol	www.ncbi.nlm.nih.gov/pubmed/24785509	A genome wide association study (GWAS) providing evidence of an association between common genetic variants and late radiotherapy toxicity.	Response to radiotherapy in cancer (late toxicity)	579 European ancestry prostate cancer cases, 1,194 European ancestry breast cancer cases	516 European ancestry prostate cancer cases, 862 prostate cancer cases, 355 breast cancer cases	10q24.31	10	100170652	ERLIN1	ERLIN1			10613			rs11595238-?	rs11595238	0	11595238	intron_variant	0	0.04	2E-6	5.698970004336019	(Prostate cancer, rectal incontinence, multivariable analysis)	6.61		Illumina [2417493] (imputed)	N
2014-11-12	24785509	Barnett GC	2014-04-28	Radiother Oncol	www.ncbi.nlm.nih.gov/pubmed/24785509	A genome wide association study (GWAS) providing evidence of an association between common genetic variants and late radiotherapy toxicity.	Response to radiotherapy in cancer (late toxicity)	579 European ancestry prostate cancer cases, 1,194 European ancestry breast cancer cases	516 European ancestry prostate cancer cases, 862 prostate cancer cases, 355 breast cancer cases	3p24.1	3	29287529	RBMS3	RBMS3			27303			rs9832625-?	rs9832625	0	9832625	intron_variant	0	0.08	3E-6	5.522878745280337	(Prostate cancer, rectal incontinence, univariable analysis)	0.07	[NR] unit increase	Illumina [2417493] (imputed)	N
2014-11-12	24785509	Barnett GC	2014-04-28	Radiother Oncol	www.ncbi.nlm.nih.gov/pubmed/24785509	A genome wide association study (GWAS) providing evidence of an association between common genetic variants and late radiotherapy toxicity.	Response to radiotherapy in cancer (late toxicity)	579 European ancestry prostate cancer cases, 1,194 European ancestry breast cancer cases	516 European ancestry prostate cancer cases, 862 prostate cancer cases, 355 breast cancer cases	21q21.1	21	16396204	CNTNAP2	MIR99AHG			388815			rs2823779-?	rs2823779	0	2823779	intron_variant	0	0.09	7E-6	5.154901959985743	(Prostate cancer, urine incontinence, univariable analysis)	0.1	[NR] unit increase	Illumina [2417493] (imputed)	N
2015-04-23	25117820	Schneider BP	2014-08-12	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/25117820	Genetic variant predicts bevacizumab-induced hypertension in ECOG-5103 and ECOG-2100.	Response to chemotherapy in breast cancer (hypertension) (bevacizumab)	255 European ancestry cases, 387 European ancestry controls		5q13.3	5	76143375	SV2C	SV2C			22987			rs6453204-?	rs6453204	0	6453204	intron_variant	0	NR	6E-8	7.221848749616356		3.3	[NR]	Illumina [up to 810372] (imputed)	N
2015-04-23	25117820	Schneider BP	2014-08-12	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/25117820	Genetic variant predicts bevacizumab-induced hypertension in ECOG-5103 and ECOG-2100.	Response to chemotherapy in breast cancer hypertensive cases (cumulative dose) (bevacizumab)	255 European ancestry cases, 387 European ancestry controls		5q13.3	5	76143375	SV2C	SV2C			22987			rs6453204-?	rs6453204	0	6453204	intron_variant	0	NR	5E-8	7.301029995663981		2.2	[NR]	Illumina [up to 810372] (imputed)	N
2015-04-23	25117820	Schneider BP	2014-08-12	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/25117820	Genetic variant predicts bevacizumab-induced hypertension in ECOG-5103 and ECOG-2100.	Response to chemotherapy in breast cancer (hypertension) (bevacizumab)	255 European ancestry cases, 387 European ancestry controls		22q13.31	22	44080184	PARVB	PARVB			29780			rs130318-?	rs130318	0	130318	intron_variant	0	NR	4E-6	5.3979400086720375		1.72	[NR]	Illumina [up to 810372] (imputed)	N
2015-04-23	25117820	Schneider BP	2014-08-12	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/25117820	Genetic variant predicts bevacizumab-induced hypertension in ECOG-5103 and ECOG-2100.	Response to chemotherapy in breast cancer (hypertension) (bevacizumab)	255 European ancestry cases, 387 European ancestry controls		11q24.1	11	123393934	intergenic	GRAMD1B			57476			rs1943466-?	rs1943466	0	1943466	intron_variant	0	NR	1E-6	6.0		1.82	[NR]	Illumina [up to 810372] (imputed)	N
2015-04-23	25117820	Schneider BP	2014-08-12	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/25117820	Genetic variant predicts bevacizumab-induced hypertension in ECOG-5103 and ECOG-2100.	Response to chemotherapy in breast cancer hypertensive cases (cumulative dose) (bevacizumab)	255 European ancestry cases, 387 European ancestry controls		22q13.31	22	44080184	PARVB	PARVB			29780			rs130318-?	rs130318	0	130318	intron_variant	0	NR	4E-7	6.3979400086720375		1.7	[NR]	Illumina [up to 810372] (imputed)	N
2015-04-23	25117820	Schneider BP	2014-08-12	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/25117820	Genetic variant predicts bevacizumab-induced hypertension in ECOG-5103 and ECOG-2100.	Response to chemotherapy in breast cancer hypertensive cases (cumulative dose) (bevacizumab)	255 European ancestry cases, 387 European ancestry controls		11q24.1	11	123393934	intergenic	GRAMD1B			57476			rs1943466-?	rs1943466	0	1943466	intron_variant	0	NR	6E-7	6.221848749616356		1.69	[NR]	Illumina [up to 810372] (imputed)	N
2015-04-23	25117820	Schneider BP	2014-08-12	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/25117820	Genetic variant predicts bevacizumab-induced hypertension in ECOG-5103 and ECOG-2100.	Response to chemotherapy in breast cancer hypertensive cases (cumulative dose) (bevacizumab)	255 European ancestry cases, 387 European ancestry controls		2q14.2	2	119990995	intergenic	PTPN4 - RPL27P7	5775	100129234		6096	2173	rs11685222-?	rs11685222	0	11685222	downstream_gene_variant	1	NR	4E-6	5.3979400086720375		1.98	[NR]	Illumina [up to 810372] (imputed)	N
2015-04-23	25117820	Schneider BP	2014-08-12	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/25117820	Genetic variant predicts bevacizumab-induced hypertension in ECOG-5103 and ECOG-2100.	Response to chemotherapy in breast cancer hypertensive cases (cumulative dose) (bevacizumab)	255 European ancestry cases, 387 European ancestry controls		2p24.2	2	18106253	intergenic	KCNS3 - LOC105373451	3790	105373451		173292	161785	rs12467348-?	rs12467348	0	12467348	intron_variant	1	NR	9E-6	5.045757490560675		2.05	[NR]	Illumina [up to 810372] (imputed)	N
2015-04-23	25117820	Schneider BP	2014-08-12	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/25117820	Genetic variant predicts bevacizumab-induced hypertension in ECOG-5103 and ECOG-2100.	Response to chemotherapy in breast cancer hypertensive cases (cumulative dose) (bevacizumab)	255 European ancestry cases, 387 European ancestry controls		3p24.1	3	30677040	TGFBR2	TGFBR2			7048			rs3773651-?	rs3773651	0	3773651	intron_variant	0	NR	7E-6	5.154901959985743		2.15	[NR]	Illumina [up to 810372] (imputed)	N
2015-04-23	25117820	Schneider BP	2014-08-12	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/25117820	Genetic variant predicts bevacizumab-induced hypertension in ECOG-5103 and ECOG-2100.	Response to chemotherapy in breast cancer hypertensive cases (cumulative dose) (bevacizumab)	255 European ancestry cases, 387 European ancestry controls		12p12.3	12	19774866	intergenic	RNU1-146P - LOC105369682	106480198	105369682		50267	68881	rs2731620-?	rs2731620	0	2731620	upstream_gene_variant	1	NR	7E-6	5.154901959985743		1.59	[NR]	Illumina [up to 810372] (imputed)	N
2015-04-23	25117820	Schneider BP	2014-08-12	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/25117820	Genetic variant predicts bevacizumab-induced hypertension in ECOG-5103 and ECOG-2100.	Response to chemotherapy in breast cancer hypertensive cases (cumulative dose) (bevacizumab)	255 European ancestry cases, 387 European ancestry controls		5q35.2	5	174280232	intergenic	LOC105377737 - LINC01411	105377737	101928176		36731	56122	rs6878584-?	rs6878584	0	6878584	intergenic_variant	1	NR	7E-6	5.154901959985743		2.27	[NR]	Illumina [up to 810372] (imputed)	N
2015-04-23	25117820	Schneider BP	2014-08-12	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/25117820	Genetic variant predicts bevacizumab-induced hypertension in ECOG-5103 and ECOG-2100.	Response to chemotherapy in breast cancer hypertensive cases (cumulative dose) (bevacizumab)	255 European ancestry cases, 387 European ancestry controls		6q24.2	6	143412439	intergenic	LOC100288558 - ADAT2	100288558	134637		22901	10393	rs2496589-?	rs2496589	0	2496589	intergenic_variant	1	NR	5E-6	5.301029995663981		1.7	[NR]	Illumina [up to 810372] (imputed)	N
2015-04-23	25117820	Schneider BP	2014-08-12	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/25117820	Genetic variant predicts bevacizumab-induced hypertension in ECOG-5103 and ECOG-2100.	Response to chemotherapy in breast cancer hypertensive cases (cumulative dose) (bevacizumab)	255 European ancestry cases, 387 European ancestry controls		8p23.1	8	10403043	MSRA	MSRA			4482			rs1962073-?	rs1962073	0	1962073	intron_variant	0	NR	2E-6	5.698970004336019		1.69	[NR]	Illumina [up to 810372] (imputed)	N
2015-04-23	25117820	Schneider BP	2014-08-12	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/25117820	Genetic variant predicts bevacizumab-induced hypertension in ECOG-5103 and ECOG-2100.	Response to chemotherapy in breast cancer hypertensive cases (cumulative dose) (bevacizumab)	255 European ancestry cases, 387 European ancestry controls		8p23.1	8	9932039	intergenic	MIR124-1 - LOC105379235	406907	105379235		28567	51270	rs11786541-?	rs11786541	0	11786541	intergenic_variant	1	NR	2E-6	5.698970004336019		1.65	[NR]	Illumina [up to 810372] (imputed)	N
2015-04-23	25117820	Schneider BP	2014-08-12	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/25117820	Genetic variant predicts bevacizumab-induced hypertension in ECOG-5103 and ECOG-2100.	Response to chemotherapy in breast cancer hypertensive cases (cumulative dose) (bevacizumab)	255 European ancestry cases, 387 European ancestry controls		10p15.1	10	6195193	PFKFB3	PFKFB3			5209			rs11257188-?	rs11257188	0	11257188	intron_variant	0	NR	9E-6	5.045757490560675		2.19	[NR]	Illumina [up to 810372] (imputed)	N
2015-04-23	25117820	Schneider BP	2014-08-12	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/25117820	Genetic variant predicts bevacizumab-induced hypertension in ECOG-5103 and ECOG-2100.	Response to chemotherapy in breast cancer hypertensive cases (cumulative dose) (bevacizumab)	255 European ancestry cases, 387 European ancestry controls		11q21	11	96198321	MAML2	MAML2			84441			rs479825-?	rs479825	0	479825	intron_variant	0	NR	6E-6	5.221848749616356		1.64	[NR]	Illumina [up to 810372] (imputed)	N
2011-11-24	22037553	Haiman CA	2011-10-30	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/22037553	A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor-negative breast cancer.	Breast cancer	1,004 African American cases, 2,745 African American controls,1,718 European ancestry cases, 3,670 European ancestry controls	2,292 European ancestry cases, 16,901 European ancestry controls	5p15.33	5	1279675	TERT	TERT			7015			rs10069690-T	rs10069690	0	10069690	intron_variant	0	0.26	1E-10	10.0		1.18	[1.13-1.25]	Illumina [3154485] (imputed)	N
2013-09-12	23535729	Michailidou K	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	10,052 European ancestry cases, 12,575 European ancestry controls	45,290 European ancestry cases, 41,880 European ancestry controls	1p36.22	1	10506158	PEX14	PEX14			5195			rs616488-A	rs616488	0	616488	intron_variant	0	0.67	2E-10	9.698970004336019		1.06	[1.04-1.09]	Affymetrix, Illumina [~ 2600000] (imputed)	N
2013-09-12	23535729	Michailidou K	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	10,052 European ancestry cases, 12,575 European ancestry controls	45,290 European ancestry cases, 41,880 European ancestry controls	1p13.2	1	113905767	BCL2L15, AP4B1, DCLRE1B, HIPK1, PTPN22	DCLRE1B			64858			rs11552449-T	rs11552449	0	11552449	missense_variant	0	0.17	2E-8	7.698970004336019		1.07	[1.04-1.09]	Affymetrix, Illumina [~ 2600000] (imputed)	N
2013-09-12	23535729	Michailidou K	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	10,052 European ancestry cases, 12,575 European ancestry controls	45,290 European ancestry cases, 41,880 European ancestry controls	2q14.2	2	120487546	intergenic	LINC01101 - LOC105373585	84931	105373585		21197	55312	rs4849887-C	rs4849887	0	4849887	intergenic_variant	1	0.902	4E-11	10.397940008672037		1.1	[1.06-1.14]	Affymetrix, Illumina [~ 2600000] (imputed)	N
2013-09-12	23535729	Michailidou K	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	10,052 European ancestry cases, 12,575 European ancestry controls	45,290 European ancestry cases, 41,880 European ancestry controls	2q31.1	2	172108243	METAP1D, DLX1, DLX2	DLX2-AS1			104326193			rs2016394-G	rs2016394	0	2016394	intron_variant	0	0.52	1E-8	8.0		1.05	[1.03-1.08]	Affymetrix, Illumina [~ 2600000] (imputed)	N
2013-09-12	23535729	Michailidou K	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	10,052 European ancestry cases, 12,575 European ancestry controls	45,290 European ancestry cases, 41,880 European ancestry controls	2q35	2	217431785	DIRC3	DIRC3			729582			rs16857609-T	rs16857609	0	16857609	intron_variant	0	0.26	1E-15	15.0		1.08	[1.06-1.10]	Affymetrix, Illumina [~ 2600000] (imputed)	N
2013-09-12	23535729	Michailidou K	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	10,052 European ancestry cases, 12,575 European ancestry controls	45,290 European ancestry cases, 41,880 European ancestry controls	3p26.1	3	4700592	ITPR1, EGOT	ITPR1			3708			rs6762644-G	rs6762644	0	6762644	intron_variant	0	0.4	2E-12	11.698970004336019		1.07	[1.04-1.09]	Affymetrix, Illumina [~ 2600000] (imputed)	N
2013-09-12	23535729	Michailidou K	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	10,052 European ancestry cases, 12,575 European ancestry controls	45,290 European ancestry cases, 41,880 European ancestry controls	3p24.1	3	30641447	TGFBR2	TGFBR2			7048			rs12493607-C	rs12493607	0	12493607	intron_variant	0	0.35	2E-8	7.698970004336019		1.06	[1.03-1.08]	Affymetrix, Illumina [~ 2600000] (imputed)	N
2013-09-12	23535729	Michailidou K	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	10,052 European ancestry cases, 12,575 European ancestry controls	45,290 European ancestry cases, 41,880 European ancestry controls	4q24	4	105163621	TET2	TET2			54790			rs9790517-T	rs9790517	0	9790517	intron_variant	0	0.23	4E-8	7.3979400086720375		1.05	[1.03-1.08]	Affymetrix, Illumina [~ 2600000] (imputed)	N
2013-09-12	23535729	Michailidou K	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	10,052 European ancestry cases, 12,575 European ancestry controls	45,290 European ancestry cases, 41,880 European ancestry controls	4q34.1	4	174925275	ADAM29	ADAM29			11086			rs6828523-C	rs6828523	0	6828523	intron_variant	0	0.87	4E-16	15.397940008672037		1.11	[1.09-1.15]	Affymetrix, Illumina [~ 2600000] (imputed)	N
2013-09-12	23535729	Michailidou K	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	10,052 European ancestry cases, 12,575 European ancestry controls	45,290 European ancestry cases, 41,880 European ancestry controls	5q11.2	5	58888234	RAB3C	RAB3C - PDE4D	115827	5144		28840	80804	rs10472076-C	rs10472076	0	10472076	intergenic_variant	1	0.38	3E-8	7.522878745280337		1.05	[1.03-1.07]	Affymetrix, Illumina [~ 2600000] (imputed)	N
2013-09-12	23535729	Michailidou K	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	10,052 European ancestry cases, 12,575 European ancestry controls	45,290 European ancestry cases, 41,880 European ancestry controls	5q33.3	5	158817075	EBF1	EBF1			1879			rs1432679-C	rs1432679	0	1432679	intron_variant	0	0.43	2E-14	13.698970004336019		1.07	[1.05-1.09]	Affymetrix, Illumina [~ 2600000] (imputed)	N
2013-09-12	23535729	Michailidou K	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	10,052 European ancestry cases, 12,575 European ancestry controls	45,290 European ancestry cases, 41,880 European ancestry controls	6p25.3	6	1318643	FOXQ1	FOXQ1 - LINC01394	94234	106144586		3885	2566	rs11242675-T	rs11242675	0	11242675	downstream_gene_variant	1	0.61	7E-9	8.154901959985743		1.06	[1.04-1.09]	Affymetrix, Illumina [~ 2600000] (imputed)	N
2013-09-12	23535729	Michailidou K	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	10,052 European ancestry cases, 12,575 European ancestry controls	45,290 European ancestry cases, 41,880 European ancestry controls	6p23	6	13722291	RANBP9	RANBP9 - MCUR1	10048	63933		10709	64258	rs204247-G	rs204247	0	204247	intergenic_variant	1	0.43	8E-9	8.096910013008056		1.05	[1.03-1.07]	Affymetrix, Illumina [~ 2600000] (imputed)	N
2013-09-12	23535729	Michailidou K	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	10,052 European ancestry cases, 12,575 European ancestry controls	45,290 European ancestry cases, 41,880 European ancestry controls	7q35	7	144377836	ARHGEF5, NOBOX	ARHGEF5			7984			rs720475-G	rs720475	0	720475	intron_variant	0	0.75	7E-11	10.154901959985743		1.06	[1.04-1.09]	Affymetrix, Illumina [~ 2600000] (imputed)	N
2013-09-12	23535729	Michailidou K	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	10,052 European ancestry cases, 12,575 European ancestry controls	45,290 European ancestry cases, 41,880 European ancestry controls	8p12	8	29652100	intergenic	RPL17P33 - LINC00589	646909	619351		19417	69159	rs9693444-A	rs9693444	0	9693444	intergenic_variant	1	0.32	9E-14	13.045757490560675		1.07	[1.05-1.09]	Affymetrix, Illumina [~ 2600000] (imputed)	N
2013-09-12	23535729	Michailidou K	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	10,052 European ancestry cases, 12,575 European ancestry controls	45,290 European ancestry cases, 41,880 European ancestry controls	8q21.13	8	75318066	intergenic	HIGD1AP6 - PKMP4	100874436	106480443		15492	58643	rs6472903-T	rs6472903	0	6472903	intron_variant	1	0.82	2E-17	16.69897000433602		1.1	[1.08-1.12]	Affymetrix, Illumina [~ 2600000] (imputed)	N
2013-09-12	23535729	Michailidou K	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	10,052 European ancestry cases, 12,575 European ancestry controls	45,290 European ancestry cases, 41,880 European ancestry controls	8q24.21	8	128182395	MYC, MIR1208	MIR1208 - RN7SKP226	100302281	106480903		32207	38109	rs11780156-T	rs11780156	0	11780156	regulatory_region_variant	1	0.16	3E-11	10.522878745280337		1.07	[1.04-1.10]	Affymetrix, Illumina [~ 2600000] (imputed)	N
2013-09-12	23535729	Michailidou K	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	10,052 European ancestry cases, 12,575 European ancestry controls	45,290 European ancestry cases, 41,880 European ancestry controls	9q31.2	9	107543834	intergenic	LOC105376206 - LOC105376205	105376206	105376205		28619	22955	rs10759243-A	rs10759243	0	10759243	upstream_gene_variant	1	0.39	1E-8	8.0		1.06	[1.03-1.08]	Affymetrix, Illumina [~ 2600000] (imputed)	N
2013-09-12	23535729	Michailidou K	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	10,052 European ancestry cases, 12,575 European ancestry controls	45,290 European ancestry cases, 41,880 European ancestry controls	10p12.31	10	21744013	DNAJC1, MLLT10	LOC107984214			107984214			rs7072776-A	rs7072776	0	7072776	downstream_gene_variant	0	0.29	4E-14	13.397940008672037		1.07	[1.05-1.09]	Affymetrix, Illumina [~ 2600000] (imputed)	N
2013-09-12	23535729	Michailidou K	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	10,052 European ancestry cases, 12,575 European ancestry controls	45,290 European ancestry cases, 41,880 European ancestry controls	10q25.2	10	113014168	TCF7L2	TCF7L2			6934			rs7904519-G	rs7904519	0	7904519	intron_variant	0	0.46	3E-8	7.522878745280337		1.06	[1.04-1.08]	Affymetrix, Illumina [~ 2600000] (imputed)	N
2013-09-12	23535729	Michailidou K	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	10,052 European ancestry cases, 12,575 European ancestry controls	45,290 European ancestry cases, 41,880 European ancestry controls	10q26.12	10	121334387	intergenic	LOC105378523 - RN7SKP167	105378523	106479169		11442	76529	rs11199914-C	rs11199914	0	11199914	intergenic_variant	1	0.68	2E-8	7.698970004336019		1.05	[1.03-1.08]	Affymetrix, Illumina [~ 2600000] (imputed)	N
2013-09-12	23535729	Michailidou K	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	10,052 European ancestry cases, 12,575 European ancestry controls	45,290 European ancestry cases, 41,880 European ancestry controls	11q13.1	11	65815595	DKFZp761E198, OVOL1, SNX32, CFL1, MUS81	OVOL1 - SNX32	5017	254122		18376	18041	rs3903072-G	rs3903072	0	3903072	regulatory_region_variant	1	0.53	9E-12	11.045757490560675		1.05	[1.04-1.08]	Affymetrix, Illumina [~ 2600000] (imputed)	N
2013-09-12	23535729	Michailidou K	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	10,052 European ancestry cases, 12,575 European ancestry controls	45,290 European ancestry cases, 41,880 European ancestry controls	11q24.3	11	129591276	intergenic	RPS27P20 - LINC01395	100271581	101929557		53103	20840	rs11820646-C	rs11820646	0	11820646	upstream_gene_variant	1	0.59	1E-9	9.0		1.05	[1.03-1.08]	Affymetrix, Illumina [~ 2600000] (imputed)	N
2013-09-12	23535729	Michailidou K	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	10,052 European ancestry cases, 12,575 European ancestry controls	45,290 European ancestry cases, 41,880 European ancestry controls	12p13.1	12	14260997	intergenic	GNAI2P1 - RPL30P11	2772	100271303		5511	95868	rs12422552-C	rs12422552	0	12422552	regulatory_region_variant	1	0.26	4E-8	7.3979400086720375		1.05	[1.03-1.07]	Affymetrix, Illumina [~ 2600000] (imputed)	N
2013-09-12	23535729	Michailidou K	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	10,052 European ancestry cases, 12,575 European ancestry controls	45,290 European ancestry cases, 41,880 European ancestry controls	12q22	12	95633983	NTN4	USP44 - PGAM1P5	84101	100132594		82454	15272	rs17356907-A	rs17356907	0	17356907	intron_variant	1	0.7	2E-22	21.69897000433602		1.1	[1.08-1.12]	Affymetrix, Illumina [~ 2600000] (imputed)	N
2013-09-12	23535729	Michailidou K	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	10,052 European ancestry cases, 12,575 European ancestry controls	45,290 European ancestry cases, 41,880 European ancestry controls	13q13.1	13	32398489	BRCA2, N4BP2L1, N4BP2L2	BRCA2			675			rs11571833-T	rs11571833	0	11571833	stop_gained	0	0.0080	5E-8	7.301029995663981		1.26	[1.14-1.39]	Affymetrix, Illumina [~ 2600000] (imputed)	N
2013-09-12	23535729	Michailidou K	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	10,052 European ancestry cases, 12,575 European ancestry controls	45,290 European ancestry cases, 41,880 European ancestry controls	14q13.3	14	36663564	PAX9, SLC25A21	PAX9			5083			rs2236007-G	rs2236007	0	2236007	intron_variant	0	0.79	2E-13	12.698970004336019		1.08	[1.05-1.1]	Affymetrix, Illumina [~ 2600000] (imputed)	N
2013-09-12	23535729	Michailidou K	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	10,052 European ancestry cases, 12,575 European ancestry controls	45,290 European ancestry cases, 41,880 European ancestry controls	14q24.1	14	68193711	RAD51L1	RAD51B			5890			rs2588809-T	rs2588809	0	2588809	intron_variant	0	0.16	1E-10	10.0		1.08	[1.05-1.11]	Affymetrix, Illumina [~ 2600000] (imputed)	N
2013-09-12	23535729	Michailidou K	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	10,052 European ancestry cases, 12,575 European ancestry controls	45,290 European ancestry cases, 41,880 European ancestry controls	14q32.11	14	91374725	CCDC88C	CCDC88C			440193			rs941764-G	rs941764	0	941764	intron_variant	0	0.34	4E-10	9.397940008672037		1.06	[1.04-1.09]	Affymetrix, Illumina [~ 2600000] (imputed)	N
2013-09-12	23535729	Michailidou K	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	10,052 European ancestry cases, 12,575 European ancestry controls	45,290 European ancestry cases, 41,880 European ancestry controls	16q12.2	16	53779455	FTO, MIR1972-2	FTO			79068			rs17817449-T	rs17817449	0	17817449	intron_variant	0	0.6	6E-14	13.221848749616356		1.08	[1.05-1.1]	Affymetrix, Illumina [~ 2600000] (imputed)	N
2013-09-12	23535729	Michailidou K	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	10,052 European ancestry cases, 12,575 European ancestry controls	45,290 European ancestry cases, 41,880 European ancestry controls	16q23.2	16	80616908	CDYL2	CDYL2			124359			rs13329835-G	rs13329835	0	13329835	intron_variant	0	0.22	2E-16	15.698970004336019		1.08	[1.05-1.10]	Affymetrix, Illumina [~ 2600000] (imputed)	N
2013-09-12	23535729	Michailidou K	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	10,052 European ancestry cases, 12,575 European ancestry controls	45,290 European ancestry cases, 41,880 European ancestry controls	18q11.2	18	26757460	intergenic	PCAT18 - LOC105372035	728606	105372035		53822	65353	rs527616-G	rs527616	0	527616	intron_variant	1	0.62	2E-10	9.698970004336019		1.05	[1.03-1.08]	Affymetrix, Illumina [~ 2600000] (imputed)	N
2013-09-12	23535729	Michailidou K	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	10,052 European ancestry cases, 12,575 European ancestry controls	45,290 European ancestry cases, 41,880 European ancestry controls	19p13.11	19	18460331	SSBP4, ISYNA1, ELL	ELL			8178			rs4808801-A	rs4808801	0	4808801	intron_variant	0	0.65	5E-15	14.301029995663981		1.08	[1.05-1.1]	Affymetrix, Illumina [~ 2600000] (imputed)	N
2013-09-12	23535729	Michailidou K	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	10,052 European ancestry cases, 12,575 European ancestry controls	45,290 European ancestry cases, 41,880 European ancestry controls	19q13.31	19	43782361	C19orf61, KCNN4, LYPD5, ZNF283	KCNN4 - LOC107987268	3783	107987268		222	1931	rs3760982-A	rs3760982	0	3760982	upstream_gene_variant	1	0.46	2E-10	9.698970004336019		1.06	[1.04-1.08]	Affymetrix, Illumina [~ 2600000] (imputed)	N
2013-09-12	23535729	Michailidou K	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	10,052 European ancestry cases, 12,575 European ancestry controls	45,290 European ancestry cases, 41,880 European ancestry controls	22q12.2	22	29225488	EMID1, RHBDD3, EWSR1, CHEK2	EMID1			129080			rs132390-C	rs132390	0	132390	intron_variant	0	0.036	3E-9	8.522878745280337		1.12	[1.07-1.18]	Affymetrix, Illumina [~ 2600000] (imputed)	N
2013-09-12	23535729	Michailidou K	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	10,052 European ancestry cases, 12,575 European ancestry controls	45,290 European ancestry cases, 41,880 European ancestry controls	22q13.1	22	40480230	MKL1	MKL1			57591			rs6001930-C	rs6001930	0	6001930	intron_variant	0	0.11	9E-19	18.045757490560675		1.12	[1.09-1.16]	Affymetrix, Illumina [~ 2600000] (imputed)	N
2013-09-12	23535729	Michailidou K	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	10,052 European ancestry cases, 12,575 European ancestry controls	45,290 European ancestry cases, 41,880 European ancestry controls	1p11.2	1	121538815	intergenic	EMBP1			647121			rs11249433-G	rs11249433	0	11249433	intron_variant	0	0.4	2E-26	25.69897000433602		1.09	[1.07-1.11]	Affymetrix, Illumina [~ 2600000] (imputed)	N
2013-09-12	23535729	Michailidou K	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	10,052 European ancestry cases, 12,575 European ancestry controls	45,290 European ancestry cases, 41,880 European ancestry controls	2q35	2	217041109	intergenic	LOC105373874, LOC101928278			105373874, 101928278			rs13387042-A	rs13387042	0	13387042	intergenic_variant	0	0.51	2E-57	56.69897000433602		1.14	[1.11-1.16]	Affymetrix, Illumina [~ 2600000] (imputed)	N
2013-09-12	23535729	Michailidou K	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	10,052 European ancestry cases, 12,575 European ancestry controls	45,290 European ancestry cases, 41,880 European ancestry controls	3p24.1	3	27374522	SLC4A7	SLC4A7			9497			rs4973768-T	rs4973768	0	4973768	3_prime_UTR_variant	0	0.47	2E-30	29.69897000433602		1.1	[1.08-1.12]	Affymetrix, Illumina [~ 2600000] (imputed)	N
2013-09-12	23535729	Michailidou K	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	10,052 European ancestry cases, 12,575 European ancestry controls	45,290 European ancestry cases, 41,880 European ancestry controls	5p15.33	5	1279675	TERT	TERT			7015			rs10069690-T	rs10069690	0	10069690	intron_variant	0	0.26	7E-9	8.154901959985743		1.06	[1.04-1.09]	Affymetrix, Illumina [~ 2600000] (imputed)	N
2013-09-12	23535729	Michailidou K	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	10,052 European ancestry cases, 12,575 European ancestry controls	45,290 European ancestry cases, 41,880 European ancestry controls	5p12	5	44706396	intergenic	LOC102723839 - RN7SL383P	102723839	106479363		196114	9797	rs10941679-G	rs10941679	0	10941679	intergenic_variant	1	0.25	2E-37	36.69897000433602		1.13	[1.10-1.15]	Affymetrix, Illumina [~ 2600000] (imputed)	N
2013-09-12	23535729	Michailidou K	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	10,052 European ancestry cases, 12,575 European ancestry controls	45,290 European ancestry cases, 41,880 European ancestry controls	5q11.2	5	56736057	MAP3K1	LOC101928448 - LOC105378979	101928448	105378979		129825	30338	rs889312-C	rs889312	0	889312	regulatory_region_variant	1	0.28	3E-36	35.52287874528034		1.12	[1.10-1.15]	Affymetrix, Illumina [~ 2600000] (imputed)	N
2013-09-12	23535729	Michailidou K	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	10,052 European ancestry cases, 12,575 European ancestry controls	45,290 European ancestry cases, 41,880 European ancestry controls	6q14.1	6	81483392	intergenic	LOC105377871			105377871			rs17530068-G	rs17530068	0	17530068	intergenic_variant	0	0.22	8E-9	8.096910013008056		1.05	[1.03-1.08]	Affymetrix, Illumina [~ 2600000] (imputed)	N
2013-09-12	23535729	Michailidou K	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	10,052 European ancestry cases, 12,575 European ancestry controls	45,290 European ancestry cases, 41,880 European ancestry controls	6q25.1	6	151592978	ESR1	CCDC170			80129			rs3757318-A	rs3757318	0	3757318	intron_variant	0	0.07	2E-21	20.69897000433602		1.16	[1.12-1.21]	Affymetrix, Illumina [~ 2600000] (imputed)	N
2013-09-12	23535729	Michailidou K	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	10,052 European ancestry cases, 12,575 European ancestry controls	45,290 European ancestry cases, 41,880 European ancestry controls	8q24.21	8	127343372	intergenic	CASC8, CASC21			727677, 103021164			rs13281615-G	rs13281615	0	13281615	intron_variant	0	0.41	1E-27	27.0		1.09	[1.07-1.12]	Affymetrix, Illumina [~ 2600000] (imputed)	N
2013-09-12	23535729	Michailidou K	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	10,052 European ancestry cases, 12,575 European ancestry controls	45,290 European ancestry cases, 41,880 European ancestry controls	9p21.3	9	22062135	CDKN2A, CDKN2B	CDKN2B-AS1			100048912			rs1011970-T	rs1011970	0	1011970	intron_variant	0	0.17	6E-8	7.221848749616356		1.06	[1.03-1.08]	Affymetrix, Illumina [~ 2600000] (imputed)	N
2013-09-12	23535729	Michailidou K	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	10,052 European ancestry cases, 12,575 European ancestry controls	45,290 European ancestry cases, 41,880 European ancestry controls	9q31.2	9	108126198	intergenic	LOC105376214			105376214			rs865686-T	rs865686	0	865686	intergenic_variant	0	0.62	1E-34	34.0		1.12	[1.1-1.14]	Affymetrix, Illumina [~ 2600000] (imputed)	N
2013-09-12	23535729	Michailidou K	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	10,052 European ancestry cases, 12,575 European ancestry controls	45,290 European ancestry cases, 41,880 European ancestry controls	10q21.2	10	62518923	ZNF365	ZNF365			22891			rs10995190-G	rs10995190	0	10995190	intron_variant	0	0.84	1E-36	36.0		1.16	[1.14-1.19]	Affymetrix, Illumina [~ 2600000] (imputed)	N
2013-09-12	23535729	Michailidou K	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	10,052 European ancestry cases, 12,575 European ancestry controls	45,290 European ancestry cases, 41,880 European ancestry controls	10q22.3	10	79081391	ZMIZ1	ZMIZ1			57178			rs704010-T	rs704010	0	704010	intron_variant	0	0.38	7E-22	21.154901959985743		1.08	[1.06-1.10]	Affymetrix, Illumina [~ 2600000] (imputed)	N
2013-09-12	23535729	Michailidou K	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	10,052 European ancestry cases, 12,575 European ancestry controls	45,290 European ancestry cases, 41,880 European ancestry controls	10q26.13	10	121577821	FGFR2	FGFR2			2263			rs2981579-A	rs2981579	0	2981579	intron_variant	0	0.4	2E-170	169.69897000433602		1.27	[1.24-1.29]	Affymetrix, Illumina [~ 2600000] (imputed)	N
2013-09-12	23535729	Michailidou K	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	10,052 European ancestry cases, 12,575 European ancestry controls	45,290 European ancestry cases, 41,880 European ancestry controls	11p15.5	11	1887776	LSP1	LSP1			4046			rs3817198-C	rs3817198	0	3817198	intron_variant	0	0.31	2E-11	10.698970004336019		1.07	[1.05-1.09]	Affymetrix, Illumina [~ 2600000] (imputed)	N
2013-09-12	23535729	Michailidou K	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	10,052 European ancestry cases, 12,575 European ancestry controls	45,290 European ancestry cases, 41,880 European ancestry controls	11q13.3	11	69513996	intergenic	LINC01488 - CCND1	101928292	595		20453	127109	rs614367-T	rs614367	0	614367	intergenic_variant	1	0.15	2E-63	62.69897000433602		1.21	[1.18-1.24]	Affymetrix, Illumina [~ 2600000] (imputed)	N
2013-09-12	23535729	Michailidou K	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	10,052 European ancestry cases, 12,575 European ancestry controls	45,290 European ancestry cases, 41,880 European ancestry controls	12p11.22	12	28002147	PTHLH	PTHLH - LOC105369710	5744	105369710		27960	59494	rs10771399-A	rs10771399	0	10771399	intergenic_variant	1	0.88	8E-31	30.096910013008056		1.16	[1.14-1.2]	Affymetrix, Illumina [~ 2600000] (imputed)	N
2013-09-12	23535729	Michailidou K	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	10,052 European ancestry cases, 12,575 European ancestry controls	45,290 European ancestry cases, 41,880 European ancestry controls	12q24.21	12	115398717	intergenic	LOC105370003			105370003			rs1292011-A	rs1292011	0	1292011	regulatory_region_variant	0	0.58	9E-22	21.045757490560675		1.09	[1.06-1.11]	Affymetrix, Illumina [~ 2600000] (imputed)	N
2013-09-12	23535729	Michailidou K	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	10,052 European ancestry cases, 12,575 European ancestry controls	45,290 European ancestry cases, 41,880 European ancestry controls	14q24.1	14	68567965	RAD51L1	RAD51B			5890			rs999737-C	rs999737	0	999737	intron_variant	0	0.77	3E-19	18.522878745280337		1.09	[1.06-1.11]	Affymetrix, Illumina [~ 2600000] (imputed)	N
2013-09-12	23535729	Michailidou K	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	10,052 European ancestry cases, 12,575 European ancestry controls	45,290 European ancestry cases, 41,880 European ancestry controls	16q12.1	16	52552429	TOX3	CASC16			643714			rs3803662-A	rs3803662	0	3803662	non_coding_transcript_exon_variant	0	0.26	2E-114	113.69897000433602		1.24	[1.21-1.27]	Affymetrix, Illumina [~ 2600000] (imputed)	N
2013-09-12	23535729	Michailidou K	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	10,052 European ancestry cases, 12,575 European ancestry controls	45,290 European ancestry cases, 41,880 European ancestry controls	17q22	17	54979110	COX11	STXBP4			252983			rs6504950-G	rs6504950	0	6504950	intron_variant	0	0.72	2E-13	12.698970004336019		1.06	[1.04-1.09]	Affymetrix, Illumina [~ 2600000] (imputed)	N
2013-09-12	23535729	Michailidou K	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	10,052 European ancestry cases, 12,575 European ancestry controls	45,290 European ancestry cases, 41,880 European ancestry controls	21q21.1	21	15148511	NRIP1	LOC107985483 - LOC105372739	107985483	105372739		26075	40082	rs2823093-G	rs2823093	0	2823093	intergenic_variant	1	0.73	7E-16	15.154901959985743		1.09	[1.06-1.11]	Affymetrix, Illumina [~ 2600000] (imputed)	N
2012-11-30	22976474	Siddiq A	2012-09-13	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/22976474	A meta-analysis of genome-wide association studies of breast cancer identifies two novel susceptibility loci at 6q14 and 20q11.	Breast cancer	3,666 European ancestry cases, 28,864 European ancestry controls, 1,004 African American cases, 2,744 African American controls	562 European ancestry cases, 6,410 European ancestry controls, 84 Japanese ancestry cases, 830 Japanese ancestry controls, 300 Latino cases, 1,164 Latino controls	19p13.11	19	17282085	NR	ANKLE1			126549			rs8100241-G	rs8100241	0	8100241	missense_variant	0	NR	4E-8	7.3979400086720375		1.14	[NR]	Illumina [2608509] (imputed)	N
2012-11-30	22976474	Siddiq A	2012-09-13	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/22976474	A meta-analysis of genome-wide association studies of breast cancer identifies two novel susceptibility loci at 6q14 and 20q11.	Breast cancer	3,666 European ancestry cases, 28,864 European ancestry controls, 1,004 African American cases, 2,744 African American controls	562 European ancestry cases, 6,410 European ancestry controls, 84 Japanese ancestry cases, 830 Japanese ancestry controls, 300 Latino cases, 1,164 Latino controls	6q25.1	6	151666222	NR	ESR1			2099			rs9383938-T	rs9383938	0	9383938	intron_variant	0	NR	2E-10	9.698970004336019		1.28	[NR]	Illumina [2608509] (imputed)	N
2013-09-12	23535729	Michailidou K	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	10,052 European ancestry cases, 12,575 European ancestry controls	45,290 European ancestry cases, 41,880 European ancestry controls	2q31.1	2	173348166	CDCA7	LOC100289479 - CDCA7	100289479	83879		9705	5851	rs1550623-A	rs1550623	0	1550623	intron_variant	1	0.84	3E-8	7.522878745280337		1.06	[1.03-1.09]	Affymetrix, Illumina [~ 2600000] (imputed)	N
2013-09-12	23535729	Michailidou K	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	10,052 European ancestry cases, 12,575 European ancestry controls	45,290 European ancestry cases, 41,880 European ancestry controls	5q11.2	5	59041654	PDE4D	PDE4D			5144			rs1353747-T	rs1353747	0	1353747	intron_variant	0	0.905	3E-8	7.522878745280337		1.09	[1.05-1.12]	Affymetrix, Illumina [~ 2600000] (imputed)	N
2013-09-12	23535729	Michailidou K	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	10,052 European ancestry cases, 12,575 European ancestry controls	45,290 European ancestry cases, 41,880 European ancestry controls	8q21.13	8	75505702	HNF4G	HNF4G			3174			rs2943559-G	rs2943559	0	2943559	intron_variant	0	0.07	6E-15	14.221848749616356		1.13	[1.09-1.17	Affymetrix, Illumina [~ 2600000] (imputed)	N
2013-09-12	23535729	Michailidou K	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	10,052 European ancestry cases, 12,575 European ancestry controls	45,290 European ancestry cases, 41,880 European ancestry controls	10p12.31	10	22026914	DNAJC1	DNAJC1 - ADIPOR1P1	64215	645220		23146	137662	rs11814448-C	rs11814448	0	11814448	intergenic_variant	1	0.02	9E-16	15.045757490560675		1.26	[1.18-1.35]	Affymetrix, Illumina [~ 2600000] (imputed)	N
2013-09-12	23535729	Michailidou K	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	10,052 European ancestry cases, 12,575 European ancestry controls	45,290 European ancestry cases, 41,880 European ancestry controls	18q11.2	18	26990703	CHST9	CHST9			83539			rs1436904-T	rs1436904	0	1436904	intron_variant	0	0.6	3E-8	7.522878745280337		1.04	[1.02-1.06]	Affymetrix, Illumina [~ 2600000] (imputed)	N
2012-11-30	22976474	Siddiq A	2012-09-13	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/22976474	A meta-analysis of genome-wide association studies of breast cancer identifies two novel susceptibility loci at 6q14 and 20q11.	Breast cancer	3,666 European ancestry cases, 28,864 European ancestry controls, 1,004 African American cases, 2,744 African American controls	562 European ancestry cases, 6,410 European ancestry controls, 84 Japanese ancestry cases, 830 Japanese ancestry controls, 300 Latino cases, 1,164 Latino controls	20q11.22	20	34000289	RALY, EIF2S2, ASIP	RALY			22913			rs2284378-T	rs2284378	0	2284378	intron_variant	0	0.31	1E-8	8.0		1.16	[1.10-1.22]	Illumina [2608509] (imputed)	N
2012-11-30	22976474	Siddiq A	2012-09-13	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/22976474	A meta-analysis of genome-wide association studies of breast cancer identifies two novel susceptibility loci at 6q14 and 20q11.	Breast cancer	3,666 European ancestry cases, 28,864 European ancestry controls, 1,004 African American cases, 2,744 African American controls	562 European ancestry cases, 6,410 European ancestry controls, 84 Japanese ancestry cases, 830 Japanese ancestry controls, 300 Latino cases, 1,164 Latino controls	6q14.1	6	81483392	FAM46A, C6orf37	LOC105377871			105377871			rs17530068-C	rs17530068	0	17530068	intergenic_variant	0	0.24	3E-7	6.522878745280337		1.16	[1.10-1.23]	Illumina [2608509] (imputed)	N
2013-06-26	23518928	Liu M	2013-03-21	Mol Endocrinol	www.ncbi.nlm.nih.gov/pubmed/23518928	TSPYL5 SNPs: association with plasma estradiol concentrations and aromatase expression.	Estradiol plasma levels (breast cancer)	700 European ancestry cases, 50 African ancestry cases, 17 Asian ancestry cases, 5 American Indian ancestry cases	NA	8q22.1	8	97269961	TSPYL5	LOC101927066			101927066			rs1864729-?	rs1864729	0	1864729	downstream_gene_variant	0	0.098	3E-8	7.522878745280337		1.589	[1.35-1.871] unit increase	Illumina [563945]	N
2013-06-26	23518928	Liu M	2013-03-21	Mol Endocrinol	www.ncbi.nlm.nih.gov/pubmed/23518928	TSPYL5 SNPs: association with plasma estradiol concentrations and aromatase expression.	Estradiol plasma levels (breast cancer)	700 European ancestry cases, 50 African ancestry cases, 17 Asian ancestry cases, 5 American Indian ancestry cases	NA	2p11.2	2	85478554	NR	RN7SL251P - RPSAP22	106480990	100270874		35763	12371	rs11688246-?	rs11688246	0	11688246	intergenic_variant	1	0.052	1E-7	7.0		1.832	[1.469-2.285] unit increase	Illumina [563945]	N
2013-06-26	23518928	Liu M	2013-03-21	Mol Endocrinol	www.ncbi.nlm.nih.gov/pubmed/23518928	TSPYL5 SNPs: association with plasma estradiol concentrations and aromatase expression.	Estradiol plasma levels (breast cancer)	700 European ancestry cases, 50 African ancestry cases, 17 Asian ancestry cases, 5 American Indian ancestry cases	NA	14q23.2	14	62501677	NR	LOC105370529			105370529			rs4902141-?	rs4902141	0	4902141	intergenic_variant	0	0.026	1E-7	7.0		2.161	[1.629-2.867] unit increase	Illumina [563945]	N
2013-06-26	23518928	Liu M	2013-03-21	Mol Endocrinol	www.ncbi.nlm.nih.gov/pubmed/23518928	TSPYL5 SNPs: association with plasma estradiol concentrations and aromatase expression.	Estradiol plasma levels (breast cancer)	700 European ancestry cases, 50 African ancestry cases, 17 Asian ancestry cases, 5 American Indian ancestry cases	NA	1p35.1	1	33463157	NR	PHC2 - TLR12P	1912	100131451		32140	3092	rs12565140-?	rs12565140	0	12565140	upstream_gene_variant	1	0.136	3E-7	6.522878745280337		1.425	[1.247-1.629] unit increase	Illumina [563945]	N
2013-06-26	23518928	Liu M	2013-03-21	Mol Endocrinol	www.ncbi.nlm.nih.gov/pubmed/23518928	TSPYL5 SNPs: association with plasma estradiol concentrations and aromatase expression.	Estradiol plasma levels (breast cancer)	700 European ancestry cases, 50 African ancestry cases, 17 Asian ancestry cases, 5 American Indian ancestry cases	NA	1p31.1	1	80445429	NR	HMGB1P18 - HNRNPA1P64	646526	100129325		161260	5519	rs12118390-?	rs12118390	0	12118390	intergenic_variant	1	0.022	3E-7	6.522878745280337		2.253	[1.658-3.06] unit increase	Illumina [563945]	N
2013-06-26	23518928	Liu M	2013-03-21	Mol Endocrinol	www.ncbi.nlm.nih.gov/pubmed/23518928	TSPYL5 SNPs: association with plasma estradiol concentrations and aromatase expression.	Estradiol plasma levels (breast cancer)	700 European ancestry cases, 50 African ancestry cases, 17 Asian ancestry cases, 5 American Indian ancestry cases	NA	4q22.3	4	94694618	NR	PDLIM5 - BMPR1B-AS1	10611	100507012		26391	49050	rs4699587-?	rs4699587	0	4699587	intron_variant	1	0.048	5E-7	6.301029995663981		1.763	[1.416-2.194] unit increase	Illumina [563945]	N
2013-06-26	23518928	Liu M	2013-03-21	Mol Endocrinol	www.ncbi.nlm.nih.gov/pubmed/23518928	TSPYL5 SNPs: association with plasma estradiol concentrations and aromatase expression.	Estradiol plasma levels (breast cancer)	700 European ancestry cases, 50 African ancestry cases, 17 Asian ancestry cases, 5 American Indian ancestry cases	NA	10q11.21	10	44539224	NR	RPL9P21 - EIF2AP4	728374	100874401		124022	267219	rs7072122-?	rs7072122	0	7072122	intergenic_variant	1	0.051	6E-7	6.221848749616356		1.73	[1.397-2.141] unit increase	Illumina [563945]	N
2013-06-26	23518928	Liu M	2013-03-21	Mol Endocrinol	www.ncbi.nlm.nih.gov/pubmed/23518928	TSPYL5 SNPs: association with plasma estradiol concentrations and aromatase expression.	Estradiol plasma levels (breast cancer)	700 European ancestry cases, 50 African ancestry cases, 17 Asian ancestry cases, 5 American Indian ancestry cases	NA	12q22	12	94289428	NR	PLXNC1, CEP83			10154, 51134			rs4761470-?	rs4761470	0	4761470	intron_variant	0	0.177	6E-7	6.221848749616356		1.375	[1.214-1.556] unit increase	Illumina [563945]	N
2013-06-26	23518928	Liu M	2013-03-21	Mol Endocrinol	www.ncbi.nlm.nih.gov/pubmed/23518928	TSPYL5 SNPs: association with plasma estradiol concentrations and aromatase expression.	Estradiol plasma levels (breast cancer)	700 European ancestry cases, 50 African ancestry cases, 17 Asian ancestry cases, 5 American Indian ancestry cases	NA	5q15	5	97740844	NR	LOC391813 - LOC105379098	391813	105379098		1944	345022	rs10515260-?	rs10515260	0	10515260	downstream_gene_variant	1	0.035	6E-7	6.221848749616356		1.913	[1.485-2.463] unit increase	Illumina [563945]	N
2013-06-26	23518928	Liu M	2013-03-21	Mol Endocrinol	www.ncbi.nlm.nih.gov/pubmed/23518928	TSPYL5 SNPs: association with plasma estradiol concentrations and aromatase expression.	Estradiol plasma levels (breast cancer)	700 European ancestry cases, 50 African ancestry cases, 17 Asian ancestry cases, 5 American Indian ancestry cases	NA	3q26.33	3	182133496	NR	LOC105374242 - LOC105374243	105374242	105374243		105788	16029	rs16832889-?	rs16832889	0	16832889	intron_variant	1	0.011	1E-6	6.0		3.085	[1.965-4.844] unit increase	Illumina [563945]	N
2013-06-26	23518928	Liu M	2013-03-21	Mol Endocrinol	www.ncbi.nlm.nih.gov/pubmed/23518928	TSPYL5 SNPs: association with plasma estradiol concentrations and aromatase expression.	Estradiol plasma levels (breast cancer)	700 European ancestry cases, 50 African ancestry cases, 17 Asian ancestry cases, 5 American Indian ancestry cases	NA	2p16.3	2	52284656	NR	LOC730100			730100			rs17042688-?	rs17042688	0	17042688	intron_variant	0	0.038	1E-6	6.0		1.911	[1.474-2.476] unit increase	Illumina [563945]	N
2013-06-26	23518928	Liu M	2013-03-21	Mol Endocrinol	www.ncbi.nlm.nih.gov/pubmed/23518928	TSPYL5 SNPs: association with plasma estradiol concentrations and aromatase expression.	Estradiol plasma levels (breast cancer)	700 European ancestry cases, 50 African ancestry cases, 17 Asian ancestry cases, 5 American Indian ancestry cases	NA	11q24.2	11	126160720	NR	LOC105369591 - RPUSD4	105369591	84881		20082	41374	rs10501858-?	rs10501858	0	10501858	non_coding_transcript_exon_variant	1	0.091	1E-6	6.0		1.539	[1.295-1.829] unit increase	Illumina [563945]	N
2013-06-26	23518928	Liu M	2013-03-21	Mol Endocrinol	www.ncbi.nlm.nih.gov/pubmed/23518928	TSPYL5 SNPs: association with plasma estradiol concentrations and aromatase expression.	Estradiol plasma levels (breast cancer)	700 European ancestry cases, 50 African ancestry cases, 17 Asian ancestry cases, 5 American Indian ancestry cases	NA	2q11.2	2	101413184	NR	RFX8			731220			rs12620464-?	rs12620464	0	12620464	intron_variant	0	0.143	1E-6	6.0		1.397	[1.221-1.579] unit increase	Illumina [563945]	N
2013-06-26	23518928	Liu M	2013-03-21	Mol Endocrinol	www.ncbi.nlm.nih.gov/pubmed/23518928	TSPYL5 SNPs: association with plasma estradiol concentrations and aromatase expression.	Estradiol plasma levels (breast cancer)	700 European ancestry cases, 50 African ancestry cases, 17 Asian ancestry cases, 5 American Indian ancestry cases	NA	20p12.3	20	8723905	NR	PLCB1			23236			rs6077414-?	rs6077414	0	6077414	intron_variant	0	0.092	1E-6	6.0		1.466	[1.257-1.711] unit increase	Illumina [563945]	N
2013-06-26	23518928	Liu M	2013-03-21	Mol Endocrinol	www.ncbi.nlm.nih.gov/pubmed/23518928	TSPYL5 SNPs: association with plasma estradiol concentrations and aromatase expression.	Estradiol plasma levels (breast cancer)	700 European ancestry cases, 50 African ancestry cases, 17 Asian ancestry cases, 5 American Indian ancestry cases	NA	1p31.3	1	65049850	NR	JAK1, LOC107983962			3716, 107983962			rs478665-?	rs478665	0	478665	intergenic_variant	0	0.05	1E-6	6.0		1.772	[1.407-2.233] unit increase	Illumina [563945]	N
2013-06-26	23518928	Liu M	2013-03-21	Mol Endocrinol	www.ncbi.nlm.nih.gov/pubmed/23518928	TSPYL5 SNPs: association with plasma estradiol concentrations and aromatase expression.	Estradiol plasma levels (breast cancer)	700 European ancestry cases, 50 African ancestry cases, 17 Asian ancestry cases, 5 American Indian ancestry cases	NA	21q22.2	21	40331020	NR	DSCAM			1826			rs727333-?	rs727333	0	727333	intron_variant	0	0.081	1E-6	6.0		1.542	[1.295-1.837] unit increase	Illumina [563945]	N
2013-06-26	23518928	Liu M	2013-03-21	Mol Endocrinol	www.ncbi.nlm.nih.gov/pubmed/23518928	TSPYL5 SNPs: association with plasma estradiol concentrations and aromatase expression.	Estradiol plasma levels (breast cancer)	700 European ancestry cases, 50 African ancestry cases, 17 Asian ancestry cases, 5 American Indian ancestry cases	NA	3q29	3	194004541	NR	LOC647323 - LOC285389	647323	285389		882	915	rs724767-?	rs724767	0	724767	intron_variant	1	0.115	2E-6	5.698970004336019		1.436	[1.241-1.663] unit increase	Illumina [563945]	N
2013-06-26	23518928	Liu M	2013-03-21	Mol Endocrinol	www.ncbi.nlm.nih.gov/pubmed/23518928	TSPYL5 SNPs: association with plasma estradiol concentrations and aromatase expression.	Estradiol plasma levels (breast cancer)	700 European ancestry cases, 50 African ancestry cases, 17 Asian ancestry cases, 5 American Indian ancestry cases	NA	1p36.11	1	27405147	NR	WASF2			10163			rs11548323-?	rs11548323	0	11548323	3_prime_UTR_variant	0	0.17	2E-6	5.698970004336019		1.396	[1.219-1.598] unit increase	Illumina [563945]	N
2015-06-12	25342443	Lindstrom S	2014-10-24	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25342443	Genome-wide association study identifies multiple loci associated with both mammographic density and breast cancer risk.	Mammographic density (dense area)	7,600 European ancestry individuals	343 European ancestry individuals, 1,472 Old Order Amish individuals, 8,564 individuals	4q13.3	4	74554070	AREG	LOC107986229			107986229			rs10034692-A	rs10034692	0	10034692	intron_variant	0	0.74	2E-10	9.698970004336019		0.16	[0.1-0.22] unit decrease	Affymetrix, Illumina [~ 2500000] (imputed)	N
2015-06-12	25342443	Lindstrom S	2014-10-24	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25342443	Genome-wide association study identifies multiple loci associated with both mammographic density and breast cancer risk.	Mammographic density (dense area)	7,600 European ancestry individuals	343 European ancestry individuals, 1,472 Old Order Amish individuals, 8,564 individuals	4q13.3	4	74618075	AREG	LOC107986229 - BTC	107986229	685		32977	126684	rs12642133-A	rs12642133	0	12642133	intergenic_variant	1	0.3	8E-10	9.096910013008056				Affymetrix, Illumina [~ 2500000] (imputed)	N
2015-06-12	25342443	Lindstrom S	2014-10-24	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25342443	Genome-wide association study identifies multiple loci associated with both mammographic density and breast cancer risk.	Mammographic density (dense area)	7,600 European ancestry individuals	343 European ancestry individuals, 1,472 Old Order Amish individuals, 8,564 individuals	5q23.2	5	123118610	PRDM6	PRDM6			93166			rs186749-A	rs186749	0	186749	intron_variant	0	0.28	3E-7	6.522878745280337				Affymetrix, Illumina [~ 2500000] (imputed)	N
2015-06-12	25342443	Lindstrom S	2014-10-24	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25342443	Genome-wide association study identifies multiple loci associated with both mammographic density and breast cancer risk.	Mammographic density (dense area)	7,600 European ancestry individuals	343 European ancestry individuals, 1,472 Old Order Amish individuals, 8,564 individuals	6q25.1	6	151625494	ESR1	CCDC170 - ESR1	80129	2099		4301	28654	rs12665607-A	rs12665607	0	12665607	downstream_gene_variant	1	0.08	2E-8	7.698970004336019		0.17	[0.092-0.248] unit decrease	Affymetrix, Illumina [~ 2500000] (imputed)	N
2015-06-12	25342443	Lindstrom S	2014-10-24	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25342443	Genome-wide association study identifies multiple loci associated with both mammographic density and breast cancer risk.	Mammographic density (dense area)	7,600 European ancestry individuals	343 European ancestry individuals, 1,472 Old Order Amish individuals, 8,564 individuals	7q21.11	7	78285026	MAGI2	MAGI2			9863			rs798336-T	rs798336	0	798336	intron_variant	0	0.88	2E-6	5.698970004336019				Affymetrix, Illumina [~ 2500000] (imputed)	N
2015-06-12	25342443	Lindstrom S	2014-10-24	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25342443	Genome-wide association study identifies multiple loci associated with both mammographic density and breast cancer risk.	Mammographic density (dense area)	7,600 European ancestry individuals	343 European ancestry individuals, 1,472 Old Order Amish individuals, 8,564 individuals	10q21.2	10	62518923	ZNF365	ZNF365			22891			rs10995190-A	rs10995190	0	10995190	intron_variant	0	0.16	1E-16	16.0		0.24	[0.18-0.30] unit decrease	Affymetrix, Illumina [~ 2500000] (imputed)	N
2015-06-12	25342443	Lindstrom S	2014-10-24	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25342443	Genome-wide association study identifies multiple loci associated with both mammographic density and breast cancer risk.	Mammographic density (dense area)	7,600 European ancestry individuals	343 European ancestry individuals, 1,472 Old Order Amish individuals, 8,564 individuals	11p15.5	11	1887776	LSP1, TNNT3	LSP1			4046			rs3817198-C	rs3817198	0	3817198	intron_variant	0	0.66	1E-10	10.0		0.14	[0.081-0.199] unit increase	Affymetrix, Illumina [~ 2500000] (imputed)	N
2015-06-12	25342443	Lindstrom S	2014-10-24	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25342443	Genome-wide association study identifies multiple loci associated with both mammographic density and breast cancer risk.	Mammographic density (dense area)	7,600 European ancestry individuals	343 European ancestry individuals, 1,472 Old Order Amish individuals, 8,564 individuals	12p12.1	12	26293692	intergenic	LOC105369705			105369705			rs11836164-T	rs11836164	0	11836164	intron_variant	0	0.77	1E-7	7.0				Affymetrix, Illumina [~ 2500000] (imputed)	N
2015-06-12	25342443	Lindstrom S	2014-10-24	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25342443	Genome-wide association study identifies multiple loci associated with both mammographic density and breast cancer risk.	Mammographic density (dense area)	7,600 European ancestry individuals	343 European ancestry individuals, 1,472 Old Order Amish individuals, 8,564 individuals	12q23.2	12	102618116	IGF1	LOC105369944			105369944			rs703556-A	rs703556	0	703556	intergenic_variant	0	0.98	4E-10	9.397940008672037		0.41	[0.25-0.57] unit decrease	Affymetrix, Illumina [~ 2500000] (imputed)	N
2015-06-12	25342443	Lindstrom S	2014-10-24	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25342443	Genome-wide association study identifies multiple loci associated with both mammographic density and breast cancer risk.	Mammographic density (dense area)	7,600 European ancestry individuals	343 European ancestry individuals, 1,472 Old Order Amish individuals, 8,564 individuals	20p12.2	20	11016263	C20orf187	C20orf187			728434			rs6104691-A	rs6104691	0	6104691	intergenic_variant	0	0.34	1E-6	6.0				Affymetrix, Illumina [~ 2500000] (imputed)	N
2015-06-12	25342443	Lindstrom S	2014-10-24	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25342443	Genome-wide association study identifies multiple loci associated with both mammographic density and breast cancer risk.	Mammographic density (dense area)	7,600 European ancestry individuals	343 European ancestry individuals, 1,472 Old Order Amish individuals, 8,564 individuals	22q13.1	22	38232300	TMEM184B, PLA2G6	TMEM184B			25829			rs7289126-A	rs7289126	0	7289126	intron_variant	0	0.4	3E-8	7.522878745280337		0.11	[0.071-0.149] unit decrease	Affymetrix, Illumina [~ 2500000] (imputed)	N
2015-06-12	25342443	Lindstrom S	2014-10-24	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25342443	Genome-wide association study identifies multiple loci associated with both mammographic density and breast cancer risk.	Mammographic density (dense area)	7,600 European ancestry individuals	343 European ancestry individuals, 1,472 Old Order Amish individuals, 8,564 individuals	22q13.1	22	40382227	SGSM3, MKL1, TNRC6B	SGSM3, ADSL, LOC107985538			27352, 158, 107985538			rs17001868-A	rs17001868	0	17001868	intron_variant	0	0.92	2E-13	12.698970004336019		0.18	[0.12-0.24] unit decrease	Affymetrix, Illumina [~ 2500000] (imputed)	N
2015-06-12	25342443	Lindstrom S	2014-10-24	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25342443	Genome-wide association study identifies multiple loci associated with both mammographic density and breast cancer risk.	Mammographic density (non-dense area)	7,600 European ancestry individuals	343 European ancestry individuals, 1,472 Old Order Amish individuals, 8,564 individuals	6p25.1	6	6751826	intergenic	LOC101928004			101928004			rs1294438-T	rs1294438	0	1294438	regulatory_region_variant	0	0.34	1E-6	6.0				Affymetrix, Illumina [~ 2500000] (imputed)	N
2015-06-12	25342443	Lindstrom S	2014-10-24	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25342443	Genome-wide association study identifies multiple loci associated with both mammographic density and breast cancer risk.	Mammographic density (non-dense area)	7,600 European ancestry individuals	343 European ancestry individuals, 1,472 Old Order Amish individuals, 8,564 individuals	7p12.3	7	46905209	intergenic	EPS15P1 - LOC105375267	55380	105375267		121689	64481	rs2190016-T	rs2190016	0	2190016	intron_variant	1	0.62	3E-6	5.522878745280337				Affymetrix, Illumina [~ 2500000] (imputed)	N
2015-06-12	25342443	Lindstrom S	2014-10-24	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25342443	Genome-wide association study identifies multiple loci associated with both mammographic density and breast cancer risk.	Mammographic density (non-dense area)	7,600 European ancestry individuals	343 European ancestry individuals, 1,472 Old Order Amish individuals, 8,564 individuals	8p11.23	8	36988591	intergenic	RPL26P25 - LOC105379377	100270966	105379377		93	77543	rs7816345-T	rs7816345	0	7816345	upstream_gene_variant	1	0.18	2E-23	22.69897000433602		0.24	[0.18-0.30] unit decrease	Affymetrix, Illumina [~ 2500000] (imputed)	N
2015-06-12	25342443	Lindstrom S	2014-10-24	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25342443	Genome-wide association study identifies multiple loci associated with both mammographic density and breast cancer risk.	Mammographic density (non-dense area)	7,600 European ancestry individuals	343 European ancestry individuals, 1,472 Old Order Amish individuals, 8,564 individuals	9p13.3	9	35758581	intergenic	NPR2			4882			rs10814275-A	rs10814275	0	10814275	upstream_gene_variant	0	0.95	6E-7	6.221848749616356				Affymetrix, Illumina [~ 2500000] (imputed)	N
2015-06-12	25342443	Lindstrom S	2014-10-24	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25342443	Genome-wide association study identifies multiple loci associated with both mammographic density and breast cancer risk.	Mammographic density (non-dense area)	7,600 European ancestry individuals	343 European ancestry individuals, 1,472 Old Order Amish individuals, 8,564 individuals	10q21.1	10	51695802	PRKG1, CSTF2T	CSTF2T, PRKG1			23283, 5592			rs14168-A	rs14168	0	14168	3_prime_UTR_variant	0	0.94	3E-6	5.522878745280337				Affymetrix, Illumina [~ 2500000] (imputed)	N
2015-06-12	25342443	Lindstrom S	2014-10-24	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25342443	Genome-wide association study identifies multiple loci associated with both mammographic density and breast cancer risk.	Mammographic density (non-dense area)	7,600 European ancestry individuals	343 European ancestry individuals, 1,472 Old Order Amish individuals, 8,564 individuals	10q21.2	10	62459241	ZNF365	ZNF365			22891			rs12220488-A	rs12220488	0	12220488	intron_variant	0	0.55	8E-7	6.096910013008056				Affymetrix, Illumina [~ 2500000] (imputed)	N
2015-06-12	25342443	Lindstrom S	2014-10-24	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25342443	Genome-wide association study identifies multiple loci associated with both mammographic density and breast cancer risk.	Mammographic density (non-dense area)	7,600 European ancestry individuals	343 European ancestry individuals, 1,472 Old Order Amish individuals, 8,564 individuals	10q25.1	10	107620506	intergenic	RNA5SP326 - LOC101927573	100873592	101927573		158837	69047	rs10884482-T	rs10884482	0	10884482	intergenic_variant	1	0.07	6E-8	7.221848749616356				Affymetrix, Illumina [~ 2500000] (imputed)	N
2015-06-12	25342443	Lindstrom S	2014-10-24	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25342443	Genome-wide association study identifies multiple loci associated with both mammographic density and breast cancer risk.	Mammographic density (non-dense area)	7,600 European ancestry individuals	343 European ancestry individuals, 1,472 Old Order Amish individuals, 8,564 individuals	14q12	14	26201719	intergenic	LOC107984700 - CYB5AP5	107984700	100289051		363187	6243	rs1546939-T	rs1546939	0	1546939	intergenic_variant	1	0.37	9E-6	5.045757490560675				Affymetrix, Illumina [~ 2500000] (imputed)	N
2015-06-13	25342443	Lindstrom S	2014-10-24	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25342443	Genome-wide association study identifies multiple loci associated with both mammographic density and breast cancer risk.	Percent mammographic density	7,916 European ancestry individuals	343 European ancestry individuals, 1,472 Old Order Amish individuals, 8,564 individuals	5q23.2	5	123118610	PRDM6	PRDM6			93166			rs186749-A	rs186749	0	186749	intron_variant	0	0.28	3E-9	8.522878745280337		0.1	[0.061-0.139] unit increase	Affymetrix, Illumina [~ 2500000] (imputed)	N
2015-06-13	25342443	Lindstrom S	2014-10-24	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25342443	Genome-wide association study identifies multiple loci associated with both mammographic density and breast cancer risk.	Percent mammographic density	7,916 European ancestry individuals	343 European ancestry individuals, 1,472 Old Order Amish individuals, 8,564 individuals	8p11.23	8	36988591	intergenic	RPL26P25 - LOC105379377	100270966	105379377		93	77543	rs7816345-T	rs7816345	0	7816345	upstream_gene_variant	1	0.18	5E-8	7.301029995663981		0.08	[0.041-0.119] unit increase	Affymetrix, Illumina [~ 2500000] (imputed)	N
2015-06-13	25342443	Lindstrom S	2014-10-24	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25342443	Genome-wide association study identifies multiple loci associated with both mammographic density and breast cancer risk.	Percent mammographic density	7,916 European ancestry individuals	343 European ancestry individuals, 1,472 Old Order Amish individuals, 8,564 individuals	9q31.2	9	107621302	intergenic	LOC105376205			105376205			rs1110403-A	rs1110403	0	1110403	intergenic_variant	0	0.58	7E-6	5.154901959985743				Affymetrix, Illumina [~ 2500000] (imputed)	N
2015-06-13	25342443	Lindstrom S	2014-10-24	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25342443	Genome-wide association study identifies multiple loci associated with both mammographic density and breast cancer risk.	Percent mammographic density	7,916 European ancestry individuals	343 European ancestry individuals, 1,472 Old Order Amish individuals, 8,564 individuals	10q21.2	10	62498069	ZNF365	ZNF365			22891			rs10509168-T	rs10509168	0	10509168	intron_variant	0	0.41	1E-9	9.0				Affymetrix, Illumina [~ 2500000] (imputed)	N
2015-06-13	25342443	Lindstrom S	2014-10-24	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25342443	Genome-wide association study identifies multiple loci associated with both mammographic density and breast cancer risk.	Percent mammographic density	7,916 European ancestry individuals	343 European ancestry individuals, 1,472 Old Order Amish individuals, 8,564 individuals	22q13.1	22	38232300	TMEM184B, PLA2G6	TMEM184B			25829			rs7289126-A	rs7289126	0	7289126	intron_variant	0	0.4	5E-9	8.301029995663981		0.1	[0.061-0.139] unit decrease	Affymetrix, Illumina [~ 2500000] (imputed)	N
2017-09-28	28763429	Serie DJ	2017-07-31	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/28763429	Genome-wide association study of cardiotoxicity in the NCCTG N9831 (Alliance) adjuvant trastuzumab trial.	Change in LVEF in response to paclitaxel and trastuzumab in HER2+ breast cancer	800 European ancestry cases	NA	4p15.32	4	16501144	LDB2	LOC105374505			105374505			rs55756123-?	rs55756123	0	55756123	intron_variant	0	NR	9E-8	7.045757490560675		6.11	[3.89-8.32] unit decrease	Affymetrix [618793]	N
2017-09-28	28763429	Serie DJ	2017-07-31	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/28763429	Genome-wide association study of cardiotoxicity in the NCCTG N9831 (Alliance) adjuvant trastuzumab trial.	Change in LVEF in response to paclitaxel and trastuzumab in HER2+ breast cancer	800 European ancestry cases	NA	9q33.1	9	119096829	BRINP1	LOC101928849 - BRINP1	101928849	1620		113169	69801	rs10117876-?	rs10117876	0	10117876	intergenic_variant	1	NR	6E-7	6.221848749616356		7.79	[4.76-10.82] unit decrease	Affymetrix [618793]	N
2017-09-28	28763429	Serie DJ	2017-07-31	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/28763429	Genome-wide association study of cardiotoxicity in the NCCTG N9831 (Alliance) adjuvant trastuzumab trial.	Change in LVEF in response to paclitaxel and trastuzumab in HER2+ breast cancer	800 European ancestry cases	NA	6p22.3	6	22957508	intergenic	LOC105374972 - LOC105374974	105374972	105374974		239584	99229	rs4305714-?	rs4305714	0	4305714	intron_variant	1	NR	1E-6	6.0		1.87	[1.12-2.63] unit decrease	Affymetrix [618793]	N
2017-09-28	28763429	Serie DJ	2017-07-31	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/28763429	Genome-wide association study of cardiotoxicity in the NCCTG N9831 (Alliance) adjuvant trastuzumab trial.	Change in LVEF in response to paclitaxel and trastuzumab in HER2+ breast cancer	800 European ancestry cases	NA	20q13.32	20	58367256	RAB22A	RAB22A			57403			rs707557-?	rs707557	0	707557	3_prime_UTR_variant	0	NR	6E-6	5.221848749616356		1.46	[0.83-2.08] unit increase	Affymetrix [618793]	N
2017-09-28	28763429	Serie DJ	2017-07-31	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/28763429	Genome-wide association study of cardiotoxicity in the NCCTG N9831 (Alliance) adjuvant trastuzumab trial.	Change in LVEF in response to paclitaxel and trastuzumab in HER2+ breast cancer	800 European ancestry cases	NA	11q22.1	11	101582777	TRPC6	TRPC6			7225			rs77679196-?	rs77679196	0	77679196	intron_variant	0	NR	8E-6	5.096910013008056		7.0	[3.96-10.05] unit decrease	Affymetrix [618793]	N
2017-09-28	28763429	Serie DJ	2017-07-31	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/28763429	Genome-wide association study of cardiotoxicity in the NCCTG N9831 (Alliance) adjuvant trastuzumab trial.	Change in LVEF in response to paclitaxel and trastuzumab in HER2+ breast cancer	800 European ancestry cases	NA	4q35.2	4	188634793	LINC01060	LINC01060 - HSPA8P12	401164	100420038		32885	78851	rs7698718-?	rs7698718	0	7698718	intron_variant	1	NR	8E-6	5.096910013008056		1.78	[1.01-2.56] unit increase	Affymetrix [618793]	N
2012-07-11	22532574	Stevens KN	2012-04-24	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/22532574	Identification of a novel percent mammographic density locus at 12q24.	Percent mammographic density	1,241 European ancestry female individuals	9,126 European ancestry individuals	12q24.21	12	114430333	TBX5, TBX3	LOC105369998			105369998			rs1265507-?	rs1265507	0	1265507	regulatory_region_variant	0	NR	1E-8	8.0				Illumina [2510880]	N
